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Abstract 
 
A stereoselective approach has been developed for the flexible synthesis of substituted 2-
pyrrolidones and 2-piperidones. By employing the key Overman rearrangement, efficient 
transfer of stereochemistry was achieved, and an acylation and ring closing metathesis 
strategy afforded a library of target N-heterocycles. 
 
 
 
In addition, the optimisation of a synthesis of 4-oxopipecolic acid derivatives from L-
aspartic acid was investigated. A novel, milder and higher yielding 6-endo-trig cyclisation 
procedure was developed. This allowed for the generation of a library of 2,6-cis-substituted 
4-oxopipecolic derivatives. Stereoselective carbonyl reduction extended the synthesis 
further to include 4-hydroxypipecolic acid derivatives. 
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1  Introduction 
 
1.1  2-Pyrrolidones and 2-Piperidones as Synthetic Targets 
 
Heterocycles are structures of great importance throughout the natural and synthetic worlds 
of chemistry. The wide variety of structures that fall under the heterocycle banner are 
compounds ranging from natural products isolated from marine species to man-made 
polymers, and as a result their synthesis has received substantial attention in the 
literature.
1,2,3
 Our contribution to heterocycle synthesis includes novel methodology 
towards substituted 2-pyrrolidones and 2-piperidones, also known as - and -lactams 
respectively. Both these moieties can be found in a variety of biologically active 
compounds. Examples of the 2-pyrrolidone moiety in interesting target molecules can be 
found in Figure 1. Levetiracetam 1 is an anticonvulsant drug used in the treatment of 
epileptic seizures.
4
 Although the exact mechanism of action is unknown, it is believed to 
bind to synaptic vesicle protein SVA2, and integral membrane protein found on every 
synaptic vesicle, and in doing so impedes nerve conduction. Reutericyclin 2 is a product of 
Lactobacillus reuteri bacteria that shows promising antibacterial activity against Gram-
positive strains, including Clostridium difficile, and is believed to have potential 
therapeutic value.
5
 Glimepiride 3 is an antidiabetic sulfonylurea drug that increases insulin 
production in the pancreas and the activity of intracellular insulin receptors.
6 
 
 
 
 
Figure 1: 2-Pyrrolidone containing compounds 
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The 2-piperidone moiety is also a component of several compounds of interest (Figure 2). 
Finasteride 4 is an inhibitor of 5-reductase, an enzyme that converts testosterone to 
dihydrotestosterone, and is used in the treatment of benign prostatic hyperplasia and male 
pattern baldness.
7
 Apixaban 5 is a compound currently undergoing clinical trials as a 
treatment for venous thromboembolism.
8
 Compound UK-224,671 6 is a potent antagonist 
of the neurokinin 2 (NK2) receptor. The NK2 receptor is known to be involved in 
numerous pathways in the central nervous system, and antagonists have been postulated as 
potential therapies for psychiatric disorders.
9
 The aforementioned compounds comprise a 
small selection of the range of biologically, synthetically and commercially useful 
compounds that bear the 2-pyrrolidone and 2-piperidone motifs. In addition, these moieties 
are often utilised as an intermediate in the synthesis of piperidines and pyrrolidines, which 
are in turn present in a wide array of useful compounds.  
 
 
 
Figure 2: 2-Piperidone containing compounds 
 
As a result of their synthetic utility and frequent presence in biologically active 
compounds, the synthesis of the 2-pyrrolidone and 2-piperidone moieties has received 
substantial attention in the literature for several decades.
10, 11, 12
 Although they are 
 12 
relatively simple structures, a diverse array of chemistry has been employed in their 
synthesis. This is perhaps due to the high level of substitution possible around the core of 
the 2-pyrrolidone and 2-piperidone rings, and the natural progression towards more 
stereoselective syntheses observed throughout the majority of the synthetic organic 
literature. The syntheses presented below are not intended to provide an exhaustive list of 
possible synthetic routes to 2-pyrrolidone and 2-piperidone based structures, but to 
illustrate some generalised approaches that have been used to access the aforementioned 
moieties. 
 13 
 
1.2  Synthesis of 2-Pyrrolidones 
 
1.2.1  Lactamisation 
 
An attractive synthetic approach towards 2-pyrrolidones is the lactamisation of γ-
aminobutyric acid and derivatives thereof. With suitable compounds, this cyclisation can 
be remarkably straightforward, as demonstrated by Rigo and co-workers (Scheme 1).
13
 
Reductive amination with a range of aryl aldehydes was conducted on the 
triethylammonium salt of glutamic acid 7. Following acidification to the carboxylic acid 8, 
cyclisation was effected by stirring under reflux in ethanol or water to afford the 5-
carboxylic acid-2-pyrrolidone 9 in good yield. 
 
 
 
Scheme 1: Cyclisation of glutamic acid derivatives 
 
Similar transformations were conducted in an arguably more efficient manner by Kambe 
and co-workers by combining the reductive amination and cyclisation in one step (Scheme 
2).
14
 Employing N-Boc-D-glutamic acid derivative 10, a number of transformations led to 
allylic alcohol 11. Imine formation with 2-(4-bromophenyl)acetaldehyde, followed by 
reduction with sodium triacetoxyborohydride effected cyclisation with the ester moiety; 
overall, an N-alkylation and cyclisation in a one-pot process, affording lactam 12. This 
compound and a number of others with similar structural backbones were synthesised by 
Kambe to investigate their potential as prostaglandin mimetics. A key component of this 
strategy was the substitution of the naturally occurring γ-hydroxycyclopentanone moiety 
with the 2-pyrrolidinone core in an attempt to increase selectivity and stability. 
 14 
 
 
Scheme 2: Synthesis of prostaglandin mimetics 
 
Lactamisation has also been observed occurring in situ upon the generation of appropriate 
functionality within the precursor, as exemplified by Schmidt and co-workers (Scheme 
3).
15
 Investigation of the cross metathesis between acetal diene 14 and methyl acrylate lead 
to conditions that favoured the formation of mono-cross-metathesis product 15. The ,-
unsaturated ester allowed for the 1,4-addition of nitromethane, forming nitroalkane 16 as a 
single diastereomer in excellent yield. Nitro reduction was then investigated; 
hydrogenation over palladium/carbon afforded the cyclised lactam 18 in 45% yield, but the 
uncyclised free amine 17 was also isolated in 24% yield. This could be cyclised under 
basic conditions, albeit in modest yield. Alternatively, nitro reduction could be effected by 
employing zinc and acetic acid. This formed exclusively the lactam product, but in a 
moderate 47% yield. Whilst this procedure may be relatively low yielding, it may be fairer 
to consider it a two-step, one-pot procedure that reduces the amount of practical 
manipulation required. 
 
 15 
 
 
Scheme 3: Nitro reduction and cyclisation 
 
The coupling of an amine and a carboxylic acid to form the amide bond using 
carbodiimides and similar reagents is most commonly utilised in the synthesis of peptides, 
but as demonstrated by Yu and co-workers, it also finds utility in the cyclisation of lactams 
(Scheme 4).
16
 This methodology can be found in their synthesis of compound 27, a 
precursor to the cardiac anti-arrythmic drug vernakalant (Brinavess). Reaction of the meso 
compound epoxy cyclohexane 19 with aqueous ammonia followed by N-protection with 
benzyl chloroformate, silyl protection of the hydroxyl with TBDMS-Cl then Cbz removal 
by hydrogenation led to racemic 21. Separately, enantiopure chloroester 23 was 
synthesised from commercially available ethyl (R)-4-chloro-3-hydroxybutanoate by 
reaction with benzyl bromide in the presence of silver oxide. Chloroester 23 was treated 
with potassium iodide and used to N-alkylate amine 21. Saponification with sodium 
hydroxide afforded the carboxylic acid, which was cyclised with the amino moiety using 
 16 
DCC and DMAP. The lactam diastereomers 25 and 26 were easily separable by column 
chromatography. This is reported as a significant benefit over previous syntheses; the 
original medicinal chemistry route required multiple chiral resolutions, and a later route 
used chiral ligands or boranes that were difficult to recycle. Acidic desilylation and hydride 
amide reduction led to the desired synthetic intermediate 27. 
 
 
 
Scheme 4: DCC coupling for the formation of lactams 
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1.2.2  Intramolecular Nucleophilic Substitution 
 
Intramolecular nucleophilic substitution can be utilised as a cyclisation technique, as 
demonstrated by Postel and co-workers (Scheme 5).
17
 Their study of the cyclopropanation 
of nitriles necessitated the protection of primary amine 28 as a tertiary amide, and the 2-
pyrrolidone moiety was trialled in this role. Synthesis proved facile; amine acylation with 
4-bromobutyryl chloride followed by amide deprotonation with sodium hydride and 
subsequent cyclisation afforded the desired compounds in good yield. 
 
 
 
Scheme 5: Intramolecular cyclisation 
 
1.2.3  Ring-Closing Metathesis 
 
Whilst ring-closing metathesis (RCM) reactions are often applied to the synthesis of 
medium and large sized rings, the have also been utilised in the synthesis of smaller γ-
lactam derivatives. Hanessian and co-workers used RCM reactions to good effect in their 
synthesis of an inhibitor for aspartyl protease β-secretase (BACE-1), an enzyme implicated 
in the pathogenesis of Alzheimer’s disease (Scheme 6).18 Nitro hydrogenation of 
substituted cyclohexane 31 afforded the primary amine derivative. Alkylation with allyl 
bromide followed by acylation with acryloyl chloride afforded the diene precursor 33. 
Grubbs 1
st
 generation catalyst mediated RCM then afforded the unsaturated γ-lactam 
intermediate 34 in good yield.  
 
 18 
 
 
Scheme 6: RCM in the synthesis of BACE-1 inhibitor 
 
The ring-closing metathesis of diene amides as exemplified above is often facile, and in 
some cases a greater challenge is experienced in the synthesis of the precursors, as was 
found by Lee and co-workers.
19
 In this work, an intermediate in the synthesis of a variety 
of lactams was chiral allylic amine 37 generated from the iridium catalysed amination of 
allylic carbonates (Scheme 7). Once the regioselective difficulties of the amination were 
investigated, it was found that O-alkylated allylic methyl carbonate 35 could undergo 
amination with benzylamine in the presence of [Ir(COD)Cl]2 and Feringa’s 
phosphoramidite chiral ligand
20
 36 to afford allyl amine 37 in excellent yield and 
stereoselectivity. Alkylation with bromoalkenes afforded diene precursors to aza-cycles. 
More relevant to this discussion, acylation with acyl chlorides afforded amide dienes such 
as 38 that cyclised smoothly in the presence of Grubbs 2
nd
 generation catalyst to afford a 
small range of lactams, including unsaturated 2-pyrrolidone 39. 
 
 19 
 
 
Scheme 7: Iridium catalysed amination and subsequent RCM 
 
While the mainstay of ruthenium alkylidene catalysts is metathesis, several non-metathetic 
reactions have been noted, often originally as unintended side reactions. However, in some 
cases, these side reactions can be exploited to become useful methodologies in their own 
right. This was demonstrated in the tandem RCM/isomerisation/N-acyliminium cyclisation 
published by Nielsen and co-workers (Scheme 8).
21
 Reaction of dienes containing a 
tethered nucleophile 40–43 with Hoveyda-Grubbs 1st generation catalyst in refluxing m-
xylene afforded polycyclic compounds 45–48. The presence of a stereocentre in substrates 
41 and 42 promoted a diastereoselective cyclisation, forming 46 and 47 with reasonable 
selectivity. Product 49 demonstrates the scope of the reaction to include intermolecular 
nucleophilic additions. 
 
 20 
 
 
Scheme 8: Tandem RCM/isomerisation/N-acyliminium cyclisation 
 
Manipulation of the reaction conditions yielded results that alluded to some mechanistic 
properties of the reaction (Scheme 9a). Reaction of the diene for a reduced amount of time 
at 60 °C rather than under reflux afforded the metathesis product 50 only. Reflux of 50 in 
m-xylene only afforded a 1:1 mix of diene and tetracyclic product. However, addition of 
fresh ruthenium catalyst afforded a quantitative conversion to 45, as did the use of 
trifluoroacetic acid. This suggested that while a background thermal isomerisation does 
 21 
occur, addition of acid or ruthenium catalyst accelerates the reaction. As TFA promotes 
tetracycle formation as effectively as the ruthenium catalyst, this suggested that the 
ruthenium in some way effects tautomerisation rather than a ruthenium hydride species 
being involved. The isomerisation shown in Scheme 9b was proposed. 
 
 
 
 
 
Scheme 9: Investigations into the tandem RCM/isomerisation/N-acyliminium cyclisation 
 
1.2.4  Oxidation of Pyrrolidine 
 
Whilst it is common to see reduction of pyrrolidones and piperidones to pyrrolidines and 
piperidines respectively, it is possible to perform the reverse transformation. This was 
utilised by Correia and co-workers in their synthesis of rolipram, a phosphodiesterase IV 
 22 
(PDE4) inhibitor that shows promising anti-inflammatory and anti-depressant properties 
(Scheme 10).
22
 Their synthesis began with 2-methoxy-5-nitrophenol, which after a number 
of straightforward reactions was converted to the aryldiazonium tetrafluoroborate 57. 
Coupling of 57 with N-Boc-3-pyrroline 58 in a Heck-Matsuda reaction afforded 
intermediate 59, which under the aqueous acidic reaction conditions was hydrolysed in situ 
to lactamol 60. Oxidation of 60 using catalytic amounts of tetrapropylammonium 
perruthenate (TPAP) and NMO as a co-oxidant afforded 2-pyrrolidone 61, which after 
acidic Boc-deprotection afforded the target rolipram 62. This six step synthesis was 
performed in an overall yield of 45% and provides a cost effective and efficient route to a 
pharmacologically interesting molecule. 
 
 
 
Scheme 10: Synthesis of rolipram 
 
1.2.5  C-3 to C-4 Disconnections 
 
The retrosynthetic strategy of disconnection between the C-3 and C-4 of 2-pyrrolidone has 
received attention; for example, the palladium catalysed intramolecular allylation reported 
by Poli and co-workers (Scheme 11).
23
 Benzylamine was alkylated with freshly prepared 
(Z)-1-acetoxy-4-chloro-but-2-ene 63, then acylated with methyl malonyl chloride to afford 
enamide 65. Investigations into cyclisation conditions revealed Pd2(dba)2/PPh3 as the most 
 23 
suitable catalyst for the formation of the -allyl-palladium complex, and potassium 
acetate/bis(trimethylsilyl)acetamide (BSA), the most effective base mixture for enolisation. 
These conditions afforded pyrrolidone 67 in good yield and solely the anti-diastereomer 
was detected in the product. The absence of a potentially competing 7-endo-trig product 
shows complete favour for the observed 5-exo-trig cyclisation process. Substitution of the 
malonyl chloride with acid chlorides bearing various electron withdrawing groups such as 
nitrile, acetyl and phenylsulfonyl gave analogous 2-pyrrolidones in comparable yields. 
 
 
 
Scheme 11: Palladium catalysed intramolecular allylation 
 
More recently, Poli and Prestat published a further refined intramolecular allylation 
domino reaction, allowing the synthesis of 4-styryl substituted 2-pyrrolidones (Scheme 
12).
24
 In this work, the allyl acetate is replaced by an allene, which undergoes 
carbopalladation followed by nucleophilic addition to afford compounds of the type 
represented by 69. The reaction was shown to have a broad scope in terms of substituents 
and nature of the coupling aryl iodide, as analogues 70–78 illustrate. As above, the 5-exo-
trig cyclisation and selectivity for the trans-diastereomer was displayed. The slightly 
unusual catalyst system using n-butyl lithium as an in situ reducing agent was trialled as a 
phosphine free alternative, and afforded improved yields. The addition of 
tetrabutylammonium bromide was also found to improve yields, as previously described in 
the literature.
25
 
 
 24 
 
 
Scheme 12: Carbopalladation and allylic alkylation domino sequence 
 
The catalytic cycle proposed by Poli and Prestat is shown below (Scheme 13). Oxidative 
addition of palladium(0) to the aryl iodide forms the aryl palladium species 79. This 
species coordinates to the allene, which undergoes carbopalladation to form π-allyl 
palladium intermediate 82. This undergoes nucleophilic attack by the deprotonated β-
carbonyl amide forming the desired 2-pyrrolidone and releasing [Pd
0
]. 
 25 
 
 
Scheme 13: Proposed mechanistic cycle for carbopalladation and allylic alkylation 
 
1.2.6  Radical Mediated Cyclisations 
 
Transition metal catalysed atom transfer radical cyclisation (ATRC) reactions have 
recently been the subject of increased interest. Copper complexes have been most 
extensively investigated for these reactions, but studies into ruthenium and iron based 
complexes have also been published. The basic transformation is depicted in Scheme 14; 
transition metal mediated halogen (X) abstraction from an alkyl halide forms an alkyl 
radical 84. This cyclises onto a tethered alkene (or alkyne) forming intermediate 85 and the 
resulting radical is quenched with the metal complexed halogen, hence atom transfer. 
 26 
 
 
Scheme 14: General pathway of ATRC reactions 
 
2-Pyrrolidone analogues appear to be frequently chosen as desired products in ATRC 
investigations. As the catalytic cycles involved are thought to be understood, further 
research often focuses on increasing the efficiency of reactions, with a view to better 
suitability for industrial processes. One such study was conducted by Clark and Wilson,
26
 
who noted the relatively high loadings of Cu(I)
 
catalysts (around 30 mol%) required in 
some procedures, and suggested that this could be the result of a gradual oxidation to the 
inactive Cu(II) species throughout the reaction. While not the first investigation of 
reductive additives, their investigation of AIBN in the reaction mixture succinctly shows 
the benefits of such additives (Scheme 15). The original conditions employed to convert 
alkene 87 to 2-pyrrolidinone 88 used 30 mol% CuBr (with tripyridylamine ligand 89) and 
gave excellent yields, but lowering the catalyst concentration to a more commercially 
favourable 1 mol% led to a substantial drop. Whilst increasing the temperature to 50 °C 
shows marginal improvement, addition of just 10 mol% of AIBN returns the yield to 
100%. Additionally, the reaction ran with 1 mol% of the more stable CuBr2 replacing 
CuBr, with equally impressive results.  
 27 
 
 
Scheme 15: AIBN as a reductive additive in ATRC reactions 
 
Clark also increased the industrial appeal of the Cu(I) mediated ATRC by investigating the 
use of solid supported ligands and catalyst.
27
 A range of ligands on three types of solid 
support (Si – silica, P – cross-linked polystyrene and JJ – JandaJel) were investigated. The 
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variation in the mmols of complex per gram of support. Having completed this analysis 
however, the quantity of catalyst per reaction could be kept constant at 30 mol%.  Their 
results showed that that support type had little effect on yield (Scheme 16). For example, in 
Scheme 16a, using the PMI ligand on all three support types (92–94) showed minor 
variation in yield, and this was broadly true throughout the study. The cyclisation of 95 in 
Scheme 16b reveals a drawback of the heterogenous catalyst system. In comparison to the 
homogenous solution catalyst 97, the solid supported variety 98 afforded no product at 
room temperature and required heating to afford a similar result.  
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Scheme 16: Investigation of solid supported catalysts in ATRC reactions 
 
 
 
 
 
 
 29 
1.3 Synthesis of 2-piperidones 
 
1.3.1  Lactamisation 
 
Similarly to the 2-pyrrolidones, an obvious disconnection in the retrosynthesis of 2-
piperidones for the organic chemist lies in the amide bond, affording the straight -
carboxy -amino synthon. Indeed, a review of the literature shows that a simple 
lactamisation has been utilised in a variety of syntheses to afford the desired heterocycle.  
 
An acid catalysed lactamisation was employed by Stevenson and co-workers as part of 
their synthesis of pumiliotoxin alkaloids, a range of related compounds originally isolated 
from Dendrobates frogs (Scheme 17).
28
 Starting from the commercially available (S)-2-
aminoadipic acid 99, a diesterification followed by reductive amination of the amine 
afforded the N-benzyl amino diester 100. Heating under reflux with ‘a few drops’ of acetic 
acid afforded 2-piperidone 101 after four days in 86% yield. Subsequent transformations 
led to 1,1-disubstituted alkene containing compound 103, which was further functionalised 
and subjected to intramolecular Heck reaction, ultimately leading to homopumiliotoxin 
233F (104). Although the piperidone was used to access the corresponding piperidine by 
carbonyl reduction (which, as previously mentioned, is not uncommon throughout the 
literature), the amide moiety was beneficial to the synthetic strategy; the group note that 
amines can prove problematic in palladium catalysed reactions, hence the amide 
functionality was deliberately chosen to help circumvent this issue. 
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Scheme 17: Synthesis of homopumiliotoxin 233F 
 
Equally as straightforward, mild basic conditions have also been used to promote 
lactamisation. This is demonstrated by Abe and co-workers in the first synthesis of 
sulphostin, which included the determination of absolute configuration.
29
 Sulphostin, a 
compound isolated from a Streptomyces cultural broth, is an inhibitor of dipeptidyl 
peptidase IV (DPP-IV), a peptide cleavage enzyme involved in the mechanisms of diabetic 
and immune disorders. As the absolute configuration of naturally occurring sulphostin was 
unknown, all four possible stereoisomers were synthesised and their spectra and in vitro 
activity were compared with the extracted samples to determine the correct configuration 
(Scheme 18). Both stereoisomers of ornithine hydrochloride 105 were (individually) 
protected as the methyl esters, and the resulting dihydrochloride salts were treated with 
sodium hydrogencarbonate to effect lactamisation to both enantiomers of 2-piperidone 
107. This was followed by the protection of the primary amine with a Cbz group. Reaction 
with phosphorous oxychloride and ammonia afforded compounds 108, which were reacted 
with sulphur trioxide-pyridine complex then sodium hydrogencarbonate to afford all four 
stereoisomers of 109. Separation of each set of diastereomers by column chromatography 
was found to be incomplete. However, reaction with the appropriate enantiomer of 1-
phenylethylamine hydrochloride allowed for complete separation of the subsequently 
formed salts. Hydrogenation removed the Cbz protecting group to afford each sulphostin 
stereoisomer. Comparison with natural compound data allowed the group to propose that 
the C-3-S and phosphorous-R isomer 110a was the natural configuration.  
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Scheme 18: Synthesis of all four stereoisomers of sulphostin 
 
1.3.2 Intramolecular Nucleophilic Substitution 
 
An attractive synthetic strategy for the preparation of 2-piperidones is intramolecular 
amide N-alkylation. In this approach, the presence of a hydroxyl group on the C-6 carbon 
of the straight chain cyclisation precursor to the 2-piperidone allows for the use of 
Mitsunobu-type reactions. This was demonstrated by Malachowski and co-workers in their 
work on a generalised synthesis towards -, -, and -lactams for incorporation into 
peptidomimetic structures (Scheme 19).
30
 Considering specifically the synthesis of the -
lactam, a few high-yielding transformations starting from L-glutamic acid 111 afforded the 
Mitsunobu substrate 112. Reaction of this substrate with triphenylphosphine and di-tert-
butyl azodicarboxylate (DBAD) afforded the cyclised compound 113 in a highly 
satisfactory 82% yield. In addition to demonstrating a general synthesis of homologous 
lactams from enantiopure and relatively inexpensive starting materials, this work 
demonstrated the utility of the 2-piperidone motif in peptidomimetics. 
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Scheme 19: Synthesis of a substituted -lactam 
 
An alternative approach to amide N-alkylation was demonstrated by Toyota and co-
workers in their diastereoselective synthesis of ()--skytanthine 117 (Scheme 20).31 Here, 
the 2-piperidone unit was accessed from the -lactone 114. Reaction with methylamine at 
high temperature opened the lactone ring to afford the -hydroxyamide 115. Previous work 
by the group had found that Mitsunobu-type conditions on this type of substrate gave 
unsatisfactory yields. However, use of phosphorous oxychloride led to substantial 
improvements, in this case affording the cyclised piperidone 116 in 73% yield. 
 
 
 
Scheme 20: Synthesis of ()--skytanthine 
 
Amide alkylation need not employ leaving groups or Mitsunobu type reactions. Yamamoto 
demonstrated this in his work on palladium catalysed hydroamidation (Scheme 21).
32
 N-
Tosyl amides of the type represented by 118 cyclised onto aryl substituted alkynes to 
 33 
afford 6-substituted 2-piperidones 119 in the presence of acid and a palladium catalyst in 
good yield. 
 
 
 
Scheme 21: Hydroamidation of aryl alkynes 
 
Yamamoto proposed a catalytic cycle for the hydroamidation, shown in Scheme 22. 
Hydridopalladium species 120 is formed by reaction of 
tetrakis(triphenylphosphine)palladium(0) with benzoic acid. Aryl alkyne 121 undergoes 
hydropalladation by the hydridopalladium catalyst, then forms an aryl allene intermediate 
123 via -hydride elimination. The allene undergoes hydropalladation with the expelled 
hydridocatalyst to form -allylpalladium species 124. Nucleophilic attack of the 
allylpalladium system by the tosylamide forms the desired piperidone and regenerates the 
active catalyst. 
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Scheme 22: Catalytic cycle of hydroamidation 
 
1.3.3  Ring-Closing Metathesis 
 
Ring closing metathesis has developed into a powerful synthetic tool for the synthesis of 
medium and large ring sizes, and it is a viable reaction for the synthesis of 2-piperidones. 
Being a 6-membered ring, piperidone has three potential diene metathesis precursors 
leading to three unsaturated Z-piperidone analogues (Scheme 23). 
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Scheme 23: Potential diene precursors for RCM 
 
An example of the first precursor can be found in a publication by Vankar on their 
synthesis of azasugars and their intermediates (Scheme 24).
33
 Starting with D-mannitol 
derived 131, imine formation followed by a Barbier reaction with allyl bromide and zinc 
with a catalytic amount of cerium chloride afforded compound 133 as a separable 3:1 
mixture of diastereomers. This intermediate was initially alkylated for the synthesis of 
piperidines, but was also acylated with acryloyl chloride to form diene 134. Cyclisation 
with Grubbs 2
nd
 generation catalyst afforded the unsaturated piperidone 135. Following a 
number of transformations, intermediate 136 was generated, a compound which the 
authors note could be useful in the synthesis of azasugars. 
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Scheme 24: Synthesis of azasugar intermediate 
 
Analogues of the di-allyl substituted diene moiety were used by Spino and co-workers in 
the synthesis of substituted 2-piperidones alongside a variety of other heterocycles, 
carbocycles and amino acids (Scheme 25).
34
 Their syntheses began with a common starting 
material, p-menthane-3-carboxaldehyde 137, which can be synthesised as either 
enantiomer from commercially available menthone. The menthane moiety acts as a chiral 
auxillary for the stereoselective attack of the aldehyde by a variety of vinyllithium 
analogues in the presence of trimethylaluminium to form allylic alcohols 138. 
Diastereomeric ratios for the allylic alcohol products varied depending on the R group 
from 19:1 to 200:1. Trimethylaluminium was found essential to maintaining reasonable 
stereoselectivity, as analogues reacted in its absence gave diastereomer ratios of between 
2:1 and 6:1. The allylic alcohols were subjected to Mitsunobu conditions using hydrazoic 
acid as the nucleophile. Stereospecific SN2 displacement followed by an in situ 
stereoselective 3,3-sigmatropic rearrangement of the allylic azide afforded compounds 
139. The authors note that while they believe the majority of the compound reacted via this 
mechanism, it was possible that it was in competition with a SN2’ mechanism. Either way, 
the rearranged allylic azides were formed in generally excellent diastereoselectivities. 
Lithium aluminium hydride reduction of azides 139 afforded amines 140, which were 
acylated with 3-butenoic acid to form dienes 141. Ring closing metathesis with Grubbs-
Nolan catalyst afforded the cyclised piperidones in good yield with removal of the 
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menthone moiety. However, the reactions would not proceed without the presence of a 
Lewis acid, in this case PhBCl2. This was believed to be due to the coordination of the 
amide oxygen to the ruthenium carbene intermediate. 
 
 
 
Scheme 25: Synthesis of substituted 2-piperidones 
 
Finally, the use of the N-vinyl amide in ring closing metathesis appeared in a methodology 
study of piperidone synthesis by Rutjes and co-workers (Scheme 26).
35
 Unsaturated amides 
were generated by reaction of the acid chloride precursor with ammonia. Reaction of the 
amide with ethyl pyruvate 143 under Dean Stark conditions afforded the dehydroamino 
ester 144, which was N-alkylated with p-methoxybenzyl bromide. Ring closing metathesis 
was effected by Grubbs 2
nd
 generation catalyst, affording the cyclised product 145 in good 
yield. 
 
 
 
Scheme 26: Synthesis of unsaturated 2-piperidones 
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Additionally, enantiomerically pure substituted amides were generated in several steps 
from pentose-based lactones, which were used in the aforementioned synthetic pathway to 
generate substituted piperidones in moderate to good yields. The utility of the endo double 
bond was illustrated with the conversion to the iodinated enamide 146 and subsequent 
palladium catalysed coupling with a variety of coupling partners (Scheme 27). 
 
 
 
Scheme 27: Iodination and coupling of 2-piperidone derivatives 
 
1.3.4  Ring Expansion 
 
Ring rearrangement/expansion of -lactams was used by Tanaka in the synthesis of 
peptidomimetic 2-piperidones (Scheme 28).
36
 A literature procedure was used for the 
conversion of commercially available trans-4-hydroxy-L-proline 148 to the protected 
pyrrolidine azide 149. Oxidation with ruthenium oxide afforded the -lactam 150. 
Subsequent hydrogenation of the azide functionality to the free amine initiated the 
transamidation/ring expansion to form the substituted 2-piperidone 151, and further 
transformations led to the Dab-Gly surrogate peptidomimetic 152. 
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Scheme 28: Synthesis of Dab-Gly peptidomimetic 
 
1.3.5  Pericyclic Reactions 
 
The Diels-Alder reaction has received attention in the synthesis of 2-piperidones. This is 
commonly in the synthesis of fused bicyclic lactams, where the Diels-Alder reaction forms 
a carbocyclic ring in addition to completing the piperidone ring itself. In this synthetic 
strategy, it is possible to visualise two potential triene precursors types; those of the type 
exemplified by 153 with the diene unit attached to the nitrogen side, and those like 155, 
where it is attached to the carbonyl side (Scheme 29). 
 
 
 
Scheme 29: Potential triene precursors for bicyclic lactam sythesis 
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Jones and co-workers investigated the use of the Diels-Alder reaction in the synthesis of 
bicyclic fragments of the morphine structure (Scheme 30).
37
 Synthesis of the Diels-Alder 
precursor was facile; conjugate addition to an aryl vinyl ketone afforded secondary amines 
158. Amine acylation with hexa-2,4-dienoyl chloride installed the diene moiety, while 
Wittig reaction of the ketone with methylenetriphenylphosphorane afforded the alkene 
dienophile. With the trienes in hand, the Diels-Alder reaction was able to proceed in good 
yield to afford the single diastereomer 162 after isomerisation of the initial Diels-Alder 
adduct 161. After determination of the relative stereochemistries of the C-4 aryl and C-6 
methyl groups by X-ray crystallography, and with the knowledge that the E,E- geometry of 
the diene was set, it was deduced that the reaction had proceeded solely via the endo 
transition state. 
 
 
 
Scheme 30: Synthesis of bicyclic lactam morphine fragments 
 
The alternative strategy of employing a diene alkylated nitrogen as in compound 153 has 
been used by Taguchi and co-workers (Scheme 31).
38
 Their work focused on the 
development of the synthesis of bicyclic lactones via an indium(III) 
trifluoromethanesulfonate catalysed Diels-Alder reaction in aqueous media. This gave the 
Diels-Alder adduct in higher yield and selectivity than previous reaction conditions.
39
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Scheme 31: Indium triflate catalysed Diels-Alder reaction 
 
1.3.6  Domino Reactions 
 
Domino reactions are powerful tools for the synthetic chemist, and reactions can be 
designed to form multiple bonds and increase chemical complexity in a single step. 
Comesse and co-workers used a domino reaction in the formation of bicyclic lactams such 
as 165.
40
 Although the majority of examples were based on pyrrolidones, they also 
demonstrated the formation of fused bicyclic 2-piperidones (Scheme 32). The reaction of 
ethoxy methylene derivatives such as 163 with N-hydroxyalkyl haloamides like 164 in the 
presence of base resulted in the formation of three bonds in a single step.  
 
 
 
Scheme 32: Domino reactions in the synthesis of bicyclic lactams 
 
1.3.7  Radical-Mediated Reactions 
 
Syntheses of substituted heterocycles that are efficient and broad in scope are highly 
desirable in the pharmaceutical and agrochemical industries. Modern organic chemistry 
often focuses on the ability to rapidly synthesise a library of compounds containing 
substituents suitable for further elaboration. Zard and co-workers demonstrated the 
synthesis of 4-aryl-2-piperidones using radical cyclisation and transamidation (Scheme 
33).
41
 A range of xanthate esters, exemplified by dichloro compound 166, was readily 
prepared from substituted anilines. Extension of the alkyl chain with N-Boc allylamine was 
catalysed by dilauroyl peroxide (DLP). Radical cyclisation to form benzazepinone 168 was 
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initiated by di-tert-butyl peroxide (DTBP). This step also resulted in the loss of the 
methanesulfonamide protecting group, but this was not found to have a detrimental effect 
on the subsequent reactions. Trifluoroacetic acid removal of the Boc-group followed by 
cyclisation in the presence of base afforded the desired substituted 2-piperidone 169. Iodo- 
and bromo-substituted analogues were also synthesised and have potential utility in 
coupling reactions, while Zard indicates that the benzazepinones are also a much studied 
pharmacaphore in their own right. 
 
 
 
Scheme 33: Synthesis of 4-aryl-2-piperidones 
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1.4  Summary 
 
The synthesis of 2-pyrrolidones and 2-piperidones has received substantial literature 
attention, inidicative of the utility of these molecules in various areas of industry and 
research. It is perhaps as a result of, rather than in spite of, the relative simplicity of these 
molecules that has allowed the use of a broad range of chemistries for their synthesis. For 
both 2-pyrrolidones and 2-piperidones, the most straightforward transformation is 
lactamisation from linear chain - and -amino carboxylic acids and their derivatives. A 
variety of methods such as acid catalysed, based catalysed or simple heating make this a 
flexible approach.  
 
Ring closing metathesis reactions are an effective method for heterocycle formation, and as 
discussed above, the synthesis of diene precursors via amine acylation endow these 
methodologies with great flexibility over the ring size of target products. Although more 
commonly employed for the synthesis of 2-piperidones, pericyclic reactions such as the 
Diels-Alder reaction are powerful tools for constructing cyclic system in an often highly 
stereoselective fashion. Finally, the carbocyclic portion of the 2-piperidone and 2-
pyrrolidone rings provides ample room for the investigation of various intramolecular 
alkylations, couplings etc., of which it is hoped the above discussion provides an 
interesting selection of examples. 
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2  Results and Discussion 
 
2.1  Synthesis of 2-Pyrrolidones and 2-Piperidones 
 
2.1.1  Introduction 
 
As previously discussed, the 2-pyrrolidone and 2-piperidone motifs are important in 
various fields of chemistry, and numerous routes have been developed towards their 
synthesis. However, with any synthetic route, critical consideration can reveal drawbacks. 
To make a legitimate contribution to this area of chemistry, it was important that a novel 
synthesis address some of these issues. In modern organic chemistry there is a trend 
towards highly stereoselective reactions and syntheses. This is understandable given, for 
example, the requirements of the pharmaceutical industry, where opposing enantiomers 
may have different effects. One example of this is methamphetamine; the 
dextromethamphetamine enantiomer is a prescription psychological stimulant, whilst 
levomethamphetamine is sold as an over the counter nasal spray and affects the peripheral 
nervous system with little psychological effect.
42
 
 
The aim of the following project was to develop a flexible synthesis of 2-pyrrolidones and 
2-piperidones, which allowed for the incorporation of a variety of substituents, and the 
ability to generate both ring sizes from a common intermediate. The key transformations of 
this methodology are illustrated in Scheme 34. The starting material chosen was L-
phenylalanine 170, an inexpensive and enantiopure compound. A number of facile 
transformations lead to phosphonate ester 171. Following a Horner-Wadsworth-Emmons 
(HWE) protocol, this intermediate reacts with a variety of aldehydes to form ,-
unsaturated ketones, which are subsequently stereoselectively reduced to form allylic 
alcohols. This is followed by a key step of the synthesis, the Overman rearrangement of 
allylic trichloroacetimidates to allylic trichloroacetamides 173, which results in a highly 
selective transfer of stereochemistry. Hydrolysis of the trichloroacetamide affords a 
primary amine common intermediate, which is acylated with homologous carboxylic acid 
derivatives to form dienes 174. The final, critical step is the ring closing metathesis (RCM) 
of dienes 174 to form unsaturated heterocycles 175, the double bond of which allows for 
further elaboration. Overall, the proposed methodology affords substituted, chiral 2-
pyrrolidones and 2-piperidones in a highly flexible manner from an inexpensive starting 
material. 
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Scheme 34: Key intermediates in proposed synthesis 
 
2.1.2  Synthesis of ,-Unsaturated Ketones 
 
The synthesis began as previously mentioned with the -amino acid, L-phenylalanine 170. 
Treatment under acidic conditions with sodium nitrite afforded the -hydroxy acid 178 in 
71% yield with retention of stereochemistry.
43
 The stereochemical outcome can be 
explained by examination of the proposed reaction mechanism; following formation of the 
diazonium salt 176, nitrogen is displaced by the intramolecular attack of the carboxylic 
acid forming the -lactone 177. Nucleophilic ring-opening of the lactone by water, 
analogous to an epoxide ring-opening, affords the -hydroxy acid with overall retention of 
stereochemistry.  
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Scheme 35: Diazotization of L-phenylalanine 
 
Protection of the -hydroxy acid then followed (Scheme 36). Methyl esterification 
proceeded in excellent yield, as did hydroxyl protection with the methoxymethyl ether 
(MOM) group. Regarding the choice of hydroxyl protecting group, the MOM group is 
primarily suitable due to its stability to the proposed reaction conditions later in the 
synthesis. It has also been successfully employed in previous group work as a palladium 
coordinating moiety in asymmetric Overman rearrangements, affording increased 
flexibility to investigate alternative routes.
44
 Formation of the phosphonate ester 171 by 
reaction of methyl ester 179 with the dimethyl methylphosphonate ester anion proved 
facile.
45
  
 
 
 
Scheme 36: Synthesis of phosphonate ester 
 
The phosphonate ester intermediate marks the first divergent point of the synthesis, as the 
choice of the aldehyde reagent for the HWE reaction determines the nature of the 
substituent in the final product. Regarding the selection of aldehydes, it was necessary to 
 47 
consider the subsequent Overman rearrangement that would later be employed to transfer 
stereochemistry; it has been reported that the Overman rearrangement proceeds in 
improved yields with electron rich substituents on the terminal carbon of the allylic system, 
and reduced or even zero yields for electron withdrawing groups.
46
 For this reason, a small 
range of aliphatic aldehydes was chosen to participate in the HWE reaction. Due to the 
position of the stereocentre directly adjacent to the carbonyl functionality, it was thought 
prudent to avoid strong bases in the HWE reaction, lest racemisation is induced. To this 
end, the mild Masamune-Roush conditions of 1,8-diazabicycloundec-7-ene (DBU) and 
lithium chloride were investigated.
47
 The addition of lithium chloride increases the acidity 
of the -methylene protons, and allows the use of a milder base such as DBU. 
Unfortunately, despite investigation of elevated temperatures and extended reaction times, 
no reaction was observed using the Masamune-Roush protocol. A successful alternative 
was found in conditions developed by Lubell, employing potassium carbonate in 
acetonitrile.
48
 HWE reactions using these conditions afforded the desired α,β-unsaturated 
ketones with the general structure of compound 180, with various alkyl side chains 181–
183 in moderate to high yields. Observation of alkene proton coupling in the region of 16 
Hz, and the absence of significant by-products, suggests the HWE reaction is entirely 
selective for the E-isomers of the α,β-unsaturated ketones. 
 
 
 
Scheme 37: Horner-Wadsworth-Emmons reaction 
 
2.1.3  Stereoselective Ketone Reduction 
 
The strategy of employing the Overman rearrangement required the conversion of the α,β-
unsaturated ketones to chiral allylic alcohols. Rather than employ chiral, stereoselective 
reducing agents, the stereocentre already present in the molecule allowed for the 
investigation of a chelation controlled reduction. Zinc borohydride is readily prepared from 
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zinc chloride and sodium borohydride, and has previously been employed in the chelation 
controlled, stereoselective reduction of -hydroxy ketones.49 Figure 3 depicts the proposed 
chelated intermediate that results in a stereoselective reduction. The zinc cation is thought 
to coordinate to the carbonyl oxygen and at least one of the MOM-protected hydroxyl 
oxygens. The Newman projection demonstrates the steric bias provided by the benzyl 
moiety.  
 
 
 
Figure 3: Felkin-Anh representation of chelation controlled reduction 
 
These reactions consistently afforded a 7:1 mixture of diastereomers in favour of the 
desired anti isomer illustrated by structure 172, a satisfactory outcome for a reaction that 
does not employ a chiral reducing agent. Other reagents trialled in this reaction confirm the 
suitability of zinc borohydride; sodium borohydride and lithium borohydride were shown 
by 
1
H NMR spectroscopy to afford 2:3 and 1:3 anti:syn diastereomer ratios, respectively. 
These results are hardly surprising, however, as the 2+ charge affords a greater likelihood 
of bidentate coordination. Unfortunately, column chromatography conditions for 
satisfactory separation of the diastereomers proved elusive. It was found that separation 
was considerably easier at a later stage in the synthesis, as detailed below.  
 
 
 
 
Scheme 38: Zinc borohydride reduction of enones 
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A question remained over the outcome of the ketone reduction; how was it possible to 
determine that the theoretically preferable anti diastereomer was in reality the major 
product? To investigate the stereochemistry, the removal of the MOM protecting group 
followed by cyclic acetal formation with the two free hydroxyl groups to afford structure 
188 was proposed (Scheme 39). It was thought that this may lead to improved separation 
of diastereomers by column chromatography, but perhaps more importantly the 
constrained cyclic structure would allow the use of NOESY techniques for stereochemical 
determination. In practice this was not as straightforward as envisaged. The MOM 
protecting group appeared quite robust in the face of acidic conditions, and while extended 
reaction times and heating did afford some of the desired diol, it also incurred the 
formation of multiple by-products. Unfortunately, the formation of the cyclic acetal proved 
difficult under the conditions trialled. Despite a number of attempts, only starting material 
was returned, and NOESY confirmation of stereochemistry was not conducted. It was 
therefore necessary to devise an alternative method for the validation of the proposed 
stereochemistry. A number of the pyrrolidone and piperidone final products or their 
enantiomers are known literature compounds. The 
1
H NMR spectra and []D values 
obtained from these compounds compare favourably with those found in the literature, so it 
is possible to confidently state that the structure of these compounds is as reported.
5054
 
Hypothetically, to arrive at the correct target compounds from the syn allylic alcohol 
diastereomer would infer that the stereochemical outcome of another step in the synthesis, 
likely the Overman rearrangement, was also not as expected. The likelihood of both the 
reduction and the Overman rearrangement proceeding with theoretically disfavoured 
stereochemical outcomes is thought to be very low. Thus, it is inferred that as the target 
products are of the correct configuration, the intermediates are also.    
 
 
 
 
Scheme 39: Attempted acetal formation for NOESY analysis 
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2.1.4  Trichloroacetimidate Synthesis and Overman      
Rearrangement 
 
In preparation for the Overman rearrangement, the alcohol was treated with 
trichloroacetonitrile to form an allylic trichloroacetimidate. Previous research in the group 
has utilised this reaction, and typical conditions employed DBU (0.5 equiv.) and 
trichloroacetonitrile. However, under the aforementioned conditions, the desired allylic 
trichloroacetimidate was observed in a modest 30–40% conversion after 24 hours. This is 
possibly due to the increased substitution of compounds 184–186 when compared to 
previous allylic alcohol intermediates prepared in the group, as greater steric hindrance 
surrounding the hydroxyl group may lead to lower reaction rates. In an attempt to 
accelerate the reaction, stronger bases were suggested, the hypothesis being that an 
increased proportion of alkoxide present in the reaction would lead to greater conversion 
and shorter reaction times. Initially n-butyl lithium was trialled, but despite some evidence 
of alkoxide formation (reaction mixture changing from colourless to deep red upon reagent 
addition), no trichloroacetimidate formation was observed by 
1
H NMR spectroscopy. 
Substituting n-butyl lithium for sodium hydride led to improved results; using an excess of 
sodium hydride afforded 70% conversion to trichloroacetimidate after 2.5 hours. However, 
extension of reaction times did not lead to an increase in conversion, but to a gradual 
increase in by-product formation. Ultimately it was found that increasing the quantity of 
DBU to 1.2 equivalents and lengthening the reaction time to 48–60 hours led to 
conversions of over 80% with minimal by-product formation. Allylic trichloroacetimidates 
are sensitive to column chromatography. Hence, rapid filtration of the crude product 
through a short silica plug was necessary to remove DBU, and the product present in the 
filtrate was used without further purification. 
 
Subsequent to the formation of the allylic trichloroacetimidates is the Overman 
rearrangement, which yields allylic trichloroacetamides.
55
 This is a key step in the 
synthesis, as it involves the conversion of an sp
2
 hybridised carbon to the tertiary 
stereocentre of the final compounds in a stereoselective fashion. The Overman 
rearrangement is a [3,3]-sigmatropic rearrangement. It can be initiated thermally or with 
the use of palladium(II) or mercury(II) catalysts.
46
 The rearrangement preferentially 
proceeds through chair-like transition state 190, which in conjunction with the concerted 
nature of the thermal rearrangement leads to the highly selective transfer of 
stereochemistry from acetimidiate to acetamide (Scheme 40). 
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Scheme 40: Preferred chair-like transition state of the Overman rearrangement 
 
The investigation of the Overman rearrangement began with the exploration of the 
thermally promoted method, which involves reaction of the allylic trichloroacetimidate in 
p-xylene at 140 C for 18–24 hours. While the energy costs of maintaining this 
temperature for extended periods cannot be ignored, it was reasoned that economically and 
environmentally it would be preferable to employ thermal initiation if possible, as opposed 
to transition metal catalysts. In practice, the thermal Overman rearrangement proved to be 
very effective (Scheme 41). Yields over two steps from the allylic alcohol were in the 
range of 42–62%. The addition of a substoichiometric quantity of potassium carbonate to 
the reaction mixture has been shown to improve the yield of rearrangements.
56
 It is not 
believed to participate directly in the rearrangement mechanism, rather it neutralises the 
trichloroacetic acid by-product that can be formed as a result of allylic trichloroacetamide 
hydrolysis, and therefore reduces the amount of acid catalysed trichloroacetimidate 
decomposition. 
 
 
 
Scheme 41: Acetimidate formation and Overman rearrangement 
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Unfortunately, an area of ambiguity was the diastereomeric outcome of the rearrangement. 
While the diastereomers of the allylic alcohol were distinguishable by 
1
H NMR 
spectroscopy, no such distinction could be made for the allylic trichloroacetamide. 
Fortunately, at a later stage in the synthesis the diastereomers could again be distinguished, 
and from these results it appears that stereochemical integrity was maintained during the 
Overman rearrangement, with diastereomer ratios being identical to those found in the 
allylic alcohols. Given the results afforded by the thermal rearrangement, it was not 
deemed necessary to investigate metal catalysed methods.  
 
2.1.5  Trichloroacetamide Hydrolysis, Acylation and Ring-Closing 
Metathesis 
 
Hydrolysis of the trichloroacetamides to primary amines proved facile. Treatment with 
sodium hydroxide was sufficient to effect complete hydrolysis after 18 hours, and after 
analysis of the 
1
H NMR spectra of the crude product, purification was deemed 
unnecessary. The primary amine is a key intermediate in the synthesis, as choice of 
acylating reagent determines ring size of the final compound; acylation with an acryloyl 
unit leads to 2-pyrrolidone structures, while the 3-butenoyl unit leads to 2-piperidones. 
Acryloyl chloride and triethylamine in dichloromethane at 0 °C were found to be suitable 
acylating conditions. While initial yields were reasonable at around 40% over two steps, 
previous literature work suggested diethyl ether in place of dichloromethane, and 
conducting the reaction at 78 C followed by warming to room temperature.57 This 
protocol led to an increase in yields over the two steps to 50–57%. Pleasingly, it was found 
that not only were the syn and anti diastereomers distinguishable by 
1
H NMR spectroscopy 
post acylation, they were easily seperable by column chromatography. Thus the anti 
diastereomer was isolated in yields of 44–48%. 
 
Acylation employing the 3-butenoyl unit was then investigated. 3-Butenoyl chloride was 
not commercially available, which was unsurprising as it was believed attempts to 
synthesise this reagent from, for example, 3-butenoic acid and thionyl chloride, would 
result in isomerisation to crotyloyl chloride under the acidic conditions. Thus, it was 
decided to investigate an amide coupling reaction involving 3-butenoic acid and EDCI 
hydrochloride. Overall yields were comparable to those of the acryloyl acylation at 55–
62%, and similarly it was found that the diastereomers were again separable by column 
chromatography, affording the anti diastereomer in yields of 39–49% over two steps. 
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Scheme 42: Trichloroamide hydrolysis and primary amine acylation 
 
Attention next turned to the ring closing metathesis of the dienes, perhaps the most critical 
step of the synthesis. Fortunately, using Grubbs 2
nd
 generation catalyst, all dienes cyclised 
smoothly to the corresponding unsaturated 2-pyrrolidones and 2-piperidones in very good 
yields (Scheme 43). One exception to this was the synthesis of (6R)-6-phenethyl-1,6-
dihydropyridin-2-one 207. While the ring closing metathesis proceeded well, the product 
was slightly unstable, appearing to isomerise to what was thought to be the α,β-unsaturated 
system. Column chromatography only served to increase the rate of isomerisation, and the 
two isomers were inseparable. As a result of this instability, (6R)-6-phenethyl-1,6-
dihydropyridin-2-one 207 was taken directly through to the hydrogenation stage. What 
caused the instability of this particular analogue and not others is unclear. Having 
successfully completed the cyclisation of all analogues, it was felt necessary to determine 
the enantiopurity of these compounds. Thus, (5R)-5-phenethyl-1,5-dihydropyrrol-2-one 
204 underwent chiral HPLC analysis, and was found to have an enantiomeric excess of 
93%. This is a highly satisfactory result for a synthesis that begins with an inexpensive 
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chiral pool source and does not utilise chiral reagents or chiral chromatographic 
techniques.  
 
 
 
Scheme 43: Ring closing metathesis of dienes 
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2.1.6 Hydrogenation and Synthesis of N-Boc Coniine 
 
Ultimately, the small library of compounds was subjected to hydrogenation, forming the 
target 2-pyrrolidones and 2-piperidones. Elevated gas pressure was not required, and the 
reactions proceeded at room temperature. Without exception, these hydrogenations 
proceeded in good yield and in a very clean fashion (Scheme 44).  
 
 
 
Scheme 44: Hydrogenation to saturated heterocycles 
 
As noted above, some of the target products had previously been reported in the literature, 
and the analytical data collected compared favorably with literature values. As discussed 
previously, the 2-pyrrolidones and 2-piperidones are sometimes used to access pyrrolidines 
and piperidines. To demonstrate this, amide reduction of the (6S)-6-propylpiperidin-2-one 
analogue 216 was investigated. This reduction would afford the known natural compound 
(+)-coniine, a toxic alkaloid produced by the poison hemlock family of plants.
58
 There was 
literature precedence for the in situ Boc-protection of the piperidine; coniine is known to 
be volatile, an undesirable characteristic given its toxicity, and the hydrochloride salt is 
known to be highly hygroscopic.
59
 Therefore, 2-piperidone 216 underwent lithium 
aluminium hydride reduction to its piperidine derivative followed by Boc protection as a 
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one-pot process (Scheme 45). N-Boc-(+)-coniine 217 was isolated in 48% yield over two 
steps, and analytical data was consistent with that reported in the literature.  
 
 
 
Scheme 45: Synthesis of N-Boc-(+)-coniine 
 
2.1.7  Summary 
 
In summary, this project achieved the aims proposed at the outset. Three key 
transformations can be identified in this synthesis. First, a chelation controlled zinc 
borohydride reduction of ,-unsaturated ketones was employed to produce allylic 
alcohols with good stereoselectivity. By utilising the stereocentre present in the ketone 
substrate, the requirement for a chiral reducing reagent was removed. Second, the 
Overman rearrangement was utilised to transfer stereochemistry from the allylic alcohol to 
the tertiary stereocentre present in the target compounds. The concerted nature of the [3,3]-
sigmatropic rearrangement with the proposed chair-like transition state led to an excellent 
retention of stereochemical integrity. Third, the ring-closing metathesis reaction was a 
critical step in the formation of the cyclised products, and presented little in the way of 
difficulties. 
 
In this synthesis, the unsaturated pyrrolidones and piperidones were hydrogenated to their 
corresponding saturated lactams. However, the presence of the alkene affords opportunities 
for further functionalisation. For example, epoxidation,
60
 dihydroxylation
61
 and 
fluorination
62
 are potential elaborations of the core structure. The ,-unsaturated system 
of the pyrrolidones allows for the investigation of 1,4-conjugate additions with 
organometallic reagents.
63
 Finally, as exemplified by the synthesis of N-Boc-coniine 
discussed above, amide reduction gives facile access to the corresponding pyrrolidine and 
piperidine derivatives. 
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2.2  Synthesis of 4-Oxopipecolic Acid Derivatives 
 
2.2.1  Introduction 
 
Pipecolic acid is a cyclic, non-proteinogenic amino acid found in a variety of biological 
systems, including plants and mammals.  It has been reported as the product of lysine 
metabolism.
64
 More specifically, it has been detected in various physiological fluids in 
humans, including blood plasma, urine and cerebrospinal fluid.
65, 66
 Interestingly, it was 
also identified as one of a variety of organic compounds found in the Murchison meteorite, 
a meteorite that landed in Murchison, Australia in 1969.
67
 The pipecolic acid motif can be 
found in a variety of biologically active compounds. Homophymine A 218 is a natural 
product isolated from the marine sponge Homophymia sp. which has demonstrated anti-
HIV activity (Figure 3).
68
  
 
 
 
Figure 3: Natural product Homophymine A 
 
Compounds L-366,682 219 and L-366,948 220 are oxytocin antagonists which each 
contain two pipecolic acid motifs (Figure 4). Oxytocin is a peptide that induces and 
maintains uterine contractions during labour.
69
 The inhibition of oxytocin function is 
thought to have potential therapeutic value in the prevention of premature births. 
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Figure 4: Oxytocin inhibitors 
 
Modified analogues of the pipecolic acid motif, for example 4-oxygenated derivatives, also 
feature in biologically relevant compounds (Figure 5). Palinavir 221 is a potent inhibitor of 
HIV protease, and contains the 4-hydroxy-pipecolic acid motif.
70
 Virginiamycin S1 222 is a 
component of the commercial antibiotic virginiamycin.
71
 It contains the 4-oxopipecolic  
acid motif, and is used in the treatment of infections in agricultural livestock. 
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Figure 5: 4-oxo and 4-hydroxypipecolic acid derivatives 
 
It is clear that compounds bearing the pipecolic acid motif display interesting biological 
activities, and in order to exploit these properties, it is important that novel and efficient 
syntheses are developed.
72
 Indeed, previous group work led to a novel synthesis of 4-oxo 
and 4-hydroxy-6-substituted pipecolic acid derivatives.
73
 It is this work that forms the basis 
of the novel methodology discussed here. 
 
2.2.2  Previous Synthesis and Proposed Novel Synthesis 
 
The previous route developed within the group began with enantiopure, commercially 
available L-aspartic acid 223, which was treated with thionyl chloride to form the dimethyl 
ester hydrochloride salt 224 (Scheme 46). The amino group was then protected with trityl 
chloride. Reaction with the anion of dimethyl methylphosphonate at the least hindered, 4-
position methyl ester afforded phosphonate ester 226. This was reacted with a variety of 
aldehydes to form α,β-unsaturated ketones 227. These compounds are themselves of 
interest, as de-tritylation and ester hydrolysis afforded a variety of unnatural amino acids, 
some of which displayed fluorescent properties.
74
 The possibility of a 6-endo-trig 
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cyclisation of these compounds was investigated, and after various conditions were 
examined, the following strategy was found to be most effective; post acidic de-tritylation, 
reaction of the amine trifluoroacetic acid salt with benzaldehyde in the presence of base 
afforded the benzyl imine. Hydride reduction of the imine initiated a 6-endo-trig 
cyclisation, postulated to proceed via transition state 228, to form the 2,6-trans-
disubstituted 4-oxopipecolic product 229 in 26–53% yield over the three steps. 
 
 
 
Scheme 46: Previous synthesis of 4-oxopipecolic acid deivatives 
 
Whilst the cyclisation afforded access to the desired 4-oxo-pipecolic acids, there were 
aspects of this synthesis which could be improved. The yields of the cyclisation, being in 
the region of 26–53%, were considered to be generally low. It was proposed that this was 
due to competing ketone reduction during the one-pot process. After attaining very good 
yields for the majority of the synthesis, it was unfortunate that the reaction conditions in 
the final step should lead to only moderate yields. Therefore, in order to improve on this 
aspect, a synthesis which did not require the use of hydride reducing agents during 
cyclisation was proposed (Scheme 47). The starting material for this synthesis was, again, 
L-aspartic acid, which was to be converted to the dimethyl ester as before. However, 
instead of the trityl protecting group, the primary amine would undergo benzylation via 
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reductive amination, followed by orthogonal protection with the Boc group. Diester 231 
could then undergo substitution with dimethyl methylphosphonate to form phosphonate 
ester 232, the precursor for HWE reactions with a variety of aldehydes, affording α,β-
unsaturated ketones 233. The Boc group would then be removed under acidic conditions, 
and the cyclisation of the N-benzyl amine in the presence of a base, such as sodium 
carbonate, would be investigated. In summary, the aim of this project was to improve upon 
the yields of the cyclisations observed in previous group work to give 2,6-trans-
disubstituted 4-oxopipecolic acid derivatives 229 more efficiently.  
 
 
 
Scheme 47: Proposed synthesis of 4-oxopipecolic acids 
 
2.2.3  Attempted Synthesis of Phosphonate Ester Intermediate 
 
The synthesis began with a number of rudimentary protections that were unproblematic 
(Scheme 48). Diesterification proceeded in near quantitative yield. Reductive amination 
afforded benzyl protected amine 230 in good yield, and avoided issues of quaternisation 
that can be observed with the use of benzyl halides. Boc protection furnished the 
compound with steric bulk around the amine, which was intended to perform a similar 
function to the trityl group by favouring attack of the distal ester by the phosphonate 
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reagent. Unfortunately, substitution at this distal ester with dimethyl methylphosphonate 
did not proceed as planned. Rather than attack the carbonyl of the methyl ester, the 
phosphonate ester anion preferentially attacked the carbonyl of the Boc carbamate, 
resulting in the loss of the Boc group. Only the N-benzyl compound 230 was isolated from 
the reaction mixture.  
 
 
 
Scheme 48: Attempted synthesis of -keto phosphonate ester 232 
 
As the N-benzyl compound 230 was already in hand, it was decided to attempt the 
formation of the phosphonate intermediate 234 without protection from the Boc group 
(Scheme 49). It was hypothesised that a mixture of products from phosphonate substitution 
at the 4-carbonyl, the 1-carbonyl, and a combination of both may be observed. In practice, 
however, the desired reaction was not observed, only a minor amount of decomposition to 
unknown by-products. The reason for this is not clear. It was suggested that one equivalent 
of the phosphonate reagent may act as a base rather than a nucleophile, removing the 
amine hydrogen atom. To compensate for this, two equivalents of the dimethyl 
methylphosphonate anion were added to the reaction mixture. Despite this, the reaction 
outcome was similar to that previously observed. One hypothesis is that electronic 
repulsion may exist between the anionic amine, and the excess anionic phosphonate 
reagent.  
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Scheme 49: Unsuccessful -keto phosphonate ester synthesis 
 
The above experimental results suggested that di-protection of the amino group was 
necessary. An interesting approach, which would not require additional protecting groups, 
would be to form β-lactam 235 from N-benzyl diester 230 (Scheme 50). This would mask 
the NH functionality, and there is literature precedence for the ring opening of β-lactams 
with anionic carbonucleophiles, for which it was intended to use the phosphonate 
reagent.
75
 The first challenge was to form the β-lactam, which in itself was not entirely 
trivial. The first attempt employed n-butyl lithium as a base, which would deprotonate the 
secondary amine and facilitate cyclisation. Unfortunately, no cyclisation was observed. 
1
H 
NMR spectroscopy of the crude product mixture suggested that n-butyl lithium had acted 
as a nucleophile towards the ester moieties. However, literature precedence was found for 
the formation of β-lactams using Grignard reagents as a base.76 Using these conditions, the 
β-lactam was isolated in 39% yield. 
 
 
 
Scheme 50: Synthesis of -lactam 236 
 
Having formed the β-lactam, the ring opening using the original conditions for 
phosphonate ester formation was attempted. Disappointingly, these conditions did not 
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effect ring opening (Scheme 51). However, the phosphonate reagent successfully attacked 
the methyl ester group, affording phosphonate ester 236 in 39% yield. 
 
 
 
Scheme 51: Attempted synthesis of -keto phosphonate ester 234 
 
Despite the setback, it was believed that this approach merited further attention. A review 
of similar ring opening reactions revealed that success was more likely using a bulkier 
ester group.
77
 Whilst it was not explicitly stated that this was to avoid unwanted reaction of 
the ester, it was inferred that a bulkier ester functionality may allow selective ring opening. 
It was decided to attempt the formation of the exo tert-butyl ester using β-lactam 
compound 235 (Scheme 52). Methyl ester 235 was hydrolysed to carboxylic acid 237 
under basic conditions in modest yield. The formation of a tert-butyl ester is often non-
trivial. In addition, a literature review of tert-butyl esterification methods revealed that the 
majority of these employed acidic conditions. As the β-lactam structure is known to be 
acid sensitive, this restricted the options. One suitable reaction employed N,N-
dimethylformamide dineopentyl acetal.
77 
Unfortunately, despite several attempts, the tert-
butyl ester 238 could not be generated from β-lactam acid 237 using these conditions.  
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Scheme 52: Ester hydrolysis and attempted ester formation 
 
An alternative approach was next investigated, installing the tert-butyl ester at an earlier 
stage of the β-lactam synthesis. Thus, installation of the tert-butyl group before 
lactamisation of the aspartic acid derivative was attempted (Scheme 53). The synthesis was 
revised, and using modification of a literature procedure,
78
 it was possible to isolate 
monoesterified product 239 in a modest yield of 37% by reaction of aspartic acid with 
thionyl chloride at 0 C in methanol. The challenge, then, was to form the tert-butyl ester 
at the 1-position. The previous approach using N,N-dimethylformamide dineopentyl acetal 
was trialled, but again, no reaction was observed using this reagent. The absence of the -
lactam unit widened the scope of possible reaction conditions, and allowed for the use of 
70% wt. perchloric acid in tert-butyl acetate.
79
 It was observed from the 
1
H NMR spectra 
of the crude product that some tert-butyl ester 240 had been formed. It was decided that the 
crude material was sufficiently clean to use without further purification. Thus, the crude 
material was subjected to a reductive amination using benzaldehyde and sodium 
borohydride, which gave the benzyl amine 241 in a 5% yield. This necessitated a 
reassessment of strategy; the first three steps of the synthesis had afforded markedly poor 
yields, and would likely require substantial time and effort in order to improve them. In 
addition, it was not certain whether deprotonated dimethyl methylphosphonate would 
effect ring opening of the proposed β-lactam. Also, it was possible that the bulky ester 
group could have a negative impact on subsequent reactions, particularly the proposed 
cyclisation. Regrettably, it was decided to abandon efforts towards this strategy, with the 
aim of developing a process more akin to the original synthesis.  
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Scheme 53: Synthesis of tert-butyl ester 241 
 
2.2.4  Revised Synthesis of 4-Oxopipecolic Acid Derivatives 
 
The revised synthesis is shown in Scheme 54. It is broadly similar to the original synthesis 
with a simple variation in protecting group, exchanging the N-benzyl moiety for N-tosyl. 
There were two main reasons for this exchange; firstly, it was proposed that by varying the 
electronics and sterics of the protecting group, the phosphonate ester formation may 
proceed without eliminating the Boc group or performing other unwanted reactions. 
Secondly, at the cyclisation stage, the electron withdrawing effects of the sulfonamide 
group may facilitate cyclisation with a weak base.  
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Scheme 53: Revised synthesis of 4-oxopipecolic acid derivatives 246 
 
Preparation of the di-protected amine 243 proved facile (Scheme 55). Following 
diesterification using previously mentioned conditions, amine protection using p-
toluenesulfonyl chloride followed by Boc anhydride afforded glutamic acid derivative 243 
in good yield. However, the subsequent phosphonate ester formation was unsuccessful. 
Whilst the Boc protecting group remained intact, no reaction at either ester was observed. 
Despite several attempts using an excess of the phosphonate ester anion, only starting 
material was isolated. 
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Scheme 55: Attempted synthesis of phosphonate ester 244 
 
By comparing the outcomes of the attempted syntheses of N,N-benzylBoc phosphonate 
ester 232 and N,N-tosylBoc phosphonate ester 244, it appeared that the nature of the 
protecting groups can have a significant impact on the reactivity of the substrate; in the 
case of 232, the Boc group was removed, whilst in the case of 244, no reaction was 
observed. Thus, it was reasoned that an attempt to form the mono-protected N-tosyl 
compound 247 would be a worthwhile investigation (Scheme 56). As expected, the 
formation of N-tosyl compound 242 presented no problems. In addition, it was found that 
in the presence of 2.5 equivalents of the dimethyl methylphosphonate anion, the 
phosphonate ester 247 was formed in 57% yield. The di-phosphonate ester and the 1-
phosphonate ester were not observed in the 
1
H NMR spectra of the crude product, 
suggesting regioselective addition had occurred. It had been previously observed that the 
N-benzyl compound 230 did not form the desired phosphonate ester when treated with the 
deprotonated phosphonate reagent, and it was proposed that the formation of an anionic 
amino species was hindering the reaction, possibly by electronic repulsion. However, the 
presence of the sulfonamide moiety in compound 242 is likely to lower the pKa of the 
amine NH relative to that of compound 230. In other words, the formation of a 
deprotonated, anionic amino derivative of 242 is of greater likelihood. That this should 
lead to the desired phosphonate ester does not correlate with the previous hypothesis. It has 
therefore been proposed that the following occurs: in the case of N-benzyl compound 230, 
the secondary amine is deprotonated, but as it is not able to disperse this charge through 
conjugating groups it is relatively reactive and quickly quenched with acidic protons 
abstracted from other modified aspartic acid molecules. The regenerated secondary amine 
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is able to react again, and hence the phosphonate reagent is rapidly quenched before it is 
able to react with the methyl ester. Whilst the N-tosyl amine 243 is more acidic, the anion 
formed is stabilised through conjugation with the sulfonamide group. It is therefore less 
likely to re-protonate, and will spectate while the remaining phosphonate reagent reacts 
with the distal methyl ester. With the successful synthesis of 248, progress to the Horner-
Wadsworth-Emmons reaction was then studied. 
 
 
 
Scheme 56: Synthesis of N-tosyl phosphonate ester 247 
 
2.2.5 The Horner-Wadsworth-Emmons Reaction 
 
The previously successful HWE conditions of potassium carbonate in acetonitrile were 
trialled using hydrocinnamaldehyde as an aldehyde substrate (Scheme 57, entry 1).
80
 
Despite several attempts, the maximum yield obtained using these conditions was 11%. 
Monitoring by TLC showed very slow progress, and the gradual increase in undesirable 
by-products over the course of the reaction led to the conclusion that extending reaction 
times would not be an effective solution. A screening of a small range of conditions was 
therefore initiated. Again using hydrocinnamaldehyde, the mild Masamune-Roush protocol 
of lithium chloride and DBU was trialled, but only starting material was isolated (entry 
2).
47
  The same result was observed when using the stronger base sodium hydride (entry 3), 
where an extra equivalent of hydride was added to compensate for the acidity of the 
sulfonamide NH. After these poor results, it was proposed that a more reactive aldehyde 
such as p-nitrobenzaldehyde may afford a better outcome. No reaction at all was observed 
using the previously successful potassium carbonate with p-nitrobenzaldehyde (entry 4). 
The Masamune-Roush protocol was attempted again, but as before, only starting material 
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was reclaimed (entry 5). A change of strategy was then proposed, where stronger bases at 
lower temperatures may allow the deprotonation of both the sulfonamide NH, and the β-
keto phosphonate methylene carbon, without excessive side reactions or degradation. Thus, 
lithium hexamethyldisilazide at 78 C was trialled, but again, no reaction was observed 
(entry 6). As an alternative, lithium diisopropylamide at 78 C was trialled (entry 7). 
While this did not afford the desired α,β-unsaturated ketone, the reaction did produce a 
substantial quantity of p-nitrobenzyl alcohol as a side product; the propensity of lithium 
dialkyl amides to act as reducing agents for carbonyl compounds has previously been 
reported and exploited by Férézou and co-workers.
81
 
 
 
 
Scheme 57: Horner-Wadsworth-Emmons conditions screen 
 
Having considered the results using aliphatic and aromatic aldehydes, and a mixture of 
inorganic and organic, strong and mild bases in the proposed HWE reaction, the 
conclusion that the phosphonate ester may be the source of the problem was reached. More 
specifically, it was suspected that the acidic NH of the sulfonamide may be detrimental to 
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reaction progress. Di-protection of the nitrogen was thought to be necessary, and as the use 
of the Boc group was originally proposed in the previous iteration of the synthesis, it 
seemed logical to utilise this protecting group. Treatment of 247 with Boc-anhydride gave 
244 in 65% yield, allowing the reinvestigation of the HWE reaction (Scheme 58). As the 
potassium carbonate conditions had given the only positive result in the previous 
conditions screen, they were deemed the most suitable choice. It was decided to continue 
with the use of p-nitrobenzaldehyde as it was believed that its increased electrophilicity 
gave the best chance of success. These conditions afforded somewhat mixed results. It 
appeared that the HWE reaction had proceeded and the α,β-unsaturated ketone had been 
formed. Unfortunately, the reaction did not stop at this point, and under the basic 
conditions, the tosyl moiety acted as a leaving group. Whilst it was not possible to obtain a 
sample clean enough for full analysis, 
1
H and 
13
C NMR spectra strongly suggested the 
formation of conjugated species 249. In forming the α,β-unsaturated system, the key 
stereocentre had inadvertently been lost. 
 
 
 
Scheme 58: Attempted Horner-Wadsworth-Emmons procedure 
 
2.2.6  Synthesis of N-Trityl ,-Unsaturated Ketone 
 
These results prompted another reappraisal of the strategy. The main objective was to 
obtain a cyclisation precursor containing the α,β-unsaturated ketone and an N-tosyl moiety 
appended to a stereocentre. In the interest of time and efficiency, it was proposed that the 
route previously developed by our group should be followed to form the N-trityl α,β-
unsaturated ketone,
73
 followed by investigation of trityl removal, tosylation, and 
cyclisation. This seemed logical as the majority of the route was well developed, and 
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theoretically the detritylation and tosylation should prove facile, allowing attention to be 
focused on the critical cyclisation step. The route began with the diesterification of L-
aspartic acid, followed by high yielding tritylation and phosphonate ester formation steps 
(Scheme 59). Hydrocinnamaldehyde was chosen as a model substrate, and unsurprisingly, 
the HWE reaction afforded ketone 250 in good yield. The considerable steric bulk of the 
trityl moiety hinders unwanted side reactions that may occur as a result of the reactivity of 
the secondary amine. 
 
 
 
Scheme 59: Synthesis of α,β-unsaturated ketone 250 
 
2.2.7  Detritylation and Tosylation 
 
Having formed N-trityl ketone 250, attention focused on its detritylation and subsequent 
tosylation. The previously published synthesis had achieved detritylation using 
trifluoroacetic acid, and therefore this was the reagent of choice. Deprotection was effected 
cleanly and quickly, and the trifluoroacetic acid salt of the primary amine 251 was isolated 
without requiring purification (Scheme 60). Standard conditions for tosylation were then 
employed, using p-toluenesulfonyl chloride and triethylamine. Surprisingly, however, the 
1
H and 
13
C NMR spectra of the isolated product showed the formation of 
trifluoroacetamide 253.  
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Scheme 60: Unexpected trifluoroacetamide synthesis 
 
This was an unexpected result, but a plausible mechanism may hold the explanation after-
the-fact (Scheme 61). It was believed that the trifluoroacetate anion 254 is more 
nucleophilic towards p-toluenesulfonyl chloride than either the amine TFA salt 251 or the 
primary amine 251b. It therefore forms intermediate 256 in situ, which likely displays 
similar reactivity characteristics to an acid anhydride. It is this species that reacts with the 
primary amine, which preferentially attacks the carbonyl component of the anhydride over 
the sulfone, leading to the formation of the trifluoroacetic amide 253. 
 
 
 
Scheme 61: Proposed mechanism of trifluoroacetic amide synthesis 
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Undeterred by this unexpected result, trifluoroacetic acid was exchanged for 2 M 
hydrochloric acid in the detritylation step, and these conditions were found to be equally as 
effective, affording the amine hydrochloride salt cleanly. This was followed by standard 
tosylation conditions, and the N-tosyl amine 252 was isolated in 39% yield over two steps 
(Scheme 62a). Finally, it was possible to investigate the crucial cyclisation procedure, and 
literature precedence had been found for the similar cyclisation of simple N-tosyl amines 
by employing potassium carbonate as a base.
82
 These conditions were applied to substrate 
252. It appeared that the cyclisation of the amine had proceeded as planned. Unfortunately, 
the reaction did not stop at this point. In a similar fashion to the unexpected synthesis of 
249, the tosyl moiety was able to act as a leaving group under the basic conditions, forming 
imine 259, which tautomerised to the more stable, conjugated product 257 (Scheme 62b). 
Whilst cyclisation had been achieved, a stereocentre had been lost, and it was not possible 
to determine the stereochemical outcome of the cyclisation. The reaction was repeated in 
acetonitrile as it was proposed that a slightly less polar solvent may lead to lower solubility 
of potassium carbonate and therefore decrease the chance of the unwanted tosyl 
elimination occurring. However, despite a reaction time of several days, only starting 
material with some evidence of decomposition was isolated from this mixture. 
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Scheme 62: Synthesis of unsaturated pipecolic acid derivative 257 and possible cyclisation 
mechanism 
 
2.2.8  Detritylation and Cyclisation 
 
It was proposed that the issues of cyclisation could be overcome by further elaboration of 
product 257. Were this pattern of detosylation to continue with different analogues, 
hydrogenation of the alkenes may be facially directed by the presence of the tertiary 
stereocentres present in the unsaturated intermediates 260 (Scheme 63). On the assumption 
that the cyclisation had not proceeded in a highly stereoselective fashion, this would give 
both cis enantiomers of the initial target compounds.  
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Scheme 63: Proposed selective hydrogenation 
 
Before work could begin on this new strategy and the hydrogenation investigated, further 
quantities of N-tosyl amine 252 had to be synthesised. One area where it was felt that 
optimisation was necessary was the detritylation and tosylation procedure, with a previous 
yield of only 39% over two steps. It was proposed that neutralisation of the hydrochloride 
salt to form the primary amine before tosylation was attempted could afford higher yields. 
The detritylation was conducted as before with 2 M hydrochloric acid. After 1 hour, the 
reaction was treated with sodium carbonate. After extraction of the reaction mixture and 
1
H 
NMR analysis of the product, it was found that the product of neutralisation was in fact the 
cyclised products 262a and 262b. The 2:1 cis:trans mixture of diastereomers proved easy 
to separate by column chromatography, and were isolated in an unoptimised 48% overall 
yield over the two steps. 
 
 
 
Scheme 64: Formation of 4-oxopipecolic acid derivatives 262a and 262b 
 
With a promising cyclisation procedure in place, the scope of the reaction was investigated 
with a variety of analogues. This began with the synthesis of a variety of ,-unsaturated 
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ketones via the HWE reaction. A variety of aliphatic and aromatic substituents were 
included. With the exception of the p-methoxyphenyl derivative, which reacted slowly and 
in moderate yield, the HWE reactions proceeded in good yield and with complete E-
selectivity (Scheme 65). 
 
 
 
Scheme 65: Synthesis of ,-unsaturated ketone analogues 
 
With a variety of ,-unsaturated ketones in hand, attention was turned to the cyclisation 
step. Using the serendipitous procedure of acidic detritylation, dilution with water and 
treatment with sodium carbonate, a variety of analogues were successfully cyclised 
(Scheme 66). The diastereomeric ratios were in the range of between 2:1 and 3:1 cis:trans, 
and the stereoisomers were separable by column chromatography. However, it was 
proposed that the cyclisation conditions should be investigated for optimisation; the 
diastereomeric ratios obtained thus far were not exceptional. Also, whilst some analogues 
had cyclised in respectable yields, others were far more modest. 
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Scheme 66: Sodium carbonate mediated cyclisation 
 
In an effort to increase the diastereomeric ratios of the product mixtures, it was proposed 
that a reduction in reaction temperature might lead to improved ratios. This was 
experimentally proven to be correct (Scheme 67). However, it was ultimately not felt 
beneficial to adopt low temperatures as part of the cyclisation for two reasons. Firstly, the 
improved ratio from 2.5:1 to 3.3:1 cis:trans was not as substantial as had been hoped. 
Secondly, the reduced temperatures slowed the reaction markedly; whilst the room 
temperature trial had proceeded to completion over the reaction period, the reaction 
conducted at 20 C had only converted around 10% of starting material to product in the 
same time. The conclusion was reached that the practical complications of maintaining the 
reaction at 20 C for extended periods outweighed the minor benefits observed with 
regards to stereochemistry.  
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Scheme 67: Effect of temperature on cyclisation 
 
In parallel, investigations to improve the overall yields of the cyclisation were also 
conducted. It had been noted that under the original conditions, despite the dilution of the 
reaction mixture with water, a visible quantity of sodium carbonate was left undissolved at 
the bottom of the reaction vessel. It was proposed that faster reactions and higher yields 
might be achieved with the use of a fully soluble, homogenous base. To this end, N-
ethyldiisopropylamine was substituted for sodium carbonate, which led to a substantial 
increase in yields. (Scheme 68). Using these optimised conditions, it was possible to 
cyclise the entire library of the N-trityl amine analogues in good overall yield and with a 
consistent preference for the cis diastereomer. 
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Scheme 68: N-Ethyldiisopropylamine mediated cyclisation 
 
2.2.9  Determination of Stereochemistry by nuclear Overhauser 
effect Spectroscopy (4-Oxo Derivatives) 
 
It has been noted above that the cyclisation affords the cis-diastereomer as the major 
component, and spectroscopic data supports this claim. Inspection of 
1
H NMR data for the 
2-H and 6-H protons of the major products displays a consistent trend for coupling 
constants in the region of 10-12 Hz. This strongly suggests that both of these protons are 
adopting axial positions, from which can be inferred a cis-relationship of the substituents in 
the equatorial 2- and 6-positions. This is in contrast to the 
1
H NMR data obtained for the 
minor products; the 2-H protons consistently afford coupling constants in the region of 6-7 
Hz. These constants are too small for axial-axial couplings, yet too large for axial-
equatorial or equatorial-equatorial. Instead, this suggests the occurrence of ring-flipping 
between chair conformations of the minor products leading to an averaged coupling 
constant between the two possible conformations. This observation lends itself to the 
assignment of a trans-product, as the energy difference between both chair conformations 
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of said trans-product is likely to be lower in comparison to that found in the cis-product as 
a result of sterics.   
 
Although the 1H NMR data of the cyclised products provided valuable information for 
stereochemical assignment, it was felt necessary to supplement this with further analysis. 
For this purpose, selective nOe (nuclear Overhauser effect) spectroscopy experiments were 
conducted on all of the cyclised products. Upon irradiating the hydrogen atoms at the 2-
position of the trans-diastereomers, no enhancement of the 6-position hydrogen peaks was 
observed. However, this result in itself was not sufficient. Between the 2-H and 6-H atoms 
lies the nitrogen atom, which contains a quadrupolar nucleus. It is known that the nuclear 
Overhauser effect may be curtailed by quadrupolar relaxation through heteroatoms. 
Therefore, it was the results of the selective nOe experiments on the cis-diastereomers that 
allowed for the confident assignment of relative stereochemistry. In the selected examples 
below, irradiation of Hb induced enhancement of the He signal, and vice versa. In addition, 
as the reaction conditions employed in this synthesis are unlikely to induce either complete 
or partial racemisation of the 2-position stereocentres, it can be stated with confidence that 
the absolute stereochemistry is as described.   
 
 
Figure 6: Key nOe couplings for isobutyl derivative 271a 
 
 
 
Figure 7: Key nOe couplings for p-bromophenyl derivative 274a 
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2.2.10  Rationale of Stereochemical Outcome 
 
One aspect of the cyclisation that required consideration was the theoretical reasoning 
behind the observed stereochemical outcome. As demonstrated in Scheme 46, the 
diastereomeric outcome of the cyclisation previously investigated in the group had shown a 
consistent preference for the trans-diastereomer. Why should the current cyclisation 
predominantly produce the cis-diastereomer? The rationale behind the previous work’s 
outcome is demonstrated in Scheme 69a. Prior to bond formation, the N-benzyl imine is 
proposed to adopt a 6-membered chair-like transition state 228. It is thought to be sterically 
more favourable for the benzyl imine moiety to adopt a pseudo-equatorial position. This is 
also true for the R group, which also orients in a pseudo-equatorial fashion. Imine 
reduction then leads to the formation of the trans-diastereomer. Whilst the methyl ester 
group adopting a pseudo-axial position may be unfavourable in terms of sterics, it could 
conceivably be necessary to allow the access of the hydride equivalent to one face of the 
imine group.   
 
In the case of the current cyclisation, the benzyl moiety on the amine is not present. This 
allows for the possibility of primary amine 279 adopting a chair-like transition state with 
both the R group and methyl ester in pseudo-equatorial positions, leading to cis-
diastereomer 261a (Scheme 69b). However, as can be seen in Scheme 69c, it is also 
possible for the primary amine to adopt transition state 280. Whilst this configuration with 
its pseudo-axial methyl ester is likely disfavoured over 279 with both substituents pseudo-
equatorial, the steric bulk of the ester is less discriminating. Hence, the primary amine can 
adopt this configuration without incurring significant steric hindrance, and this is perhaps 
why the selectivity of the cyclisation is not particularly high. However, this does leave 
scope to investigate the cyclisation with bulkier ester groups, which may lead to improved 
selectivity. 
 
As an additional note on this matter, whilst the chair conformations of Scheme 69 provide 
a convenient explanation of the observed outcomes, in reality the intermediates may be 
flatter than those depicted to allow more effective orbital overlap in the conjugated ,-
unsaturated ketone system. Modelling studies may provide further information on the true 
nature of these reactions. 
 
 83 
 
 
Scheme 69: Rationale of stereochemical outcome 
 
 84 
2.2.11  Synthesis of 4-Hydroxy Derivatives 
 
As stated, the major diastereomer obtained from the cyclisation reaction was the cis-
isomer. Previous work on the synthesis of trans-4-oxopipecolic acids had been extended 
with a stereoselective carbonyl reduction to form 4-hydroxypipecolic acid derivatives.
73
 
Using sodium borohydride, the predominant trans-diastereomers, exemplified by analogue 
281, were reduced to the 4-hydroxy derivatives with a preference for the (4S)- isomer 282a 
in ratios ranging from 2:1 to 7:1 (Scheme 70). It was therefore proposed that an 
investigation into the reduction of the cis-diastereomer would make an interesting 
comparison. 
 
 
 
Scheme 70: Previous 4-oxopipecolic acid reduction 
 
The reduction of model substrate 262a was trialled with a small range of reducing agents 
(Scheme 71a). L-Selectride proved entirely ineffective, with no reduction observed. 
Sodium borohydride afforded the desired products in modest yield. However, the 
diastereomeric ratio of 13:1 was an improvement over the ratios observed in the reduction 
of the trans-diastereomer in previous group work. Sodium cyanoborohydride afforded a 
modest improvement in yield, but a decrease in stereoselectivity. The most effective 
reagent in this trial was proven to be sodium triacetoxyborohydride, offering good 
selectivity and a very good yield. These conditions were applied to a further two 
analogues, producing 4-hydoxypipecolic acid derivatives in further improved yields and 
selectivities (Scheme 71b). In comparison with the reduction of the trans-diastereomers, 
the reduction of the cis-isomers appears to proceed with greater diastereoselectivity. 
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Scheme 71: Reduction to 4-hydroxypipecolic acid derivatives 
 
2.2.12  Determination of Stereochemistry by nuclear Overhauser 
effect Spectroscopy (4-Hydroxy Derivatives) 
 
Determination of the stereochemistry of the 4-hydroxy compound was achieved using 
selective nOe experiments. As shown in Figures 8-10, irradiation of the He peak produced 
an enhancement of the Hb and Hg signals, confirming formation of the (4R)-isomer. This 
suggests a preference for axial attack, which is often observed with small nucleophiles 
despite being the more sterically congested approach. The origin of this axial selective 
effect is thought to be the relief of torsional strain. In the ketone starting material, the 
carbonyl group is close to an eclipsed position with the C-H bonds of the C-3 and C-5 
carbons. Equatorial attack would force the C-O bond through a fully eclipsed position, 
while axial attack relieves torsional strain, and is therefore the preferred approach. 
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Figure 8: Key nOe couplings for phenethyl derivative 283a 
 
 
 
Figure 9: Key nOe couplings for p-methoxyphenyl derivative 284a 
 
 
 
Figure 10: Key nOe couplings for naphthyl derivative 285a 
 
2.2.13  Ester Hydrolysis 
 
The core structure of the compounds synthesised in this project is the pipecolic acid 
moiety. It seemed logical to hydrolyse the methyl ester to the carboxylic acid for 
completeness, at least for the three 4-hydroxy analogues (Scheme 72). Using 6 M 
hydrochloric acid this proved facile, with carboxylic acid hydrochloride salts 288–290 
formed in good yield. 
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Scheme 72: Hydrolysis of methyl esters 
 
2.2.14  Summary 
 
In summary, this project achieved the aims proposed at the outset. The serendipitous 
discovery of a cyclisation that did not require the use of hydride reducing agents afforded a 
library of 4-oxopipecolic acid derivatives. The novel cyclisation offers improved yields, 
fewer synthetic manipulations, and compared to sodium cyanoborohydride used in 
previous work, N-ethyldiisopropylamine is advantageous in terms of economy and toxicity. 
The diastereoselectivity of the novel cyclisation is admittedly poorer than the original 
methodology, but due to higher overall yields, the amount of the major diastereomers 
isolated are greatly improved for the novel procedure. There is also scope to investigate the 
cyclisation with a bulkier ester moiety. In addition, the cis-relationship of the 2,6-
substituents contributes to the higher selectivity of the 4-oxo reduction. However, as the 
major diastereomers of each procedure are opposing, these two methods can be considered 
as complementary.  
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2.3  Synthesis of Quaternary Substituted Heterocycles 
 
2.3.1  Introduction 
 
The enantioselective synthesis of quaternary stereocenters presents the synthetic chemist 
with a significant challenge that has been well noted within the literature.
8385
 However, 
the prevalence of quaternary stereocenters in biologically relevant compounds provides a 
compelling impetus for the development of novel methodologies towards their synthesis. 
Of particular relevance to this project are quaternary substituted nitrogen containing 
heterocycles, examples of which are illustrated below (Figure 11). Fawcettimine 291 is one 
of a group of alkaloids isolated from the Lycopodium genus of plants which have been 
shown to possess acetylcholinesterase activity.
86
 Veliparib (ABT-888) 292 is a poly(ADP-
ribose) polymerase inhibitor, which shows potential as an anti-cancer treatment and is 
currently in clinical trials.
87
 Halichlorine 293 is a marine alkaloid isolated from the sponge 
Halichondria okadai and has potential in treatment for inflammatory diseases as an 
inhibitor of the vascular cell adhesion molecule 1 (VCAM-1) protein.
88 
 
 
 
 
Figure 11: Selected quaternary substituted N-heterocycles 
 
As many natural products contain a 2,2-disubstituted N-heterocyclic motif, the aim of this 
project was to develop methodology that would allow access to these systems with a 
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flexibility that would accommodate variable ring sizes. The proposed synthesis was to 
begin with with N-Boc lactams of various sizes, which form the core of the heterocycles 
(Scheme 73). Following deprotonation with lithium hexamethyldisilazide, the resulting 
enolate would be trapped with Comins’ triflating reagent, affording enol triflate 295. A 
nickel and chromium based catalytic system would then be employed to effect the coupling 
of the enol triflate and a variety of aldehydes, affording allylic alcohol 296. The alcohol 
would be alkylated under basic conditions to afford ether 297. A one pot, palladium 
catalysed isomerisation-rearrangement process would first promote the tautomerisation to 
allyl-vinyl ether intermediate 298,
89
 followed by the Claisen rearrangement to afford 
tertiary substituted lactam 299. It was proposed that the route should initially be trialled 
achirally, forming a racemic mixture of tertiary enantiomers. However, if the core 
methodology proved successful it could be modified to produce a stereoselective outcome, 
perhaps with the use of a chiral palladium source, or by the integration of a set stereocentre 
within the original lactam ring.  
 
 
 
Scheme 73: Proposed synthesis of tertiary substituted N-heterocycles 
 
2.3.2  Synthesis of Enol Triflates 
 
To begin the synthesis it was necessary to produce an N-Boc lactam. The 6-membered 2-
piperidone 300 was chosen as the starting material, and Boc protection was effected in 
good yield under standard conditions (Scheme 74). The Boc group was chosen as other 
potentially suitable groups (Cbz, Tf etc.) have been shown to cause stability issues with the 
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subsequently formed enol triflates.
90
 The protected lactam 301 was then subjected to a low 
temperature deprotonation to afford the enolate species, achieved using lithium 
hexamethyldisilazide at –78 C. To trap the enolate, a triflating reagent is required. The 
most prominent triflating reagent is arguably triflic anhydride. However, this reagent is 
reported as affording, at best, moderate yields upon reaction with enol triflates in 
tetrahydrofuran. Improved yields were reported by McMurray with the use of N-
phenyltrifluoromethanesulfonimide.
91
 However, reaction times were slow, which is 
particularly undesirable when using an unstable enolate, or when using a regioselectively 
deprotonated enolate that may equilibriate. This led to the development of the N-(5-chloro-
2-pyridyl)trifluoromethanesulfonimide reagent by Comins, which, due to the 
electronegative properties of the chloropyridyl ring, displayed improved reactivity towards 
enolates.
92
 For this reason, Comins’ reagent was utilised in this synthesis. Indeed, 
monitoring of reaction progress by TLC and analysis of the crude product by 
1
H NMR 
spectroscopy suggested that the reagent had been very effective. However, after 
purification, the yields afforded were disappointingly low. After several repetitions of the 
reaction with similar results, it was proposed that the enol triflate product 302 may be 
unstable under silica based column chromatography conditions. It was found that with the 
addition of 1% triethylamine to the eluent system, yields improved markedly to 80%, 
indicating that the enol triflate was indeed sensitive to mildly acidic media.  
 
 
 
Scheme 74: Synthesis of N-Boc enol triflate 302 
 
2.3.3  Chromium and Nickel Mediated Coupling of Enol Triflate 
and Aldehydes 
 
The next step for investigation was the chromium and nickel mediated coupling with 
various aldehydes. The oxidative insertion of metals into carbon-halide or carbon-triflate 
bonds to form a reactive organometallic species is by no means uncommon. However, the 
proposed mechanisms of the chromium-nickel catalytic system are probably sufficiently 
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unfamiliar to most to warrant further discussion. The insertion of chromium species into 
carbon-halide bonds has been known and investigated for several decades.
93
 However, it 
was the groups of Kishi and Nozaki who discovered (independently) in 1986 that nickel 
contaminants in the chromium source had a catalytic effect on the formation of 
organochromium species.
94, 95
 The protocol developed from these observations has since 
been termed the Nozaki-Hiyama-Kishi (NHK) reaction. The mechanisms of this process 
were proposed by Nozaki and co-workers (Scheme 75). Chromium(II), which is employed 
in excess, reduces catalytic nickel(II) to nickel(0). Nickel(0) oxidatively inserts into the 
carbon-halide or carbon-triflate bond of a substituted vinyl species 303, forming an 
organonickel reagent 304. Transmetallation affords the organochromium species 305 
which undergoes nucleophilic addition with the corresponding aldehyde to form allylic 
alcohol 306, whilst also releasing nickel(II) to participate in further catalytic cycles.   
 
 
 
Scheme 75: Proposed mechanism of NHK coupling 
 
In practice, the NHK reaction requires the rigorous use of anhydrous techniques due to the 
sensitivity of the nickel and chromium species to water and oxygen. The nickel(II) chloride 
and chromium(II) chloride employed in this synthesis are highly hygroscopic, and are oven 
dried before use. The solvent, dimethylformamide, is dried by distillation and stored over 
molecular sieves, then degassed with argon before use. Whilst nickel(II) chloride is used in 
2 mol% amounts, 6 equivalents of chromium(II) chloride are employed relative to the enol 
triflate. This is unfortunate and not ideal when viewed from a ‘green’ chemistry 
perspective, however, fewer equivalents of chromium(II) have been shown to markedly 
reduce yields.
89
 Using these conditions, reaction of enol triflate 302 with butyraldehyde 
afforded alcohol 307 in a yield of 66% (Scheme 76). 
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Scheme 76: NHK coupling reaction with butyraldehyde 
 
Whilst this yield is reasonable, the reaction was temperamental, affording inconsistent 
yields. On one occasion, despite the previously successful conditions being employed, no 
reaction was observed. In order to determine the scope of the reaction, investigations into 
coupling with aromatic aldehydes were initiated. Benzaldehyde was reacted under the 
standard conditions several times, and also at an elevated temperature of 50 C, without 
success; only starting materials were isolated from each reaction (Scheme 77a). It was 
proposed that an electron deficient aldehyde may prove more successful, and to this end, p-
fluorobenzaldehyde was employed under the standard conditions (Scheme 77b). This 
resulted in the isolation of alcohol 309 in 71% yield. However, this result proved to be 
irreproducible. Despite several attempts and maintaining rigorously anhydrous conditions, 
subsequent reactions returned only starting materials.  
 
 
 
Scheme 77: NHK coupling reactions 
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2.3.4  Alkylation of Allylic Alcohol 
 
In spite of the issues surrounding the NHK coupling, it was thought pertinent to progress 
the project. This involved the deprotonation of the alcohol with sodium hydride and 
alkylation with allyl bromide with the intention of forming di-allyl ether 310 (Scheme 
78a). Unfortunately, the reaction did not proceed as expected. After purification and 
analysis of the major reaction product, it appears that the alkoxide anion cyclised into the 
Boc carbamate group, forming bicylic carbamate 313 in 66% yield (Scheme 78b). No 
evidence of di-allyl ether 310 was observed. 
 
 
 
Scheme 78: Attempted alcohol allylation 
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2.3.5  Summary 
 
Unfortunately, due to time constraints, it was not possible to continue the investigation of 
the project beyond this point. However, there are a number of positive elements that can be 
taken away from the work conducted so far. The enol triflate can be synthesised in good 
yield, and awareness of the acid sensitivity of the molecule has been noted for future work. 
Despite the unreliable results obtained during the investigations of the NHK couplings, it 
has been shown that good yields are possible with some aliphatic and aromatic aldehydes. 
With more time and further investigation, it is likely that improved conditions could be 
found for the consistent formation of the desired alcohols. Finally, knowledge of the 
potential cyclisation side reaction observed in the attempted di-allyl ether synthesis can be 
used to inform future work.   
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3  Conclusions 
 
In summary, this research programme consisted of three distinct projects, which will be 
considered in turn below. 
 
The synthesis of 2-pyrrolidones and 2-piperidones has, as discussed above, received a 
substantial amount of attention. The aim of the first project was to develop a flexible, 
efficient synthesis towards these classes of compounds, and this objective was achieved. 
There are several attractive facets of the developed methodology. The starting material L-
phenylalanine is inexpensive and of high enantiopurity, and the stereocentre present in the 
starting material is utilised in a chelation-controlled reduction, affording the desired allylic 
alcohols with good selectivity and without the use of chiral reducing agents. The 
stereochemistry of the allylic alcohol is transferred to the key stereocentre of the target 
products by employing the highly efficient Overman rearrangement, and the substituent 
present on the target products can be varied by variation of the aldehyde utilised in the 
HWE reaction. It is possible to synthesise both 2-pyrrolidones and 2-piperidones from a 
common amine intermediate by employing the reported acylation and RCM reaction 
procedures. As noted above, chiral HPLC analysis of target products suggests that the 
methodology affords high enantiopurity products. 
 
Whilst this project achieved its primary aims, there are a number of avenues that could be 
investigated to extend the methodology further. For example, a broader range of aldehydes 
could be employed, and the effect of the resulting substituents on the Overman 
rearrangement investigated. Amine acylation using homologues of those reagents currently 
utilised may allow for the synthesis of larger ring sizes. Finally, as mentioned previously, 
the carbon-carbon double bond present in the RCM reaction products could be further 
functionalised in a variety of ways. 
 
The second project began as an optimisation of methodology previously developed in the 
group for the synthesis of 2,6-trans-4-oxopipecolic acid derivatives. The primary aim was 
to develop a cyclisation procedure that did not utilise hydride reducing reagents, therefore 
avoiding the issues of poor yields observed in the original methodology. Several dead ends 
were met whilst developing the ultimate synthetic route reported above, requiring 
reappraisals of strategy. However, thanks to the serendipitous discovery of a mild and 
efficient cyclisation procedure, an efficient and high yielding synthesis of 2,6-cis-4-
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oxopipecolic acid derivatives can be reported. Whilst the selectivity of the cyclisation is 
poorer than the hydride based method, higher overall efficiency affords greater yields of 
the major cyclisation products. It has been demonstrated that the cis-diastereomer is the 
major product of the novel methodology, as opposed to the preference seen for the trans-
diastereomer in the previous synthetic route, and in this respect, the syntheses can be 
considered as complementary.  
 
An aspect of the novel methodology towards 4-oxopipecolic acid derivatives that may 
warrant further investigation is the diastereoselectivity of the cyclisation. Whilst yields of 
the major product are acceptable, diastereoselectivities between 2:1 and 3:1 syn:anti could 
benefit from further improvement. As mentioned above, one possible solution to this may 
be the investigation of a bulkier ester group, which could modulate the preference for 
either stereoisomer. 
 
Finally, the aim of project three was to develop a synthesis of quaternary substituted 
heterocycles. The proposed methodology has the potential to efficiently access 
traditionally challenging quaternary stereocentres. Unfortunately, investigations in this 
project were dogged by temperamental compounds and unexpected reaction outcomes, 
compounded by a lack of time to fully investigate these issues. It was demonstrated that the 
chromium and nickel mediated addition of enol triflates to aldehydes can proceed in good 
yield, but reproducibility was poor. With time, it is hoped that conditions would be found 
that could afford consistent results. A second issue was found during the attempted 
alkylation; the cyclisation of the alkoxide anion into the Boc protecting group. This would 
appear to be a fundamental issue that would likely require reappraisal of at least the 
protecting group, and possibly strategy.  
 
Despite these setbacks, the proposed methodology has great potential for the synthesis of 
valuable target molecules, and with further work, it is felt likely that a robust and efficient 
route could be developed. 
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4  Experimental 
 
4.1  General Experimental 
 
All reagents and starting materials were obtained from commercial sources and used as 
received. All dry solvents were purified using a PureSolv 500 MD solvent purification 
system. All reactions were performed under an atmosphere of argon unless otherwise 
mentioned. Brine refers to a saturated solution of sodium chloride. Flash column 
chromatography was carried out using Fisher matrix silica 60. Macherey-Nagel 
aluminium-backed plates pre-coated with silica gel 60 (UV254) were used for thin layer 
chromatography and were visualised by staining with potassium permanganate. 
1
H NMR 
and 
13
C NMR spectra were recorded on a Bruker DPX 400 spectrometer with chemical 
shift values in ppm relative to tetramethylsilane as the standard. Assignment of 
1
H and 
13
C 
NMR signals are based on two-dimensional COSY and DEPT experiments, respectively. 
Infrared spectra were recorded using Golden Gate apparatus on a JASCO FTIR 410 
spectrometer and mass spectra were obtained using a JEOL JMS-700 spectrometer. 
Melting points were determined on a Reichert platform melting point apparatus. Optical 
rotations were determined as solutions irradiating with the sodium D line ( = 589 nm) 
using an Autopol V polarimeter. D values are given in units 10
–1
 deg cm
2
 g
–1
.  
 
4.2  Experimental Procedures 
 
(2S)-2-Hydroxy-3-phenylpropionic acid
96
   
 
 
 
To a solution of L-phenylalanine (10.00 g, 60.6 mmol) stirring at 0 C in 2.5 M sulfuric 
acid (50 mL, 125 mmol) was added a solution of sodium nitrite (8.36 g, 121 mmol) in 
water (50 mL) dropwise. The reaction was stirred at 0 C for 3 h, then allowed to warm to 
room temperature and stirred for 48 h. The reaction mixture was extracted with diethyl 
ether (3  50 mL) and dichloromethane (3  50 mL). The combined organic extracts were 
washed with brine (50 mL), dried (MgSO4), filtered and concentrated under reduced 
pressure to yield an off-white solid. The solid was triturated with petroleum ether and dried 
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by vacuum filtration to afford the desired compound (7.11 g, 71%) as a white solid. Mp. 
104110 C, lit. 95 123–125 C; max /cm
1
 3443 (OH), 2929 (CH), 1727 (CO), 1394, 1240, 
1191, 1089; []D
16
 –19.3 (c 1.0, MeOH), lit.
95
 []D
24 –20.0 (c 2.0, H2O); H (400 MHz, 
CD3OD) 2.91 (1H, dd, J 13.8, 8.1 Hz, 3-HH), 3.13 (1H, dd, J 13.8, 4.2 Hz, 3-HH), 4.34 
(1H, dd, J 8.1, 4.2 Hz, 2-H), 7.20–7.36 (5H, m, Ph); C (101 MHz, CD3OD) 41.7 (CH2), 
73.0 (CH), 127.5 (2  CH), 129.2 (2  CH), 130.6 (CH), 139.1 (C), 195.3 (C); m/z (CI) 167 
(MH
+
, 100%), 149 (14), 121 (21), 79 (27). 
 
Methyl (2S)-2-hydroxy-3-phenylpropionate
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A solution of (2S)-2-hydroxy-3-phenyl-propionic acid (178) (6.89 g, 41.5 mmol) and 
concentrated hydrochloric acid (17 mL, 207 mmol) in methanol (200 mL) and toluene (80 
mL) was heated to 80 C for 18 h. The reaction was cooled to room temperature, then 
concentrated under reduced pressure to yield an aqueous residue. The residue was 
extracted with ethyl acetate (2  150 mL), and the combined organic extracts were dried 
(MgSO4), filtered and concentrated under reduced pressure to yield a yellow oil. Flash 
column chromatography (petroleum ether/ethyl acetate 8:2) afforded the desired compound 
(6.75 g, 90%) as a pale yellow oil which solidified upon standing. Mp. 4144 C, lit.96 
4243 C; max /cm
1 
3434 (OH), 1734 (CO), 1642 (C=C), 1217, 1096, 746; []D
25
 –5.8 (c 
1.4, CHCl3), lit.
96
 []D
20
 –7.3 (c 1.0, CHCl3); H (400 MHz, CDCl3) 2.71 (1H, d, J 6.4 Hz, 
OH), 2.97 (1H, dd, J 14.0, 6.8 Hz, 3-HH), 3.13 (1H, dd, J 14.0, 4.4 Hz, 3-HH), 3.78 (3H, s, 
CH3), 4.44–4.49 (1H, m, 2-H), 7.20–7.32 (5H, m, Ph); C (101 MHz, CDCl3) 40.3 (CH2), 
52.3 (CH3), 71.0 (CH), 126.7 (2  CH), 128.2 (2  CH), 129.2 (CH), 136.0 (C), 174.4 (C); 
m/z (CI) 181 (MH
+
, 100%), 162 (7), 121 (9), 81 (6). 
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Methyl (2S)-2-methoxymethoxy-3-phenylpropionate
98
  
 
 
 
To a solution of methyl (2S)-2-hydroxy-3-phenylpropionate (314) (4.69 g, 26 mmol) 
stirring at 0 C in dichloromethane (250 mL) was added diisopropylethylamine (9.07 mL, 
52 mmol) followed by bromomethyl methyl ether (4.24 mL, 52 mmol) dropwise. The 
reaction was heated to 40 C for 18 h then cooled to room temperature. The mixture was 
washed with 1 M hydrochloric acid (100 mL) and water (100mL), then dried (MgSO4), 
filtered, and concentrated under reduced pressure to yield a yellow oil. Flash column 
chromatography (petroleum ether/diethyl ether 6:4) afforded the desired compound (5.19 
g, 89%) as a colourless oil. max/cm
1
 (neat) 2952 (CH), 1751 (CO), 1438, 1210, 1022, 
700; []D
23
 –56.9 (c 0.9, CHCl3), lit.
97
 56.6 (c 1.0 CHCl3); H (400 MHz, CDCl3) 2.98 
(1H, dd, J 13.8, 9.0 Hz, 3-HH), 3.07 (3H, s, OCH3), 3.11 (1H, dd, J 13.8, 4.0 Hz, 3-HH), 
3.73 (3H, s, OCH3), 4.34 (1H, dd, J 9.0, 4.0 Hz, 2-H), 4.51 (1H, d, J 6.8 Hz, OCHHO), 
4.64 (1H, d, J 6.8 Hz, OCHHO), 7.21–7.36 (5H, m, Ph); C (101 MHz, CDCl3) 38.8 (CH2), 
51.6 (CH3), 55.3 (CH3), 75.9 (CH), 95.6 (CH2), 126.3 (CH), 127.9 (2  CH), 129.0 (2  
CH), 136.6 (C), 172.2 (C); m/z (CI) 225.1124 (MH
+
. C12H17O4 requires 225.1127), 193 
(100%), 162 (12), 133 (39), 85 (22). 
 
(3S)-1-(Dimethoxyphosphoryl)-2-oxo-3-methoxymethoxy-4-phenylbutane 
 
 
 
To a solution of dimethyl methylphosphonate (6.39 mL, 60 mmol) in tetrahydrofuran (100 
mL) stirring at –78 C was added 1.6 M n-butyllithium in hexane (45 mL, 72.4 mmol) 
dropwise and the reaction stirred for 1 h. The mixture was added dropwise to a solution of 
methyl (2S)-2-methoxymethoxy-3-phenylpropionate (179) (6.01 g, 26.8 mmol) in 
tetrahydrofuran (200 mL) stirring at –78 C. The mixture was allowed to warm to room 
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temperature over 18 h, quenched with 2 M ammonium chloride solution (50 mL), then 
concentrated under reduced pressure. The residue was extracted with ethyl acetate (2  100 
mL), and the combined organic layers were dried (MgSO4), filtered and concentrated under 
reduced pressure to yield a yellow oil. Flash column chromatography (100% ethyl acetate) 
afforded the desired compound (7.62 g, 90%) as a pale yellow oil. max/cm
1
 (neat) 2955 
(CH), 1723 (CO), 1455, 1257, 1031, 810; []D
21
 –29.6 (c 1.0, CHCl3); H (400 MHz, 
CDCl3) 2.92 (1H, dd, J 13.9, 8.6 Hz, 4-HH), 3.05 (1H, dd, J 13.9, 4.2 Hz, 4-HH), 3.10–
3.28 (5H, m, 1-H2 and OMe), 3.77 (3H, s, OCH3), 3.80 (3H, s, OCH3), 4.37 (1H, dd, J 8.6, 
4.2 Hz, 3-H), 4.49 (1H, d, J 6.8 Hz, OCHHO), 4.59 (1H, d, J 6.8 Hz, OCHHO), 7.21–7.43 
(5H, m, Ph); C (101 MHz, CDCl3) 37.1 (d, JC-P 132 Hz, CH2), 38.0 (CH2), 53.0 (CH3), 
53.1 (CH3), 55.9 (CH2), 83.1 (CH), 96.5 (CH2), 126.8 (CH), 128.5 (2  CH), 129.5 (2  
CH), 136.7 (C), 202.8 (C); m/z (FAB) 317.1158 (MH
+
. C14H22O6P requires 317.1154), 285 
(93%), 267 (51), 255 (39), 152 (54), 110 (12), 86 (6). 
 
(3E,6S)-1,7-Diphenyl-6-methoxymethoxyhept-3-en-5-one 
 
 
 
To a solution of dimethyl (3S)-1-(dimethoxyphosphoryl)-2-oxo-3-methoxymethoxy-4-
phenylbutane (171) (100 mg, 0.32 mmol) in acetonitrile (10 mL) was added anhydrous 
potassium carbonate (52 mg, 0.38 mmol) followed by hydrocinnamaldehyde (85 mg, 0.63 
mmol), and the reaction was heated to 75 C for 24 h. The reaction was cooled to room 
temperature and concentrated under reduced pressure to yield a yellow oil. The oil was 
partitioned between water (25 mL) and ethyl acetate (25 mL). The organic layer was 
separated then washed with water (2  25 mL), dried (MgSO4), filtered and concentrated 
under reduced pressure. Flash column chromatography (petroleum ether/diethyl ether 1:0 
to 8:2) afforded the desired compound (94 mg, 92%) as a pale yellow oil. max/cm
1
 (neat) 
3028, 2929 (CH), 1693 (CO), 1496, 1454, 1148, 1051; []D
23
 –36.3 (c 1.1, CHCl3);H 
(400 MHz, CDCl3) 2.55 (2H, q, J 7.4 Hz, 2-H2), 2.78 (2H, t, J 7.4 Hz, 1-H2), 2.85 (1H, dd, 
J 13.8, 9.1 Hz, 7-HH), 2.95 (1H, dd, J 13.8, 4.2 Hz, 7-HH), 3.03 (3H, s, OCH3), 4.35 (1H, 
dd, J 9.1, 4.2 Hz, 6-H), 4.44 (1H, d, J 6.9 Hz, OCHHO), 4.49 (1H, d, J 6.9 Hz, OCHHO), 
6.49 (1H, d, J 15.8 Hz, 4-H), 7.01 (1H, dt, J 15.8, 7.4 Hz, 3-H), 7.14–7.32 (10H, m, 2  
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Ph); C (100 MHz, CDCl3) 34.3 (CH2), 34.4 (CH2), 38.9 (CH2), 55.7 (CH3), 81.9 (CH), 
96.0 (CH2), 126.2 (CH), 126.3 (CH), 126.7 (CH), 128.4 (2  CH), 128.4 (2  CH), 128.5 (2 
 CH), 129.5 (2  CH), 137.2 (C), 140.7 (C), 148.1 (CH), 199.3 (CO); m/z (CI) 325.1806 
(MH
+
. C21H25O3 requires 325.1804), 294 (100%), 266 (13), 220 (5), 159 (4), 137 (5), 
85(9). 
 
(4E,7S)-2-Methyl-7-methoxymethoxy-8-phenyloct-4-en-6-one 
 
 
 
To a solution of (3S)-1-(dimethoxyphosphoryl)-2-oxo-3-methoxymethoxy-4-phenylbutane 
(4.52 g, 14.3 mmol) (171) in acetonitrile (150 mL) was added anhydrous potassium 
carbonate (2.37 g, 17.1 mmol) and 3-methylbutanal (3.08 mL, 28.6 mmol), and the 
reaction heated to 70 C for 24 h. The reaction was cooled to room temperature then 
partitioned between water (100 mL) and ethyl acetate (100 mL). The aqueous layer was 
removed, and the organic layer was washed with brine (100 mL), dried (MgSO4), filtered 
and concentrated under reduced pressure. Flash column chromatography (petroleum 
ether/diethyl ether 95:5 to 15:85) afforded the desired product (3.63 g, 92%) as a pale 
yellow oil. max/cm
1 
(neat) 2955 (CH), 1693 (CO), 1625 (C=C), 1496, 1455, 1316, 1149, 
920; []D
21
 37.0 (c 1.0, CHCl3); H (400 MHz, CDCl3) 0.92 (6H, d, J 6.8 Hz, 1-H3 and 2-
CH3), 1.77 (1H, nonet, J 6.8 Hz, 2-H), 2.11 (2H, td, J 6.8, 1.3 Hz, 3-H2), 2.89 (1H, dd, J 
14.0, 9.0 Hz, 8-HH), 3.01 (1H, dd, J 14.0, 4.2 Hz, 8-HH), 3.06 (3H, s, OCH3), 4.40 (1H, 
dd, J 9.0, 4.2 Hz, 7-H), 4.49 (1H, d, J 6.9 Hz, OCHHO), 4.54 (1H, d, J 6.9 Hz, OCHHO), 
6.40 (1H, dt, J 15.6, 1.3 Hz, 5-H), 7.00 (1H, dt, J 15.6, 6.8 Hz, 4-H), 7.20–7.31 (5H, m, 
Ph); C (100 MHz, CDCl3) 22.4 (2  CH3), 27.9 (CH), 39.0 (CH2), 42.0 (CH2), 55.7 (CH3), 
81.8 (CH), 96.0 (CH2), 126.6 (CH), 126.7 (CH), 128.4 (2  CH), 129.5 (2  CH), 137.2 
(C), 148.5 (CH), 199.3 (C); m/z (CI) 277.1802 (MH
+
. C17H25O3 requires 277.1804), 245 
(100%), 217 (13), 215 (10), 157 (4), 111 (6), 85 (7). 
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(4E,7S)-7-Methoxymethoxy-8-phenyloct-4-en-6-one 
 
 
 
To a solution of dimethyl (3S)-1-(dimethoxyphosphoryl)-2-oxo-3-methoxymethoxy-4-
phenylbutane (171) (5.28 g, 16.69 mmol) in acetonitrile (150 mL) was added butanal (3.01 
mL, 33.39 mmol) and anhydrous potassium carbonate (3.46 g, 25.04 mmol) and the 
mixture heated to 70 C for 18 h. The mixture was cooled to room temperature and 
partitioned between water (150 mL) and ethyl acetate (150 mL). The organic layer was 
separated and washed with brine (150 mL), dried (MgSO4), filtered and concentrated under 
reduced pressure. Flash column chromatography (petroleum ether/diethyl ether 9:1 to 8:2) 
afforded the desired product (2.71 g, 62%) as a yellow oil. max/cm
1
 (neat) 2959 (CH), 
1693 (CO), 1625 (C=C), 1455, 1149, 1053, 700; []D
28
 
 51.7 (c 1.1, CHCl3); H (400 
MHz, CDCl3) 0.93 (3H, t, J 7.4 Hz, 1-H3), 1.49 (2H, sextet, J 7.4 Hz, 2-H2), 2.20 (2H, qd, 
J 7.4, 1.6 Hz, 3-H2), 2.89 (1H, dd, J 14.0, 9.2 Hz, 8-HH), 3.00 (1H, dd, J 14.0, 4.4 Hz, 8-
HH), 3.06 (3H, s, OCH3), 4.40 (1H, dd, J 9.2, 4.4 Hz, 7-H), 4.48 (1H, d, J 6.8 Hz, 
OCHHO), 4.54 (1H, d, J 6.8 Hz, OCHHO), 6.40 (1H, d, J 15.7 Hz, 5-H), 7.01 (1H, dt, J 
15.7, 7.4 Hz, 4-H), 7.20–7.31 (5H, m, Ph); C (100 MHz, CDCl3) 13.7 (CH3), 21.3 (CH2), 
34.7 (CH2), 39.0 (CH2), 55.7 (CH3), 81.9 (CH), 96.0 (CH2), 125.8 (CH), 126.6 (CH), 128.4 
(2  CH), 129.5 (2  CH), 137.2 (C), 149.4 (CH), 199.4 (C); m/z (CI) 263.1651 (MH+. 
C16H23O3 requires 263.1647), 231 (100%), 201 (8), 143 (%), 121 (9), 85 (9). 
 
(3E,5R,6S)- and (3E,5S,6S)-1,7-Diphenyl-6-methoxymethoxyhept-3-en-5-ol 
 
 
 
To a solution of anhydrous zinc chloride (1.48 g, 10.8 mmol) in tetrahydrofuran (200 mL) 
stirring at 0 C was added sodium borohydride (0.82 g, 21.5 mmol) and the reaction 
mixture was stirred while warming to room temperature over 18 h. Stirring of the reaction 
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was stopped, the solids allowed to settle, and the solution was cooled to –78 C. The 
supernatant solution was added dropwise via cannula to a solution of (3E,6S)-1,7-diphenyl-
6-methoxymethoxyhept-3-en-5-one (181) (0.87 g, 2.69 mmol) in tetrahydrofuran (50 mL) 
at –78 C. The reaction was stirred while warming to room temperature over 18 h, then 
cooled to 0 C and quenched dropwise with water (20 mL). The mixture was partitioned 
between water (150 mL) and diethyl ether (150 mL). The organic phase was separated, 
washed with water (150 mL) then brine (150 mL), dried (MgSO4), filtered and 
concentrated under reduced pressure. Flash column chromatography (petroleum ether/ethyl 
acetate 9:1 to 7:3) afforded (3E,5R,6S)- and (3E,5S,6S)-1,7-diphenyl-6-
methoxymethoxyhept-3-en-5-ol (0.76 g, 87%) in a 7:1 ratio, respectively as a colourless 
oil. max/cm
1
 (neat) 3435 (OH), 2927 (CH), 1638 (C=C), 1496, 1454, 1036, 699; NMR 
spectroscopic data for major diastereomer (3E,5R,6S): H (400 MHz, CDCl3) 2.44 (2H, q, J 
7.0 Hz, 2-H2), 2.59 (1H, dd, J 14.1, 5.1 Hz, 7-HH), 2.64–2.75 (3H, m, 1-H2 and 7-HH), 
2.99 (1H, d, J 6.8 Hz, OH), 3.23 (3H, s, OCH3), 3.73 (1H, ddd, J 8.1, 5.1, 2.4 Hz, 6-H), 
4.07 (1H, td, J 6.8, 2.4 Hz, 5-H), 4.38 (1H, d, J 6.9 Hz, OCHHO), 4.60 (1H, d, J 6.9 Hz, 
OCHHO), 5.61 (1H, ddt, J 15.5, 6.8, 1.3 Hz, 4-H), 5.78 (1H, dt, J 15.5, 7.0 Hz, 3-H), 7.15–
7.30 (10H, m, 2  Ph); C (100 MHz, CDCl3) 34.2 (CH2), 35.5 (CH2), 37.5 (CH2), 55.7 
(CH3), 73.9 (CH), 84.7 (CH), 97.2 (CH2), 125.9 (2  CH), 126.3 (CH), 128.3 (2  CH), 
128.4 (2  CH), 128.5 (2  CH), 129.4 (2  CH), 133.5 (CH), 138.6 (C), 141.7 (C); m/z 
(CI) 309.1853 (MH
+–H2O. C21H25O2 requires 309.1855), 277 (100), 265 (24), 247 (18), 
175 (6), 131 (16). 
 
(4E,6R,7S)- and (4E,6S,7S)-2-Methyl-7-methoxymethoxy-8-phenyloct-4-en-6-ol 
 
 
 
To a solution of anhydrous zinc chloride (6.50 g, 47.7 mmol) in tetrahydrofuran (200 mL) 
stirring at 0 C was added sodium borohydride (3.61 g, 95.5 mmol) and the reaction 
mixture was stirred while warming to room temperature over 18 h. Stirring of the reaction 
was stopped, the solids allowed to settle, and the solution was cooled to –78 C. The 
supernatant solution was added dropwise via cannula to a solution of (4E,7S)-2-methyl-7-
methoxymethoxy-8-phenyloct-4-en-6-one (182) (3.30 g, 11.9 mmol) in tetrahydrofuran (50 
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mL) at –78 C. The reaction was stirred while warming to room temperature over 18 h, 
then cooled to 0 C and quenched dropwise with water (20 mL). The mixture was 
partitioned between water (150 mL) and diethyl ether (150 mL). The organic phase was 
separated, washed with water (150 mL) then brine (150 mL), dried (MgSO4), filtered and 
concentrated under reduced pressure. Flash column chromatography (petroleum ether/ethyl 
acetate 95:5 to 3:1) afforded (4E,6R,7S)- and (4E,6S,7S)-2-methyl-7-methoxymethoxy-8-
phenyloct-4-en-6-ol (2.17 g, 65%) in a 7:1 ratio, respectively as a colourless oil. max/cm
1
 
(neat) 3451 (OH), 2955 (CH), 1667 (C=C), 1604, 1496, 1454, 1367, 1038, 918; NMR 
spectroscopic data for major diastereomer (4E,6R,7S): H (400 MHz, CDCl3) 0.92 (3H, d, J 
6.8 Hz, 1-H3), 0.93 (3H, d, J 6.8 Hz, 2-CH3), 1.68 (1H, nonet, J 6.8 Hz, 2-H), 1.96–2.03 
(2H, m, 3-H2), 2.75 (1H, dd, J 14.0, 5.2 Hz, 8-HH), 2.81 (1H, dd, J 14.0, 8.2 Hz, 8-HH), 
2.99 (1H, d, J 6.4 Hz, OH), 3.24 (3H, s, OCH3), 3.84 (1H, ddd, J 8.2, 5.2, 2.4 Hz, 7-H), 
4.09 (1H, td, J 6.4, 2.4 Hz, 6-H), 4.40 (1H, d, J 6.9 Hz, OCHHO), 4.62 (1H, d, J 6.9 Hz, 
OCHHO), 5.58 (1H, ddt, J 15.2, 6.4, 1.2 Hz, 5-H), 5.74 (1H, dt, J 15.2, 7.6 Hz, 4-H), 7.18–
7.30 (5H, m, Ph); C (100 MHz, CDCl3) 22.3 (CH3), 22.4 (CH3), 28.3 (CH), 37.5 (CH2), 
41.9 (CH2), 55.7 (CH3), 74.0 (CH), 84.6 (CH), 97.2 (CH2), 126.2 (CH), 128.3 (2  CH), 
128.9 (CH), 129.4 (2  CH), 133.3 (CH), 138.7 (C); m/z (CI) 261.1854 (MH+–H2O. 
C17H25O2 requires 261.1855), 262 (23%), 229 (16), 217 (17), 113 (42). 
 
(4E,6R,7S)- and (4E,6S,7S)-7-Methoxymethoxy-8-phenyloct-4-en-6-ol 
 
 
 
To a solution of anhydrous zinc chloride (4.63 g, 34.00 mmol) in tetrahydrofuran (200 mL) 
stirring at 0 C was added sodium borohydride (2.57 g, 68.00 mmol) and the reaction 
mixture was stirred while warming to room temperature over 18 h. Stirring of the reaction 
was stopped, the solids allowed to settle, and the solution was cooled to –78 C. The 
supernatant solution was added dropwise via cannula to a solution of (4E,7S)-7-
methoxymethoxy-8-phenyloct-4-en-6-one (183) (2.23 g, 8.50 mmol) in tetrahydrofuran (50 
mL) at –78 C. The reaction was stirred while warming to room temperature over 18 h, 
then cooled to 0 C and quenched dropwise with water (20 mL). The mixture was 
partitioned between water (150 mL) and diethyl ether (150 mL). The organic phase was 
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separated, washed with water (150 mL) then brine (150 mL), dried (MgSO4), filtered and 
concentrated under reduced pressure. Flash column chromatography (petroleum ether/ethyl 
acetate 85:15 to 4:1) afforded (4E,6R,7S)- and (4E,6S,7S)-7-Methoxymethoxy-8-
phenyloct-4-en-6-ol (2.25 g, 100%) in a 7:1 ratio, respectively as a colourless oil. max 
(film)/cm
1
 3441 (OH), 2924 (CH), 1450, 1149, 1096, 1034, 702; NMR spectroscopic data 
for major diastereomer (4E,6R,7S): H (400 MHz, CDCl3) 0.94 (3H, t, J 7.4 Hz, 1-H3), 1.46 
(2H, sextet, J 7.4 Hz, 2-H2), 2.09 (2H, q, J 7.4 Hz, 3-H2), 2.75 (1H, dd, J 14.4, 5.2 Hz, 8-
HH), 2.81 (1H, dd, J 14.4, 8.0 Hz, 8-HH), 2.91 (1H, d, J 6.8 Hz, OH), 3.24 (3H, s, OCH3), 
3.84 (1H, ddd, J 8.0, 5.2, 2.6 Hz, 7-H), 4.09 (1H, td, J 6.8, 2.6 Hz, 6-H), 4.56 (1H, d, J 6.8 
Hz, OCHHO), 4.61 (1H, d, J 6.8 Hz, OCHHO), 5.58 (1H, dd, J 15.6, 6.8 Hz, 5-H), 5.75 
(1H, dt, J 15.6, 7.4 Hz, 4-H), 7.18–7.30 (5H, m, Ph); C (100 MHz, CDCl3) 13.7 (CH3), 
22.4 (CH2), 34.6 (CH2), 37.5 (CH2), 55.7 (CH3), 74.0 (CH), 84.6 (CH), 97.2 (CH2), 126.2 
(CH), 128.0 (CH), 128.3 (2  CH), 129.4 (2  CH), 134.4 (CH), 138.7 (C); m/z (CI) 
247.1699 (MH
+H2O. C16H23O2 requires 247.1698), 215 (100%), 203 (55), 185 (36), 171 
(21), 113 (14), 99 (42). 
 
(3R,4E,6S)- and (3S,4E,6S)-1,7-Diphenyl-3-(2’,2’,2’-trichlomethylcarbonylamino)-6-
methoxymethoxyhept-4-ene 
 
 
 
To a solution of (3E,5R,6S)- and (3E,5S,6S)-1,7-diphenyl-6-methoxymethoxyhept-3-en-5-
ol (184) (1.54 g, 4.7 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (0.71 mL, 4.7 mmol) 
in dichloromethane (150 mL) was added trichloroacetonitrile (0.95 mL, 9.4 mmol) and the 
reaction stirred for 48 h at room temperature. The mixture was filtered under reduced 
pressure through silica gel and washed with diethyl ether (50 mL). Concentration under 
reduced pressure gave a yellow oil. The oil was dissolved in p-xylene (250 mL), and 
potassium carbonate (0.10 g, 0.7 mmol) was added to the mixture. The mixture was heated 
to 140 C for 18 h, then cooled to room temperature and concentrated in vacuo. Flash 
column chromatography (petroleum ether/ethyl acetate 95:5 to 7:3) gave (3R,4E,6S)- and 
(3S,4E,6S)-1,7-diphenyl-3-(2’,2’,2’-trichlomethylcarbonylamino)-6-methoxymethoxyhept-
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4-ene (1.85 g, 84% over two steps) in a 7:1 ratio, respectively as a yellow oil. max/cm
1
 
(neat) 3328 (NH), 2928 (CH), 1697 (CO), 1516, 1040, 822; NMR spectroscopic data for 
major diastereomer (3R,4E,6S): H (400 MHz, CDCl3) 1.91 (2H, q, J 7.5 Hz, 2-H2), 2.60 
(2H, t, J 7.5 Hz, 1-H2), 2.80 (1H, dd, J 13.6, 6.4 Hz, 7-HH), 2.92 (1H, dd, J 13.6, 6.4 Hz, 
7-HH), 3.12 (3H, s, OCH3), 4.27 (1H, q, J 6.4 Hz, 6-H), 4.39–4.46 (1H, m, 3-H), 4.47 (1H, 
d, J 6.9 Hz, OCHHO), 4.64 (1H, d, J 6.9 Hz, OCHHO), 5.54 (1H, dd, J 15.8, 5.2 Hz, 4-H), 
5.61 (1H, dd, J 15.8, 6.4 Hz, 5-H), 6.42 (1H, d, J 8.2 Hz, NH), 7.10–7.32 (10H, m, 2  Ph); 
C (100 MHz, CDCl3) 31.9 (CH2), 36.2 (CH2), 42.2 (CH2), 52.4 (CH), 55.3 (CH3), 76.8 
(CH), 92.7 (CCl3), 93.9 (CH2), 126.3 (CH), 126.4 (CH), 128.3 (2  CH), 128.4 (2  CH), 
128.7 (2  CH), 129.7 (2  CH), 131.0 (CH), 132.3 (CH), 137.8 (C), 140.7 (C), 161.0 
(CO); m/z (CI) 470.1049 (MH
+
. C23H27
35
Cl3NO3 requires 470.1057), 408 (38%), 374 
(100), 340 (43). 
 
(4R,5E,7S)- and (4S,5E,7S)-2-Methyl-4-(2’,2’,2’-trichlomethylcarbonylamino)-7-
methoxymethoxy-8-phenyloct-5-ene 
 
 
 
To a solution of (4E,6R,7S)- and (4E,6S,7S)-2-methyl-7-methoxymethoxy-8-phenyloct-4-
en-6-ol (185) (2.17 g, 7.79 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (1.17 mL, 7.79 
mmol) in dichloromethane (150 mL) was added trichloroacetonitrile (1.56 mL, 15.6 mmol) 
and the reaction stirred for 48 h at room temperature. The mixture was filtered under 
reduced pressure through silica gel and washed with diethyl ether (50 mL). Concentration 
under reduced pressure gave a yellow oil. The oil was dissolved in p-xylene (250 mL), and 
potassium carbonate (0.10 g, 0.7 mmol) was added to the mixture. The mixture was heated 
to 140 C for 18 h, then cooled to room temperature and concentrated in vacuo. Flash 
column chromatography (petroleum ether/diethyl ether 1:0 to 8:2) gave (4R,5E,7S)- and 
(4S,5E,7S)-2-methyl-4-(2’,2’,2’-trichlomethylcarbonylamino)-7-methoxymethoxy-8-
phenyloct-5-ene (1.40 g, 42% over two steps) in a 7:1 ratio, respectively as a yellow oil. 
max/cm
1
 (neat) 3347 (NH), 2956 (CH), 2929, 1693 (CO), 1684 (C=C), 1519, 1037, 820; 
NMR spectroscopic data for major diastereomer (4R,5E,7S):  H (400 MHz, CDCl3) 0.94 
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(3H, d, J 7.6 Hz, 1-H3) 0.95 (3H, d, J 7.6 Hz, 2-CH3), 1.37–1.53 (2H, m, 3-H2), 1.60 (1H, 
nonet, J 7.6 Hz, 2-H), 2.82 (1H, dd, J 13.6, 6.4 Hz, 8-HH), 2.92 (1H, dd, J 13.6, 7.6 Hz, 8-
HH), 3.13 (3H, s, OCH3), 4.24–4.30 (1H, m, 7-H), 4.43–4.49 (2H, m, 4-H and OCHHO), 
4.64 (1H, d, J 6.9 Hz, OCHHO), 5.51 (1H, dd, J 16.0, 6.4 Hz, 5-H), 5.57–5.66 (1H, m, 6-
H), 6.42 (1H, d, J 8.5 Hz, NH), 7.19–7.31 (5H, m, Ph); C (100 MHz, CDCl3) 22.4 (CH3), 
22.5 (CH3), 24.8 (CH), 42.2 (CH2), 43.8 (CH2), 51.1 (CH3), 55.2 (CH), 76.8 (CH), 92.8 
(C), 93.7 (CH2), 126.3 (CH), 128.2 (2  CH), 129.7 (2  CH), 131.6 (CH), 131.7 (CH), 
137.8 (C), 160.9 (C); m/z (FAB) 444.0886 (MNa
+
. C19H26
35
Cl3NNaO3 requires 444.0876), 
360 (100%), 325 (14), 199 (36), 143 (44). 
 
(4R,5E,7S)- and (4S,5E,7S)-4-(2’,2’,2’-Trichlomethylcarbonylamino)-7-
methoxymethoxy-8-phenyloct-5-ene 
 
 
To a solution of (4E,6R,7S)- and (4E,6S,7S)-7-methoxymethoxy-8-phenyloct-4-en-6-ol 
(186) (2.52 g, 9.53 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (1.43 mL, 9.53 mmol) 
in dichloromethane (150 mL) was added trichloroacetonitrile (1.91 mL, 19.06 mmol) and 
the reaction stirred for 48 h at room temperature. The mixture was filtered under reduced 
pressure through silica gel and washed with diethyl ether (50 mL). Concentration under 
reduced pressure gave a yellow oil. The oil was dissolved in p-xylene (250 mL), and 
potassium carbonate (0.10 g, 0.7 mmol) was added to the mixture. The mixture was heated 
to 140 C for 18 h, then cooled to room temperature and concentrated in vacuo. Flash 
column chromatography (petroleum ether/diethyl ether 1:0 to 7:3) gave (4R,5E,7S)- and 
(4S,5E,7S)-4-(2’,2’,2’-Trichlomethylcarbonylamino)-7-methoxymethoxy-8-phenyloct-5-
ene (1.94 g, 48% over two steps) in a 7:1 ratio, respectively as a yellow oil. max/cm
1
 
(neat) 3325 (NH), 2932 (CH), 1697 (CO), 1512, 1033, 817; NMR spectroscopic data for 
major diastereomer (4R,5E,7S): H (400 MHz, CDCl3) 0.85 (3H, t, J 7.4 Hz, 1-H3), 1.26 
(2H, sextet, J 7.4 Hz, 2-H2), 1.47 (2H, q, J 7.4 Hz, 3-H2), 2.72 (1H, dd, J 13.6, 7.0 Hz, 8-
HH), 2.84 (1H, dd, J 13.6, 7.0 Hz, 8-HH), 3.05 (3H, s, OCH3), 4.18 (1H, q, J 7.0 Hz, 7-H), 
4.29–4.34 (1H, m, 4-H), 4.39 (1H, d, J 6.8 Hz, OCHHO), 4.45 (1H, d, J 6.8 Hz, OCHHO), 
5.44 (1H, dd, J 15.6, 6.0 Hz, 5-H), 5.48–5.55 (1H, m, 6-H), 6.33 (1H, br d, J 8.2 Hz, NH), 
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7.10–7.21 (5H, m, Ph); C (100 MHz, CDCl3) 13.7 (CH3), 18.8 (CH2), 36.8 (CH2), 42.2 
(CH2), 52.5 (CH), 55.2 (CH3), 76.9 (CH), 92.8 (C), 93.8 (CH2), 126.3 (CH), 128.2 (2  
CH), 129.7 (2  CH), 131.5 (CH), 131.8 (CH), 137.8 (C), 161.0 (C); m/z (FAB) 430.0717 
(MNa
+
. C18H24
35
Cl3NNaO3 requires 430.0719), 348 (52%), 346 (50), 297 (14), 185 (59), 
117 (18). 
 
(3R,4E,6S)-1,7-Diphenyl-3-(prop-2’-enoylamino)-6-methoxymethoxyhept-4-ene 
 
 
 
 
 
To a solution of (3R,4E,6S)- and (3S,4E,6S)-1,7-diphenyl-3-(2’,2’,2’-
trichlomethylcarbonylamino)-6-methoxymethoxyhept-4-ene (193) (0.67 g, 1.42 mmol) in 
methanol (100 mL) was added 1 M aqueous sodium hydroxide (50 mL, 50 mmol) and the 
solution heated to 70 C for 18 h. The reaction mixture was cooled, concentrated under 
reduced pressure and extracted with dichloromethane (2  25 mL) and ethyl acetate (2  25 
mL). The combined organic layers were washed with brine, dried (MgSO4), filtered and 
concentrated under reduced pressure. A portion of the oil (0.35 g, 1.08 mmol) was 
dissolved in diethyl ether (15 mL), cooled to –78 C, and triethylamine (0.20 mL, 1.40 
mmol) was added. A solution of acryloyl chloride (0.11 mL, 1.40 mmol) in diethyl ether 
(15 mL) was added dropwise and the reaction was stirred while returning to room 
temperature over 18 h. The reaction mixture was partitioned between water (30 mL) and 
diethyl ether (15 mL) and the organic layer was separated, washed with brine, dried 
(MgSO4), filtered and concentrated under reduced pressure. Flash column chromatography 
(petroleum ether/diethyl ether 1:0 to 8:2) gave (3R,4E,6S)-1,7-diphenyl-3-(prop-2’-
enoylamino)-6-methoxymethoxyhept-4-ene (0.19 g, 48%) as a colourless oil. max/cm
1
 
(neat) 3273 (NH), 2941 (CH), 1655 (CO), 1542, 1039, 699; []D
27
 –20.7 (c, 0.8, CHCl3); 
H (400 MHz, CDCl3) 1.83 (2H, q, J 6.9 Hz, 2-H2), 2.57–2.61 (2H, m, 1-H2), 2.79 (1H, dd, 
J 13.6, 6.1 Hz, 7-HH), 2.90 (1H, dd, J 13.6, 7.5 Hz, 7-HH), 3.09 (3H, s, OCH3), 4.21–4.26 
(1H, m, 6-H), 4.45 (1H, d, J 6.8 Hz, OCHHO), 4.57–4.64 (1H, m, 3-H), 4.63 (1H, d, J 6.8 
Hz, OCHHO), 5.34 (1H, d, J 8.6 Hz, NH), 5.53–5.54 (2H, m, 4-H and 5-H), 5.65 (1H, dd, 
J 10.2, 1.4 Hz, 3’-HH), 6.02 (1H, dd, J 17.0, 10.2 Hz, 2’-H), 6.26 (1H, dd, J 17.0, 1.4 Hz, 
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3’-HH), 7.00–7.47 (10H, m, 2  Ph); C (100 MHz, CDCl3) 32.1 (CH2), 36.6 (CH2), 42.3 
(CH2), 50.3 (CH), 55.2 (CH3), 77.1 (CH), 93.7 (CH2), 126.1 (CH), 126.3 (CH), 126.7 
(CH2), 128.2 (2  CH), 128.4 (2  CH), 128.5 (2  CH), 129.7 (2  CH), 130.8 (CH), 
131.1 (CH), 132.9 (CH) 138.1 (C), 141.4 (C), 164.6 (CO); m/z (CI) 380.2227 (MH
+
. 
C24H28NO3 requires 380.2226), 318 (100%), 288 (9), 249 (6), 97 (18). 
 
(4R,5E,7S)-2-Methyl-4-(prop-2’-enoylamino)-7-methoxymethoxy-8-phenyloct-5-ene 
 
 
To a solution of (4R,5E,7S)- and (4S,5E,7S)-2-methyl-4-(2’,2’,2’-
trichlomethylcarbonylamino)-7-methoxymethoxy-8-phenyl-oct-5-ene (194) (1.40 g, 3.31 
mmol) in methanol (100 mL) was added 1 M aqueous sodium hydroxide (50 mL, 50 
mmol) and the solution heated to 70 C for 18 h. The reaction mixture was cooled, 
concentrated under reduced pressure and extracted with dichloromethane (2  25 mL) and 
ethyl acetate (2  25 mL). The combined organic layers were washed with brine, dried 
(MgSO4), filtered and concentrated under reduced pressure. A portion of the oil (0.28 g, 
0.87 mmol) was dissolved in diethyl ether (15 mL), cooled to –78 C, and triethylamine 
(0.16 mL, 1.13 mmol) was added. A solution of acryloyl chloride (0.09 mL, 1.13 mmol) in 
diethyl ether (15 mL) was added dropwise and the reaction was stirred while returning to 
room temperature over 18 h. The reaction mixture was partitioned between water (30 mL) 
and diethyl ether (15 mL) and the organic layer was separated, washed with brine, dried 
(MgSO4), filtered and concentrated under reduced pressure. Flash column chromatography 
(petroleum ether/ethyl acetate 8:2 to 7:3) gave (4R,5E,7S)-2-methyl-4-(prop-2’-
enoylamino)-7-methoxymethoxy-8-phenyloct-5-ene (0.14 g, 48%) as a colourless oil. 
max/cm
1
 (neat) 3270 (NH), 2954 (CH), 1654 (CO), 1625 (C=C), 1542, 1148, 1040; []D
25
 
+12.7 (c 1.4, CHCl3); H (400 MHz, CDCl3) 0.89 (3H, d, J 6.8 Hz, 1-H3), 0.91 (3H, d, J 6.8 
Hz, 2-CH3), 1.28–1.41 (2H, m, 3-H2), 1.56 (1H, nonet, J 6.8 Hz, 2-H), 2.78 (1H, dd, J 
13.6, 6.4 Hz, 8-HH), 2.88 (1H, dd, J 13.6, 8.0 Hz, 8-HH), 3.07 (3H, s, OCH3), 4.18–4.23 
(1H, m, 7-H), 4.43 (1H, d, J 8.0 Hz, OCHHO), 4.57–4.64 (2H, m, OCHHO and 4-H), 5.31 
(1H, br d, J 8.6 Hz, NH), 5.44 (1H, dd, J 15.6, 6.0 Hz, 5-H), 5.54 (1H, dd, J 15.6, 7.2 Hz, 
6-H), 5.66 (1H, dd, J 10.2, 1.4 Hz, 3’-HH), 6.06 (1H, dd, J 16.9, 10.2 Hz, 2’-H), 6.29 (1H, 
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dd, J 16.9, 1.4 Hz, 3’-HH), 7.19–7.27 (5H, m, Ph); C (100 MHz, CDCl3) 22.5 (CH3), 22.6 
(CH3), 24.8 (CH), 42.3 (CH2), 44.6 (CH2), 48.7 (CH3), 55.2 (CH), 77.1 (CH), 93.6 (CH2), 
126.2 (CH), 126.6 (CH2), 128.1 (2  CH), 129.8 (2  CH), 130.5 (CH), 130.9 (CH), 133.6 
(CH), 138.1 (C), 164.5 (C); m/z (CI) 332.2222 (MH
+
. C20H30NO3 requires 332.2226), 333 
(8%), 307 (12), 271 (100), 240 (7). 
 
(4R,5E,7S)-4-(Prop-2’-enoylamino)-7-methoxymethoxy-8-phenyloct-5-ene 
 
 
 
To a solution of (4R,5E,7S)- and (4S,5E,7S)-4-(2’,2’,2’-trichlomethylcarbonylamino)-7-
methoxymethoxy-8-phenyloct-5-ene (195) (92 mg, 0.23 mmol) in methanol (10 mL) was 
added 1 M aqueous sodium hydroxide (5 mL, 5 mmol) and the solution heated to 70 C for 
18 h. The reaction mixture was cooled, concentrated under reduced pressure and extracted 
with dichloromethane (2  25 mL) and ethyl acetate (2  25 mL). The combined organic 
layers were washed with brine, dried (MgSO4), filtered and concentrated under reduced 
pressure. The product was dissolved in diethyl ether (15 mL), cooled to –78 C, and 
triethylamine (35 L, 0.25 mmol) was added. A solution of acryloyl chloride (20 L, 0.25 
mmol) in diethyl ether (3 mL) was added dropwise and the reaction was stirred while 
returning to room temperature over 18 h. The reaction mixture was partitioned between 
water (30 mL) and diethyl ether (15 mL) and the organic layer was separated, washed with 
brine, dried (MgSO4), filtered and concentrated under reduced pressure. Flash column 
chromatography (petroleum ether/ethyl acetate 8:2 to 7:3) gave (4R,5E,7S)-4-(prop-2’-
enoylamino)-7-methoxymethoxy-8-phenyloct-5-ene (31 mg, 44%) as a colourless oil. 
max/cm
1
 (neat) 3278 (NH), 2931 (CH), 1656 (CO), 1626 (C=C), 1544, 1041, 700; []D
25
 
+3.1 (c 1.0, CHCl3); H (400 MHz, CDCl3) 0.92 (3H, t, J 7.3 Hz, 1-H3), 1.24–1.36 (2H, m, 
2-H2), 1.45–1.52 (2H, m, 3-H2), 2.80 (1H, dd, J 13.6, 6.0 Hz, 8-HH), 2.91 (1H, dd, J 13.6, 
7.6 Hz, 8-HH), 3.10 (3H, s, OCH3), 4.21–4.26 (1H, m, 7-H), 4.46 (1H, d, J 6.8 Hz, 
OCHHO), 4.52–4.60 (1H, m, 4-H), 4.65 (1H, d, J 6.8 Hz, OCHHO), 5.31 (1H, d, J 8.9 Hz, 
NH), 5.46–5.58 (2H, m, 5-H and 6-H), 5.68 (1H, dd, J 10.2, 1.4 Hz, 3’-HH), 6.08 (1H, dd, 
J 16.9, 10.2 Hz, 2’-H), 6.31 (1H, dd, J 16.9, 1.4 Hz, 3’-HH), 7.18–7.30 (5H, m, Ph); C 
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(100 MHz, CDCl3) 13.8 (CH3), 18.9 (CH2), 37.2 (CH2), 42.3 (CH2), 50.2 (CH), 55.2 
(CH3), 77.1 (CH), 93.7 (CH2), 126.2 (CH), 126.5 (CH2), 128.1 (2  CH), 129.7 (2  CH), 
130.6 (CH), 131.0 (CH), 133.3 (CH), 138.1 (C), 168.5 (C); m/z (CI) 318.2067 (MH
+
. 
C19H28NO3 requires 318.2069), 292 (45%), 256 (100), 226 (11), 85 (9). 
 
(3R,4E,6S)-1,7-Diphenyl-3-(but-3’-enoylamino)-6-methoxymethoxyhept-4-ene 
 
 
 
To a solution of (3R,4E,6S)- and (3S,4E,6S)-1,7-diphenyl-3-(2’,2’,2’-
trichlomethylcarbonylamino)-6-methoxymethoxyhept-4-ene (193) (1.37 g, 2.91 mmol) in 
methanol (100 mL) was added 1 M aqueous sodium hydroxide (50 mL, 50 mmol) and the 
solution heated to 70 C for 18 h. The reaction mixture was cooled, concentrated under 
reduced pressure and extracted with dichloromethane (2  100 mL) and ethyl acetate (2  
100 mL). The combined organic layers were washed with brine, dried (MgSO4), filtered 
and concentrated under reduced pressure. A portion of the oil (0.51 g, 1.57 mmol) was 
dissolved in dichloromethane (50 mL) and cooled to 0 C, to which was added 3-butenoic 
acid (0.16 mL, 1.88 mmol), 4-dimethylaminopyridine (0.02 g, 0.16 mmol) and 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide hydrochloride (0.36 g, 1.88 mmol). The reaction 
mixture was stirred while returning to room temperature over 18 h, then partitioned 
between water (50 mL) and ethyl acetate (50 mL). The organic layer was separated, 
washed with brine, dried (MgSO4), filtered and concentrated under reduced pressure. Flash 
column chromatography (petroleum ether/ethyl acetate 9:1 to 6:4) gave (3R,4E,6S)-1,7-
diphenyl-3-(but-3’-enoylamino)-6-methoxymethoxyhept-4-ene (0.24 g, 39%) as a 
colourless oil. max/cm
1
 (neat) 3287 (NH), 2942 (CH), 1648 (CO), 1546 (C=C), 1147, 
1040; []D
28
 –60.8 (c 0.7, CHCl3); H (400 MHz, CDCl3) 1.72–1.85 (2H, m, 2-H2) 2.56 
(2H, t, J 7.8 Hz, 1-H2), 2.79 (1H, dd, J 13.6, 6.0 Hz, 7-HH), 2.90 (1H, dd, J 13.6, 7.6 Hz, 
7-HH), 2.95 (2H, dt, J 7.2, 1.1 Hz, 2’-H2), 3.10 (3H, s, OCH3), 4.21–4.27 (1H, m, 6-H), 
4.45 (1H, d, J 6.8 Hz, OCHHO), 4.48–4.55 (1H, m, 3-H), 4.63 (1H, d, J 6.8 Hz, OCHHO), 
5.17–5.25 (2H, m, 4’-H2), 5.35 (1H, d, J 8.7 Hz, NH), 5.45–5.54 (2H, m, 4-H and 5-H), 
5.86 (1H, ddt, J 17.2, 10.0, 7.2 Hz, 3’-H), 7.12–7.29 (10H, m, 2  Ph); C (100 MHz, 
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CDCl3) 32.1 (CH2), 36.6 (CH2), 41.8 (CH2), 42.3 (CH2), 50.2 (CH), 55.2 (CH3), 77.0 (CH) 
93.7 (CH2), 120.1 (CH2), 126.1 (CH), 126.3 (CH), 128.2 (2  CH), 128.3 (2  CH), 128.5 
(2  CH), 129.7 (2  CH), 130.7 (CH), 131.3 (CH), 133.1 (CH), 138.0 (C), 141.4 (C), 
169.6 (C); m/z (CI) 394.2376 (MH
+
. C25H32NO3 requires 394.2382), 374 (35%), 333 (100), 
302 (82), 264 (5), 185 (4), 91 (7). 
 
(4R,5E,7S)-2-Methyl-4-(but-3’-enoylamino)-7-methoxymethoxy-8-phenyloct-5-ene 
 
 
 
To a solution of (4R,5E,7S)- and (4S,5E,7S)-2-methyl-4-(2’,2’,2’-
trichlomethylcarbonylamino)-7-methoxymethoxy-8-phenyloct-5-ene (194) (0.70 g, 1.66 
mmol) in methanol (100 mL) was added 1 M aqueous sodium hydroxide (50 mL, 50 
mmol) and the solution heated to 70 C for 18 h. The reaction mixture was cooled, 
concentrated under reduced pressure and extracted with dichloromethane (2  100 mL) and 
ethyl acetate (2  100 mL). The combined organic layers were washed with brine, dried 
(MgSO4), filtered and concentrated under reduced pressure. A portion of the oil (0.30 g, 
1.08 mmol) was dissolved in dichloromethane (50 mL) and cooled to 0 C, to which was 
added 3-butenoic acid (0.11 mL, 1.30 mmol), 4-dimethylaminopyridine (0.01 g, 0.11 
mmol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (0.25 g, 1.30 
mmol). The reaction mixture was stirred while returning to room temperature over 18 h, 
then partitioned between water (50 mL) and ethyl acetate (50 mL). The organic layer was 
separated, washed with brine, dried (MgSO4), filtered and concentrated under reduced 
pressure. Flash column chromatography (petroleum ether/ethyl acetate 9:1 to 6:4) gave 
(4R,5E,7S)-2-methyl-4-(but-3’-enoylamino)-7-methoxymethoxy-8-phenyloct-5-ene (0.24 
g, 42%) as a colourless oil. max/cm
1
 (neat) 3277 (NH), 2954 (CH), 1646 (CO), 1635 
(C=C) 1544, 1040, 916; []D
23
 15.5 (c 1.1, CHCl3); H (400 MHz, CDCl3) 0.81 (6H, d, J 
6.8 Hz, 1-H3 and 2-CH3), 1.18–1.25 (2H, m, 3-H2), 1.46 (1H, nonet, J 6.8 Hz, 2-H), 2.71 
(1H, dd, J 13.6, 6.0 Hz, 8-HH), 2.81 (1H, dd, J 13.6, 7.6 Hz, 8-HH), 2.91 (2H, dt, J 7.2, 1.2 
Hz, 2’-H2), 3.00 (3H, s, OCH3), 4.11–4.16 (1H, m, 7-H), 4.35 (1H, d, J 6.8 Hz, OCHHO), 
4.40–4.47 (1H, m, 4-H), 4.54 (1H, d, J 6.8 Hz, OCHHO), 5.11–5.18 (2H, m, 4’-H2), 5.31 
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(1H, d, J 8.6 Hz, NH), 5.34–5.44 (2H, m, 5-H and 6-H), 5.82 (1H, ddt, J 17.6, 14.3, 7.2 Hz, 
3’-H), 7.09–7.21 (5H, m, Ph); C (100 MHz, CDCl3) 18.0 (CH), 22.5 (CH3), 22.6 (CH3), 
41.8 (CH2), 42.3 (CH2), 44.3 (CH2), 48.6 (CH), 55.1 (CH3), 77.0 (CH), 93.6 (CH2), 119.9 
(CH2), 126.2 (CH), 127.9 (CH), 128.1 (CH), 129.7 (2  CH), 130.0 (CH), 131.5 (CH), 
133.8 (CH), 138.1 (C), 169.4 (C); m/z (CI) 346.2378 (MH
+
. C21H32NO3 requires 
346.2382), 284 (100%), 254 (5), 107 (9), 81 (24). 
 
(4R,5E,7S)-4-(But-3’-enoylamino)-7-methoxymethoxy-8-phenyloct-5-ene 
 
 
 
To a solution of (4R,5E,7S)- and (4S,5E,7S)-4-(2’,2’,2’-trichlomethylcarbonylamino)-7-
methoxymethoxy-8-phenyloct-5-ene (195) (1.45 g, 3.55 mmol) in methanol (100 mL) was 
added 1 M aqueous sodium hydroxide (50 mL, 50 mmol) and the solution heated to 70 C 
for 18 h. The reaction mixture was cooled, concentrated under reduced pressure and 
extracted with dichloromethane (2  100 mL) and ethyl acetate (2  100 mL). The 
combined organic layers were washed with brine, dried (MgSO4), filtered and concentrated 
under reduced pressure. A portion of the oil (0.20 g, 0.76 mmol) was dissolved in 
dichloromethane (50 mL) and cooled to 0 C, to which was added 3-butenoic acid (0.08 
mL, 0.91 mmol), 4-dimethylaminopyridine (0.01 mg, 0.08 mmol) and 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (0.18 g, 0.91 mmol). The reaction 
mixture was stirred while returning to room temperature over 18 h, then partitioned 
between water (50 mL) and ethyl acetate (50 mL). The organic layer was separated, 
washed with brine, dried (MgSO4), filtered and concentrated under reduced pressure. Flash 
column chromatography (petroleum ether/ethyl acetate 9:1 to 6:4) gave (4R,5E,7S)-4-(But-
3’-enoylamino)-7-methoxymethoxy-8-phenyloct-5-ene (0.12 g, 49%) as a colourless oil. 
max/cm
1
 (neat) 3284 (NH), 2931 (CH), 1646 (CO), 1635 (C=C), 1544, 1039, 916; []D
25
 
34.4 (c 1.0, CHCl3); H (400 MHz, CDCl3) 0.88 (3H, t, J 7.3 Hz, 1-H3), 1.20–1.30 (2H, 
m, 2-H2), 1.39–1.45 (2H, m, 3-H2), 2.78 (1H, dd, J 13.6, 6.0 Hz, 8-HH), 2.89 (1H, dd, J 
13.6, 7.6 Hz, 8-HH), 2.99 (2H, dt, J 7.2, 1.1 Hz, 2’-H2), 3.09 (3H, s, OCH3), 4.19–4.24 
(1H, m, 7-H), 4.43–4.48 (2H, m, OCHHO and 4-H), 4.62 (1H, d, J 6.8 Hz, OCHHO), 
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5.19–5.27 (2H, m, 4’-H2), 5.34 (1H, d, J 8.5 Hz, NH), 5.44–5.47 (2H, m, 5-H and 6-H), 
5.91 (1H, ddt, J 17.2, 14.4, 7.2 Hz, 3’-H), 7.17–7.28 (5H, m, Ph); C (100 MHz, CDCl3) 
13.8 (CH3), 18.9 (CH2), 37.2 (CH2), 41.8 (CH2), 42.3 (CH2), 50.0 (CH), 55.2 (CH3), 77.0 
(CH), 93.6 (CH2), 119.9 (CH2), 126.2 (CH), 128.1 (2  CH), 129.7 (2  CH), 130.2 (CH), 
131.5 (CH), 133.6 (CH), 138.1 (C), 169.5 (C); m/z (FAB) 332.2224 (MH
+
. C20H30NO3 
requires 332.2226), 270 (100%), 241 (68), 204 (96), 187 (16), 175 (15), 121 (14), 96 (22), 
77 (24), 51 (98). 
 
(5R)-5-Phenethyl-1H-pyrrol-2(5H)-one 
 
 
 
A solution of (3R,4E,6S)-1,7-diphenyl-3-(prop-2’-enoylamino)-6-methoxymethoxyhept-4-
ene (198) (185 mg, 0.49 mmol) stirring in dichloromethane (250 mL) was heated to 40 C 
for 0.25 h. Grubbs 2
nd
 generation catalyst (21 mg, 0.02 mmol) was added, and the mixture 
stirred at 40 C for 18 h. The reaction was cooled and the mixture concentrated under 
reduced pressure. Flash column chromatography (dichloromethane/methanol 99:1) 
afforded (5R)-5-phenethyl-1H-pyrrol-2(5H)-one (72 mg, 83%) as a white solid. Mp 124–
126 C (decomposition); max/cm
1
 (neat) 3176 (CH), 1676 (CO), 1647 (C=C) 1647, 1456, 
820; []D
23
 –93.5 (c 0.5, CHCl3); H (400 MHz, CDCl3) 1.81–1.92 (1H, m, 1’-HH), 1.94–
2.04 (1H, m, 1’-HH), 2.68 (2H, t, J 8.0 Hz, 2’-H2), 4.18–4.26 (1H, m, 5-H), 6.11 (1H, dt, J 
5.8, 1.6 Hz, 3-H), 7.05 (1H, dt, J 5.8, 1.2 Hz, 4-H), 7.11–7.24 (5H, m, Ph), 7.75 (1H, s, 
NH); C (100 MHz, CDCl3) 32.4 (CH2), 34.8 (CH2), 59.4 (CH), 126.4 (CH), 127.2 (CH), 
128.4 (2  CH), 128.7 (2  CH), 140.7 (C), 150.2 (CH), 174.3 (C); m/z (EI) 187.0999 (M+. 
C12H13NO requires 187.0997), 118 (40%), 87 (100), 85 (100), 47 (100). 
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(5R)-5-Isobutyl-1H-pyrrol-2(5H)-one 
 
 
A solution of (4R,5E,7S)-2-methyl-4-(prop-2’-enoylamino)-7-methoxymethoxy-8-
phenyloct-5-ene (199) (145 mg, 0.44 mmol) stirring in dichloromethane (250 mL) was 
heated to 40 C for 0.25 h. Grubbs 2nd generation catalyst (19 mg, 0.02 mmol) was added, 
and the mixture stirred at 40 C for 18 h. The reaction was cooled and the mixture 
concentrated under reduced pressure. Flash column chromatography 
(dichloromethane/methanol 99:1) afforded (5R)-5-isobutyl-1H-pyrrol-2(5H)-one (50 mg, 
82%) as a white solid. Mp 76–81 C; max/cm
1 
3184 (NH), 2925 (CH), 1681 (CO), 1370, 
1220, 810; []D
24
 –203.0 (c 0.7, CHCl3); H (400 MHz, CDCl3) 0.98 (3H, d, J 6.6 Hz, 2’-
CH3), 0.99 (3H, d, J 6.6 Hz, 3’-H3), 1.37–1.50 (2H, m, 1’-H2), 1.76 (1H, nonet, J 6.6 Hz, 
2’-H), 4.25–4.29 (1H, m, 5-H), 6.09 (1H, dt, J 5.8, 1.6 Hz, 3-H), 7.08 (1H, dt, J 5.8, 1.6 
Hz, 4-H), 7.46 (1H, br s, NH); C (100 MHz, CDCl3) 22.3 (CH3), 23.2 (CH3), 26.1 (CH), 
42.3 (CH2), 58.5 (CH), 126.7 (CH), 150.9 (CH), 174.4 (C); m/z (CI) 140.1072 (MH
+
. 
C8H14NO requires 140.1075), 133 (12%), 113 (16), 97 (20), 81 (66). 
 
(5R)-5-Propyl-1H-pyrrol-2(5H)-one 
 
 
 
A solution of (4R,5E,7S)-4-(prop-2’-enoylamino)-7-methoxymethoxy-8-phenyloct-5-ene 
(200) (27 mg, 0.09 mmol)  stirring in dichloromethane (50 mL) was heated to 40 C for 
0.25 h. Grubbs 2
nd
 generation catalyst (4 mg, 4.25 mol) was added, and the mixture 
stirred at 40 C for 18 h. The reaction was cooled and the mixture concentrated under 
reduced pressure. Flash column chromatography (100% ethyl acetate) afforded (5R)-5-
propyl-1H-pyrrol-2(5H)-one (9 mg, 85%) as a white solid. Mp 98–101 C; max/cm
1
 (neat) 
3150 (NH), 1681 (CO), 1654 (C=C), 1379, 1218, 826; []D
26
 134.2 (c 0.9, CHCl3); H 
(400 MHz, CDCl3) 0.90 (3H, t, J 7.3 Hz, 3’-H3), 1.33–1.60 (4H, m, 1’-H2 and 2’-H2), 
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4.13–4.16 (1H, m, 5-H), 6.02 (1H, dt, J 5.8, 1.6 Hz, 4-H), 7.00 (1H, dt, J 5.8, 1.6 Hz, 3-H), 
7.06 (1H, s, NH); C (100 MHz, CDCl3) 14.0 (CH3), 19.5 (CH2), 35.3 (CH2), 59.9 (CH), 
126.9 (CH), 150.4 (CH), 174.2 (C); m/z (EI) 125.0837 (M
+
. C7H11NO requires 125.0841), 
110 (32%), 82 (100), 69 (39), 55 (29). 
 
(6R)-6-Isobutyl-1,6-dihydropyridin-2-one 
 
 
 
A solution of (4R,5E,7S)-2-methyl-4-(but-3’-enoylamino)-7-methoxymethoxy-8-
phenyloct-5-ene (202) (159 mg, 0.46 mmol)  stirring in dichloromethane (230 mL) was 
heated to 40 C for 0.25 h. Grubbs 2nd generation catalyst (20 mg, 0.02 mmol) was added, 
and the mixture stirred at 40 C for 18 h. The reaction was cooled and the mixture 
concentrated under reduced pressure. Flash column chromatography (100% ethyl acetate) 
afforded (6R)-6-isobutyl-1,6-dihydropyridin-2-one (57 mg, 82%) as a white solid. Mp 69–
71 C; max/cm
1
 (neat) 3206 (NH), 2957 (CH), 1676 (CO), 1655 (C=C), 1406, 827; []D
22 
26.8 (c 0.2, CHCl3); H (400 MHz, CDCl3) 0.94 (6H, t, J 6.8 Hz, 2’-CH3 and 3’-H3), 
1.37–1.47 (2H, m, 1’-H2), 1.74 (1H, nonet, J 6.8 Hz, 2’-H), 2.91–2.94 (2H, m, 3-H2), 4.04–
4.15 (1H, m, 6-H), 5.68–5.77 (2H, m, 4-H and 5-H), 6.03 (1H, br s, NH); C (100 MHz, 
CDCl3) 22.2 (CH3), 23.1 (CH3), 24.3 (CH), 31.3 (CH2), 46.6 (CH2), 52.1 (CH), 121.3 
(CH), 125.8 (CH), 169.5 (C); m/z (CI) 154.1231 (MH
+
. C9H16NO requires 154.1232), 142 
(4%), 113 (2), 96 (4), 69 (3). 
 
(6R)-6-Propyl-3,6-dihydro-1H-pyridin-2-one
50 
 
 
 
 
A solution of (4R,5E,7S)-4-(but-3’-enoylamino)-7-methoxymethoxy-8-phenyloct-5-ene 
(203) (304 mg, 0.92 mmol) stirring in dichloromethane (460 mL) was heated to 40 C for 
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0.25 h. Grubbs 2
nd
 generation catalyst (39 mg, 0.05 mmol) was added, and the mixture 
stirred at 40 C for 18 h. The reaction was cooled and the mixture concentrated under 
reduced pressure. Flash column chromatography (100% ethyl acetate) afforded (6R)-6-
propyl-3,6-dihydro-1H-pyridin-2-one (72 mg, 56%) as a white solid. Mp 134–136 C 
(decomposition); max/cm
1
 (neat) 3185 (NH), 2959 (CH), 1679 (CO, 1656 (C=C 1341, 
1153, 827; []D
26
 122.8 (c 1.0, CHCl3), lit. opposite enantiomer
50
 []D
22
 +110.5 (c 0.6, 
CHCl3); H (400 MHz, CDCl3) 0.95 (3H, t, J 7.3 Hz, 3’-H3), 1.34–1.44 (2H, m, 2’-H2), 
1.51–1.61 (2H, m, 1’-H2), 2.90–2.94 (2H, m, 3-H2), 4.06–4.10 (1H, m, 6-H), 5.66–5.72 
(1H, m, 5-H), 5.76 (1H, dtd, J 10.0, 3.2, 1.6 Hz, 4-H), 6.58 (1H, br s, NH); C (100 MHz, 
CDCl3) 13.9 (CH3), 17.8 (CH2), 31.2 (CH2), 39.3 (CH2), 53.8 (CH), 121.6 (CH), 125.5 
(CH), 169.8 (C); m/z (CI) 140.1078 (MH
+
. C8H14NO requires 140.1075), 113 (4%), 97 (8), 
85 (12), 71 (17).  
 
(5R)-5-Phenethylpyrrolidin-2-one
51
   
 
 
 
To a solution of (5R)-5-phenethyl-1H-pyrrol-2(5H)-one (204) (52 mg, 0.27 mmol) in ethyl 
acetate (15 mL) was added 10% palladium on carbon (30 mg, 0.03 mmol wrt Pd). The 
solution was purged with hydrogen gas for 0.25 h then stirred under an atmosphere of 
hydrogen at room temperature for 24 h. The reaction mixture was filtered under reduced 
pressure through Celite
®
 which was washed with ethyl acetate (15 mL). The filtrate was 
concentrated under reduced pressure to yield a brown solid. Flash column chromatography 
(100% ethyl acetate) afforded (5R)-5-phenethylpyrrolidin-2-one (38 mg, 72%) as a white 
solid. Mp. 69–71 C; max (film)/cm
1
 3412 (NH), 2927 (CH), 1688 (CO), 1454, 1147, 
1040; []D
23
 +24.5 (c 0.5, CHCl3), lit. opposite enantiomer
51
 []D
20
 –23.5 (c 0.5, CHCl3); 
H (400 MHz, CDCl3) 1.73–1.90 (3H, m, 4-HH and 1’-H2), 2.26–2.39 (3H, m, 4-HH and 3-
H2), 2.66 (2H, m, 2’-H2), 3.62–3.68 (1H, m, 5-H), 5.58 (1H, br s, NH), 7.16–7.32 (5H, m, 
Ph); C (100 MHz, CDCl3) 27.4 (CH2), 29.9 (CH2), 32.4 (CH2), 38.4 (CH2), 53.9 (CH), 
126.3 (CH), 128.3 (2  CH), 128.7 (2  CH), 140.8 (C), 177.8 (C); m/z (CI) 190.1235 
(MH
+
. C12H16NO requires 190.1232), 171 (45%), 137 (8), 121 (9), 85 (12). 
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(5R)-5-Isobutylpyrrolidin-2-one
52
  
 
 
 
To a solution of (5R)-5-isobutyl-1H-pyrrol-2(5H)-one (205) (50 mg, 0.36 mmol) in ethyl 
acetate (25 mL) was added 10% palladium on carbon (38 mg, 0.04 mmol wrt Pd). The 
solution was purged with hydrogen gas for 0.25 h then stirred under an atmosphere of 
hydrogen at room temperature for 24 h. The reaction mixture was filtered under reduced 
pressure through Celite
®
 which was washed with ethyl acetate (25 mL). The filtrate was 
concentrated under reduced pressure to yield a brown solid. Flash column chromatography 
(dichloromethane/methanol 99:1) afforded (5R)-5-isobutylpyrrolidin-2-one (38 mg, 75%) 
as a white solid. Mp. 61–63 C, lit.52 61–62 C; max (film)/cm
–1 
 3187 (NH), 2956 (CH), 
1678 (CO), 1460, 1291, 781; []D
26
 
 
+7.5 (c 1.1, CHCl3), lit.
52
 []D +9.6 (c 2.0, CH2Cl2); 
H (400 MHz, CDCl3) 0.85 (3H, s, 3’-H3), 0.87 (3H, s, 2’-CH3), 1.23–1.29 (1H, m, 1’-HH), 
1.35–1.42 (1H, m, 1’-HH), 1.53–1.62 (1H, m, 2’-H), 1.60–1.67 (1H, m, 4-HH), 2.15–2.25 
(1H, m, 4-HH), 2.23–2.28 (2H, m, 3-H2), 3.61–3.68 (1H, m, 5-H), 5.89 (1H, br s, NH); C 
(100 MHz, CDCl3) 22.4 (CH3), 22.9 (CH3), 25.4 (CH), 27.9 (CH), 30.1 (CH), 46.0 (CH2), 
52.6 (CH), 178.1 (C); m/z (CI) 142.1230 (MH
+
. C8H16NO requires 142.1232) 141 (3%), 
107 (1), 84 (6), 69 (4). 
 
(5R)-5-Isobutylpyrrolidin-2-one
53
   
 
 
 
To a solution of (5R)-5-propyl-1H-pyrrol-2(5H)-one (206) (38 mg, 0.30 mmol) in ethyl 
acetate (25 mL) was added 10% palladium on carbon (32 mg, 0.03 mmol wrt Pd). The 
solution was purged with hydrogen gas for 0.25 h then stirred under an atmosphere of 
hydrogen at room temperature for 24 h. The reaction mixture was filtered under reduced 
pressure through Celite
®
 which was washed with ethyl acetate (25 mL). The filtrate was 
concentrated under reduced pressure to yield a brown solid. Flash column chromatography 
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(dichloromethane/methanol 99:1 to 97:3) afforded (5R)-5-isobutylpyrrolidin-2-one (33 mg, 
85%) as a white solid. Mp. 43–45 C; max (film)/cm
–1
 3179 (NH), 2951 (CH), 1691 (CO), 
1458, 1286, 753; []D
25
 +7.4 (c 1.1, CHCl3), lit. opposite enantiomer
53
 []D
26
 –9.2 (c 1.2, 
CHCl3); H (400 MHz, CDCl3) 0.87 (3H, t, J 7.2 Hz, 3’-H3), 1.24–1.51 (4H, m, 1’-H2 and 
2’-H2), 1.58–1.68 (1H, m, 4-HH), 2.12–2.33 (3H, m, 3-H2 and 4-HH), 3.54–3.60 (1H, m, 
5-H), 6.84 (1H, br s, NH); C (100 MHz, CDCl3) 14.0 (CH3), 19.2 (CH2), 27.3 (CH2), 30.4 
(CH2), 39.0 (CH2), 54.5 (CH), 178.5 (C); m/z (CI) 128.1078 (MH
+
. C7H14NO requires 
128.1075) 112 (4%), 97 (6), 85 (14), 71 (16). 
 
(6S)-6-Phenethylpiperidin-2-one 
 
 
 
A solution of (3R,4E,6S)-1,7-diphenyl-3-(but-3’-enoylamino)-6-methoxymethoxyhept-4-
ene (201) (240 mg, 0.60 mmol) in dichloromethane (250 mL) was heated to 45 C for 0.25 
h. Grubbs 2nd generation catalyst (60 mg, 70 mol) was added, and the reaction stirred for 
42 h. The reaction was cooled to room temperature and concentrated under reduced 
pressure to yield a brown oil. Flash column chromatography (dichloromethane/methanol 
99:1) afforded a white solid. To a solution of the solid in ethyl acetate (35 mL) was added 
10% palladium on carbon (40 mg, 0.04 mmol wrt Pd). The solution was purged with 
hydrogen gas for 0.25 h then stirred under an atmosphere of hydrogen at room temperature 
for 18 h. The reaction mixture was filtered through Celite
®
, which was washed with ethyl 
acetate (35 mL). The filtrate was concentrated under reduced pressure to yield a white 
solid. Flash column chromatography (dichloromethane/methanol 1:0 to 96:4) afforded 
(6S)-6-phenethylpiperidin-2-one (110 mg, 88% over two steps) as a white solid. Mp. 84–
86 C; max (film)/cm
1
 3214 (NH), 2942 (CH), 1651 (CO), 1603 (C=C), 1402, 1343, 1090; 
[]D
22
 +5.0 (c 1.4, CHCl3); H (400 MHz, CDCl3) 1.37–1.47 (1H, m, 5-HH), 1.63–1.75 
(1H, m, 5-HH), 1.78–1.84 (2H, m, 1’-H2), 1.86–1.98 (2H, m, 4-H2), 2.25–2.43 (2H, m, 3-
H2), 2.62–2.73 (2H, m, 2’-H2), 3.36–3.42 (1H, m, 6-H), 6.03 (1H, br s, NH), 7.16–7.31 
(5H, m, Ph); C (100 MHz, CDCl3) 19.7 (CH2), 28.4 (CH2), 31.4 (CH2), 31.6 (CH2), 38.6 
 120 
(CH2), 52.6 (CH2), 126.2 (CH), 128.3 (2  CH), 128.6 (2  CH), 140.9 (C), 172.4 (C); m/z 
(EI) 203.1313 (M
+
. C13H17NO requires 203.1310), 186 (5%), 125 (27), 112 (66), 98 (100). 
 
(6S)-6-Isobutylpiperidin-2-one 
 
 
 
To a solution of (6R)-6-isobutyl-1,6-dihydropyridin-2-one (208) (57 mg, 0.37 mmol) in 
ethyl acetate (30 mL) was added 10% palladium on carbon (40 mg, 0.04 mmol wrt Pd). 
The solution was purged with hydrogen gas for 0.25 h then stirred under an atmosphere of 
hydrogen at room temperature for 24 h. The reaction mixture was filtered under reduced 
pressure through Celite
®
 which was washed with ethyl acetate (30 mL). The filtrate was 
concentrated under reduced pressure to yield a yellow solid. Flash column chromatography 
(dichloromethane/methanol 99:1) afforded (6S)-6-isobutylpiperidin-2-one (58 mg, 100%) 
as a white solid. Mp. 89–91 C; max (film)/cm
–1
 3194 (NH), 2951 (CH), 1651 (CO), 1404, 
1169, 822; []D
30
 
 12.1 (c 1.4, CHCl3); H (400 MHz, CDCl3) 0.85 (6H, dd, J 6.6, 1.5 Hz, 
3’-H3 and 2’-CH3), 1.21–1.33 (3H, m, 3-H2 and 1’-HH), 1.56–1.68 (2H, m, 5-HH and 2’-
H), 1.79–1.87 (2H, m, 5-HH and 1’-HH), 2.17–2.36 (2H, m, 4-H2), 3.33–3.39 (1H, m, 6-
H), 5.67 (1H, br s, NH); C (100 MHz, CDCl3) 19.9 (CH2), 22.3 (CH3), 22.8 (CH3), 24.3 
(CH), 29.0 (CH2), 31.4 (CH2), 46.2 (CH2), 51.0 (CH), 172.2 (C); m/z (EI) 155.1308 (M
+
. 
C9H17NO requires 155.1310) 120 (29%), 112 (96), 99 (100), 70 (100). 
 
(6R)-6-Propylpiperidin-2-one
54
  
 
 
 
To a solution of (6R)-6-propyl-3,6-dihydro-1H-pyridin-2-one (209) (72 mg, 0.52 mmol) in 
ethyl acetate (50 mL) was added 10% palladium on carbon (55 mg, 0.05 mmol wrt Pd). 
The solution was purged with hydrogen gas for 0.25 h then stirred under an atmosphere of 
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hydrogen at room temperature for 24 h. The reaction mixture was filtered under reduced 
pressure through Celite
®
 which was washed with ethyl acetate (50 mL). The filtrate was 
concentrated under reduced pressure to yield (6S)-6-propylpiperidin-2-one (69 mg, 94%) a 
white solid, with no further purification required. Mp. 73–76 C; max (film)/cm
–1
 2960 
(CH), 2360, 1653 (CO), 1410, 1215, 747; []D
25
 18.1 (c 1.3, CHCl3), lit. opposite 
enantiomer
54
 []D
20
 +17.9 (c 0.5, CHCl3); H (400 MHz, CDCl3) 0.87 (3H, t, J 7.2 Hz, 3’-
H3), 1.21–1.41 (5H, m, 3-H2, 1’-HH, 2’-H2), 1.56–1.66 (1H, m, 5-HH), 1.79–1.87 (2H, m, 
1’-HH, 5-HH), 2.17–2.36 (2H, m, 4-H2), 3.26–3.32 (1H, m, 6-H), 5.76 (1H, br s, NH); C 
(100 MHz, CDCl3) 13.9 (CH3), 18.5 (CH2), 19.8 (CH2), 28.5 (CH2), 31.4 (CH2), 39.1 
(CH2), 53.0 (CH), 172.3 (C); m/z (CI) 142.1236 (MH
+
. C8H16NO requires 142.1232) 113 
(26%), 97 (42), 85 (78), 71 (100). 
 
(6R)-6-Propyl-N-Boc-piperidine
59
  
 
 
 
To a solution of (6S)-6-Propylpiperidin-2-one (216) (44 mg, 0.31 mmol) in diethyl ether 
(50 mL) was added lithium aluminium hydride 1 M in diethyl ether (1.87 mL, 1.87 mmol) 
and the reaction was heated to 30 C for 18 h. The reaction was quenched with 2 M 
potassium hydroxide solution (10 mL) then partitioned between diethyl ether (20 mL) and 
water (20 mL). The organic layer was separated, washed with water (3  20 mL), dried 
over magnesium sulphate, filtered and concentrated at atmospheric pressure and 40 C. 
The residue was dissolved in diethyl ether (20 mL) to which was added di-tert-butyl 
dicarbonate (272 mg, 1.25 mmol), 4-dimethylamino pyridine (15 mg, 0.13 mmol) and 
distilled triethylamine (181 L, 1.31 mmol). The reaction was stirred at room temperature 
for 18 h, then washed with 1 M hydrochloric acid solution (10 mL), saturated sodium 
hydrogencarbonate solution (10 mL), and brine. The organic phase was dried over 
magnesium sulphate, filtered and concentrated under reduced pressure to yield a clear oil. 
Flash column chromatography (Petroleum ether/diethyl ether 85:15) afforded the desired 
product (34 mg, 48%) as a colourless oil. Spectroscopic data consistent with literature. 
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[]D
24
 25.6 (c 0.6, CHCl3), lit.
59
 []D
23
 31.6 (c 0.9, CHCl3); H (400 MHz, CDCl3) 0.85 
(3H, t, J 7.2 Hz, 3’-H3), 1.14–1.32 (4H, m, 1’-H2 and 2’-H2), 1.38 (9H, s, OtBu), 1.41-1.63 
(6H, m, 3-H2, 4-H2 and 5-H2), 2.67 (1H, td, J 13.6, 2.6 Hz, 6-HH), 3.89 (1H, d, J 2.6 Hz, 6-
HH), 4.14 (1H, br. s, 2-H); C (100 MHz, CDCl3) 14.1 (CH3), 19.1 (2  CH2), 19.5 (2  
CH2), 25.7 (CH2), 28.5 (3  CH3), 31.9 (CH2), 50.1 (CH), 17.9 (C), 155.2 (C); m/z (EI) 227 
(M
+
, 4%), 184 (M
+C3H7, 18), 149 (17), 128 (100). 
 
Dimethyl (2S)-2-aminobutanedioate hydrochloride
74
  
 
 
 
To a suspension of L-aspartic acid (5.00 g, 37.56 mmol) in methanol (50 mL) at 0 C was 
added thionyl chloride (3.84 mL, 52.59 mmol) dropwise. The mixture was warmed to 
room temperature, heated to 60 C for 3 h, then cooled to room temperature and 
concentrated under reduced pressure. The residue was azeotroped with toluene followed by 
dichloromethane, then dried under reduced pressure to afford dimethyl (2S)-2-
aminobutanedioate hydrochloride (7.36 g, 99%) as a white solid. p. 63–65 C; []D
26 
+14.0 (c 1.1, MeOH), lit.
74
 []D
24
 +22.0 (c 1.0, MeOH);  H (400 MHz, D2O) 3.05–3.18 
(2H, m, 3-H2), 3.69 (3H, s, OMe), 3.79 (3H, s, OMe), 4.44 (1H, dd, J 6.0, 4.9 Hz, 2-H); C 
(101 MHz, D2O) 33.9 (CH2), 48.3 (CH), 52.0 (CH3), 52.9 (CH3), 168.6 (C), 169.5 (C); m/z 
(CI) 162.0769 (MH
+
. C6H12NO4 requires 162.0766), 148 (22%), 128.2 (4) 102.2 (9). 
 
Dimethyl (2S)-2-(benzylamino)butanedioate
99
   
 
 
 
To a solution of dimethyl (2S)-2-aminobutanedioate hydrochloride (224) (5.76 g, 29.2 
mmol) in anhydrous methanol (125 mL) at 0 C was added triethylamine (4.84 mL, 35.0 
mmol) and benzaldehyde (3.55 mL, 35.0 mmol). The mixture was warmed to room 
temperature and stirred for 3 h, then cooled to 0 C and sodium borohydride (2.21 g, 58.3 
mmol) was added portionwise over 0.5 h. The mixture was concentrated under reduced 
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pressure and the residue partitioned between diethyl ether (50 mL) and 4 M hydrochloric 
acid solution (50 mL). The aqueous layer was separated and the organic phase extracted 
with 4 M hydrochloric acid solution (50 mL). The aqueous extractions were combined, 
neutralised to pH 8 with solid sodium hydrogen carbonate then extracted with diethyl ether 
(3  50 mL). The organic layers were combined, dried (MgSO4), filtered and concentrated 
under reduced pressure to afford an orange oil. Flash column chromatography (petroleum 
ether/ethyl acetate 3:1 with 1% triethylamine) afforded dimethyl (2S)-2-
(benzylamino)butanedioate (6.35 g, 87%) as a pale yellow oil. []D
26
 
 –39.9 (c 1.1, CHCl3), 
lit.
98
 []D
20
 –33.0 (c 1.4, CHCl3); H (400 MHz, CDCl3) 2.14 (1H, s, NH), 2.68–2.80 (2H, 
m, 3-H2), 3.69 (1H, dd, J 6.9, 6.2 Hz, 2-H), 3.70 (3H, s, OMe), 3.75 (1H, d, J 13.1 Hz, 1’-
HH), 3.77 (3H, s, OMe), 3.90 (1H, d, J 13.1 Hz, 1’-HH), 7.25–7.34 (5H, m, Ph); C (101 
MHz, CDCl3) 38.0 (CH2), 51.9 (CH3), 52.0 (CH2), 52.2 (CH3), 56.9 (CH), 127.2 (CH), 
128.3 (2  CH), 128.4 (2  CH), 139.5 (C), 171.3 (C), 174.1 (C); m/z (CI) 252 (MH+, 
100%), 229 (5), 215 (8), 192 (6). 
 
Dimethyl (2S)-2-[benzyl(tert-butoxycarbonyl)amino]butanedioate 
 
 
 
To a solution of dimethyl (2S)-2-(benzylamino)butanedioate (230) (121 mg, 0.48 mmol) in 
dichloromethane at room temperature was added di-tert-butyl dicarbonate (210 mg, 0.96 
mmol), triethylamine (140 L, 1.01 mmol) and 4-dimethylaminopyridine (12 mg, 0.10 
mmol). The mixture was stirred for 18 h then washed with 1 M hydrochloric acid solution 
(10 mL). The aqueous washings were extracted with dichloromethane (10 mL). The 
organic layers were combined, washed with saturated sodium hydrogen carbonate solution 
(20 mL) then brine, then dried (MgSO4), filtered and concentrated under reduced pressure 
to afford a yellow oil. Flash column chromatography (petroleum ether/ethyl acetate 4:1) 
afforded the desired product (127 mg, 75%) as a pale yellow oil. max (neat)/cm
–1 
2954 
(CH), 1795, 1734 (CO), 1699, 1436, 1156; []D
26
 
 –81.6 (c 1.2, CHCl3); 
1
H NMR showed 
a 4:3 mixture of rotomers, only signals for the major rotomer are recorded: H (400 MHz, 
CDCl3) 1.52 (9H, s, OtBu), 2.74 (1H, dd, J 17.1, 6.8, 3-HH), 3.23 (1H, dd, J 17.1, 6.8 Hz, 
3-HH), 3.63 (3H, s, OMe), 3.64 (3H, s, OMe), 4.51–4.56 (1H, m, 2-H), 4.63–4.72 (2H, m, 
1’-H2), 7.29–7.38 (5H, m, Ph); C (100 MHz, CDCl3) 27.4 (3  CH3), 34.4 (CH2), 52.0 
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(CH3), 52.7 (CH2), 53.1 (CH3), 57.2 (CH), 85.4 (C), 128.1 (2  CH), 128.6 (2  CH), 135.6 
(CH), 146.9 (C), 149.8 (C), 169.5 (C), 171.3 (C); m/z (CI) 352.1766 (MH
+
. C18H26NO6 
requires 352.1760), 296 (22%), 264 (13), 252 (100), 192 (6).  
 
Methyl (4S)-1-benzyl-2-oxoazetidine-4-carboxylate
100
  
 
 
 
To a solution of dimethyl (2S)-2-(benzylamino)butanedioate (230) (300 mg, 1.19 mmol) in 
diethyl ether (25 mL) at 0 C was added tert-butyl magnesium chloride (1.10 mL, 1.43 
mmol). The mixture was warmed to room temperature and stirred for 18 h, then quenched 
with saturated ammonium chloride solution (5 mL). The organic layer was separated, 
washed with water (30 mL) and brine (30 mL), then dried (MgSO4), filtered and 
concentrated under reduced pressure to afford an orange oil. Flash column chromatography 
(petroleum ether/ethyl acetate 7:3) afforded methyl (4S)-1-benzyl-2-oxoazetidine-4-
carboxylate (102 mg, 39%) as a pale yellow oil. max (neat)/cm
–1 
2955 (CH), 1743 (CO), 
1389, 1211, 1018, 709; []D
16
 
 –29.5 (c 1.1, CHCl3), lit. opposite enantiomer
99
 []D
25
 +28.0 
(c 0.5, CHCl3); H (400 MHz, CDCl3) 3.06 (1H, ddd, J 14.5, 2.7, 0.7 Hz, 3-HH), 3.23 (1H, 
dd, J 14.5, 5.6, 3-HH), 3.72 (3H, s, CH3), 3.96 (1H, dd, J 5.6, 2.7 Hz, 4-H), 4.21 (1H, d, J 
14.9 Hz, 1’-HH), 4.77 (1H, d, J 14.9 Hz, 1’-HH), 7.25–7.39 (5H, m, Ph); C (101 MHz, 
CDCl3) 42.0 (CH2), 45.7 (CH2), 49.9 (CH3), 52.4 (CH), 128.0 (CH), 128.6 (2  CH), 128.9 
(2  CH), 134.9 (C), 165.7 (C), 170.8 (C); m/z (EI) 219.0892 (M+. C12H13NO3 requires 
219.0895), 191 (100%), 132 (93), 91 (100). 
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Dimethyl 2-[(4S)-1-benzyl-2-oxoazetidin-4-yl]-2-oxoethylphosphonate 
 
 
 
To a solution of dimethyl methylphosphonate (63 L, 0.58 mmol) in tetrahydrofuran (10 
mL) at –78 C was added 2.5 M n-butyl lithium in hexanes (234 L, 0.58 mmol), and the 
mixture was stirred for 1.5 h. A solution of methyl (4S)-1-benzyl-2-oxoazetidine-4-
carboxylate (235) (64 mg, 0.29 mmol) in tetrahydrofuran (10 mL) was added to the 
mixture dropwise then stirred for 0.75 h. The mixture was warmed to room temperature, 
quenched with saturated ammonium chloride solution then diluted with dichloromethane 
(25 mL). The aqueous phase was removed, and the organic layer washed with water (2  
20 mL) then brine (20 mL), dried (MgSO4), filtered and concentrated under reduced 
pressure to afford a yellow oil. Flash column chromatography (dichloromethane/methanol 
19:1 with 1% triethylamine) afforded dimethyl 2-[(4S)-1-benzyl-2-oxoazetidin-4-yl]-2-
oxoethylphosphonate (35 mg, 39%) as a colourless oil. max (neat)/cm
–1 
3009 (CH), 2955, 
1751 (CO), 1258, 1026; []D
19
 
 –19.9 (c 1.5, CHCl3); H (400 MHz, CDCl3) 2.83 (1H, dd, J 
22.7, 13.9 Hz, CHHP(O)(OMe)2), 2.89 (1H, ddd, J 14.4, 2.8, 0.7 Hz, 3-HH), 2.98 (1H, dd, 
J 22.7, 13.9 Hz, CHHP(O)(OMe)2), 3.15 (1H, dd, J 14.4, 6.0 Hz, 3-HH), 3.62 (3H, d, J 
11.3 Hz, OMe), 3.68 (3H, d, J 11.3 Hz, OMe), 4.10 (1H, d, J 14.8 Hz, 1’-HH), 4.12 (1H, 
dd, J 6.0, 2.8 Hz, 4-H), 4.73 (1H, d, J 14.8 Hz, 1’-HH), 7.14–7.30 (5H, m, Ph); C (101 
MHz, CDCl3) 38.2 (d, J 129.0 Hz, CH2), 41.5 (CH2), 45.9 (CH2), 53.1 (d, J 3.7 Hz, CH3), 
53.2 (d, J 3.7 Hz, CH3), 56.1 (CH), 128.0 (CH), 128.7 (2  CH), 128.9 (2  CH), 134.9 
(C), 164.9 (C), 199.0 (C); m/z (EI) 311.0920 (M
+
. C14H18NO5P requires 311.0923), 179 
(93%), 160 (100), 151 (54), 106 (63), 91 (100).  
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(4S)-1-Benzyl-2-oxoazetidine-4-carboxylic acid 
 
 
 
To a solution of methyl (4S)-1-benzyl-2-oxoazetidine-4-carboxylate (235) (33 mg, 0.15 
mmol) in methanol was added 2 M sodium hydroxide solution (113 L, 0.23 mmol). The 
mixture was stirred for 16 h then concentrated under reduced pressure. The residue was 
acidified to pH 3 with 1 M hydrochloric acid solution then extracted with ethyl acetate (3  
10 mL). The organic extractions were combined, dried (MgSO4), filtered and concentrated 
under reduced pressure to afford a brown oil. Flash column chromatography 
(dichloromethane/methanol 49:1) afforded (4S)-1-benzyl-2-oxoazetidine-4-carboxylic acid 
(15 mg, 49%) as a pale yellow oil. max (neat)/cm
–1 
3033 (OH), 1740 (CO), 1707 (CO), 
1399, 1199; []D
23
 –22.0 (c 0.9, CHCl3); H (400 MHz, CDCl3) 3.03 (1H, ddd, J 14.7, 2.5, 
0.8 Hz, 3-HH), 3.21 (1H, dd, J 14.7, 5.7 Hz, 3-HH), 3.91 (1H, dd, J 5.7, 2.5 Hz, 4-H), 4.08 
(1H, d, J 14.9 Hz, 1’-HH), 4.78 (1H, d, J 14.9 Hz, 1’-HH), 7.18–7.31 (5H, m, Ph); C (101 
MHz, CDCl3) 41.9 (CH2), 45.7 (CH2), 49.6 (CH), 128.1 (CH), 128.6 (2  CH), 129.0 (2  
CH), 134.5 (C), 166.1 (C), 174.7 (C); m/z (CI) 206.0816 (MH
+
. C11H12NO3 requires 
206.0817), 180 (7%), 162 (9), 134 (4). 
 
L-Aspartic acid -methyl ester hydrochloride78  
 
 
 
To a solution of L-aspartic acid (5.00 g, 37.6 mmol) in methanol (25 mL) at –10 C was 
added thionyl chloride (3.84 mL, 52.6 mmol). The mixture was warmed to room 
temperature over 0.5 h then diluted with diethyl ether (50 mL). Scratching of the reaction 
vessel with a glass rod caused precipitation of a white solid, which was vacuum filtered 
and washed with diethyl ether, then dried under reduced pressure to afford the desired 
product (2.53 g, 37%) as a white solid. p. 169–173 C, lit.78 191–193 C;max (neat)/cm
–
1 
2847 (OH), 1736 (CO), 1497, 1196, 1103, 849; []D
29 
+17.2 (c 1.0, MeOH); H (400 
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MHz, D2O) 3.01–3.04 (2H, m, 3-H2), 3.69 (3H, s, OMe), 4.17–4.23 (1H, m, 2-H); C (101 
MHz, D2O) 34.0 (CH2), 49.8 (CH), 52.8 (CH3), 171.5 (C), 172.1 (C); m/z (CI) 148.0612 
(MH
+
. C5H10NO4 requires 148.0610), 116 (2%), 102 (6), 81 (2). 
 
N-Benzyl L-aspartic acid -tert-butyl ester, -methyl ester  
 
 
 
To a solution of L-aspartic acid -methyl ester hydrochloride (239) (250 mg, 1.36 mmol) in 
tert-butyl acetate (10 mL) at room temperature was added 70% wt. perchloric acid solution 
(117 L, 1.36 mmol) and the mixture stirred for 72 h. The mixture was extracted with 0.5 
M hydrochloric acid solution (3  10 mL), the aqueous layer was neutralised immediately 
with solid sodium hydrogen carbonate then extracted with diethyl ether (3  10 mL). The 
organic layers were dried (MgSO4), filtered and concentrated under reduced pressure to 
yield a yellow oil. The oil was dissolved in methanol (20 mL), to which was added 
triethylamine (82 L, 0.59 mmol) and benzaldehyde (60 L, 0.59 mmol), and the reaction 
stirred for 18 h. The mixture was cooled to 0 C and sodium borohydride (30 mg, 0.79 
mmol) was added portionwise over 0.5 h. The mixture was concentrated under reduced 
pressure and the residue partitioned between diethyl ether (25 mL) and 1 M sodium 
hydrogen carbonate solution (25 mL). The organic layer was washed with 1 M sodium 
hydrogen carbonate solution (25 mL), dried (MgSO4), filtered and concentrated under 
reduced pressure to yield a yellow oil. Flash column chromatography (petroleum 
ether/ethyl acetate 9:1) afforded the desired compound (18 mg, 5% over two steps) as a 
yellow oil. max (neat)/cm
–1 
2980 (CH), 1729 (CO), 1368, 1151; []D
25
 –27.7 (c 1.1, 
CHCl3); H (400 MHz, CDCl3) 1.47 (9H, s, OtBu), 2.63 (1H, dd, J 15.5, 6.8 Hz, 3-HH), 
2.69 (1H, dd, J 15.5, 6.2 Hz, 3-HH), 3.55 (1H, dd, J 6.8, 6.2 Hz, 2-H), 3.68 (3H, s, OMe), 
3.72 (1H, d, J 13.0 Hz, 1’-HH), 3.88 (1H, d, J 13.0 Hz, 1’-HH), 7.22–7.33 (5H, m, Ph); C 
(101 MHz, CDCl3) 28.0 (3  CH3), 38.3 (CH2), 51.7 (CH2), 52.0 (CH3), 57.7 (CH), 81.6 
(C), 127.1 (CH), 128.3 (2  CH), 128.4 (2  CH), 139.8 (C), 171.4 (C), 172.8 (C); m/z (CI) 
294.1703 (MH
+
. C16H24NO4 requires 294.1705), 279 (14%), 263 (8), 238 (27), 192 (13). 
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Dimethyl-N-(tert-butoxycarbonyl)-N-(p-toluenesulfonyl)-2-aminobutanedioate
101
  
 
 
 
To a solution of dimethyl (2S)-2-aminobutanedioate hydrochloride (224) (1.00 g, 5.06 
mmol) in methanol (50 mL) at 0 C was added triethylamine (2.10 mL, 15.2 mmol) and p-
toluenesulfonylchloride (1.45 g, 7.59 mmol). The mixture was warmed to room 
temperature then stirred for 20 h. The mixture was concentrated under reduced pressure, 
and the residue partitioned between ethyl acetate (25 mL) and 0.5 M hydrochloric acid 
solution (25 mL). The aqueous phase was discarded, and the organic phase was washed 
with saturated sodium hydrogen carbonate solution (25 mL), dried (MgSO4), filtered and 
concentrated under reduced pressure to yield a yellow oil. The oil was dissolved in 
dichloromethane (50 mL), to which was added di-tert-butyl dicarbonate (2.08 g, 9.51 
mmol), triethylamine (1.38 mL, 9.99 mmol) and 4-dimethylaminopyridine (0.12 g, 0.95 
mmol). The mixture was warmed to room temperature and stirred for 24 h. The mixture 
was washed with 1 M hydrochloric acid solution (30 mL) then saturated sodium hydrogen 
carbonate solution (30 mL), dried (MgSO4), filtered and concentrated under reduced 
pressure to yield a brown oil. Flash column chromatography (petroleum ether/ethyl acetate 
1:0 to 7:3) afforded N-(tert-butoxycarbonyl)-N-(p-toluenesulfonyl)-2-aminobutanedioate 
(0.91 g, 43% over two steps) as a pale yellow solid. Mp. 90–91 C, lit.101 91–92 Cmax 
(neat)/cm
–1
 2955 (CH), 1728 (CO), 1358, 1150, 1049, 972; []D
25
 
 –80.4 (c 0.5, CHCl3), 
lit.
101
 []D
25
 
 –56.1 (c 3.0, CHCl3); H (400 MHz, CDCl3) 1.32 (9H, s, OtBu), 2.45 (3H, s, 
CH3C6H4), 2.84 (1H, dd, J 16.4, 5.8 Hz, 3-HH), 3.38 (1H, dd, J 16.4, 7.8 Hz, 3-HH), 3.73 
(3H, s, OMe), 3.75 (3H, s, OMe), 5.67 (1H, dd, J 7.8, 5.8 Hz, 2-H), 7.32 (2H, dd, J 8.5, 0.7 
Hz, ArH), 7.92 (2H, d, J 8.5 Hz, ArH); C (101 MHz, CDCl3) 21.7 (CH3), 27.8 (3  CH3), 
36.5 (CH2), 52.2 (CH3), 52.8 (CH3), 55.5 (CH), 85.5 (C), 128.7 (2  CH), 129.1 (2  CH), 
136.5 (C), 146.3 (C), 154.9 (C), 169.6 (C), 170.7 (C); m/z (FAB) 416.1378 (MH
+
. 
C18H26NO8S requires 416.1379), 360 (100%), 316 (96), 256 (58), 188 (62), 160 (57). 
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Dimethyl (2S)-2-(p-toluenesulfonyl)aminobutanedioate 
 
 
 
To a solution of dimethyl (2S)-2-aminobutanedioate hydrochloride (224) (5.00 g, 25.3 
mmol) in dichloromethane (100 mL) at room temperature was added triethylamine (9.46 
mL, 68.3 mmol) followed by p-toluenesulfonyl chloride (7.23 g, 38.0 mmol), and the 
mixture was stirred for 24 h. The mixture was washed with 0.5 M hydrochloric acid 
solution (100 mL) then saturated sodium hydrogen carbonate solution (100 mL), dried 
(MgSO4), filtered and concentrated under reduced pressure to yield a yellow solid. Flash 
column chromatography  (petroleum ether/ethyl acetate 1:0 to 3:2) afforded dimethyl (2S)-
2-(p-toluenesulfonyl)aminobutanedioate (5.40 g, 68%) as a white solid. Mp. 75–77 
Cmax (neat)/cm
–1 
3295 (NH), 1745 (CO), 1732 (CO), 1339, 1223, 1161, 1092; []D
28
 
 
+39.1 (c 0.5, CHCl3);  H (400 MHz, CDCl3) 2.42 (3H, s, CH3C6H4), 2.85 (1H, dd, J 17.0, 
4.5 Hz, 3-HH), 2.96 (1H, dd, J 17.0, 4.5 Hz, 3-HH), 3.60 (3H, s, OMe), 3.67 (3H, s, OMe), 
4.15 (1H, dt, J 8.0, 4.5 Hz, 2-H), 5.59 (1H, d, J 8.0 Hz, NH), 7.30 (2H, d, J 8.2 Hz, ArH), 
7.74 (2H, d, J 8.2 Hz, ArH); C (101 MHz, CDCl3) 21.6 (CH3), 37.7 (CH2), 52.1 (CH3), 
52.1 (CH3), 53.0 (CH), 127.2 (2  CH), 129.7 (2  CH), 136.7 (C), 143.8 (C), 170.4 (C), 
170.7 (C); m/z (CI) 316.0854 (MH
+
. C13H18NO6S requires 316.0855), 296 (2%), 256 (8), 
242 (2), 160 (7). 
 
Methyl (2S)-5-(dimethoxyphosphoryl)-4-oxo-2-(p-toluenesulfonyl)aminopentanoate 
  
 
 
To a solution of dimethyl methylphosphonate (0.52 mL, 4.82 mmol) in tetrahydrofuran (25 
mL) at –78 C was added 2.5 M n-butyl lithium in hexanes (1.80 mL, 4.50 mmol) and the 
mixture stirred for 0.75 h. The mixture was added via cannula to a solution of dimethyl 
(2S)-2-(p-toluenesulfonyl)aminobutanedioate (242) (0.51 g, 1.61 mmol) in tetrahydrofuran 
(25 mL) at –78 C. The mixture was stirred at –78 C for 1 h, then warmed to room 
temperature over 1.5 h. The mixture was quenched with saturated ammonium chloride 
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solution (10 mL), concentrated under reduced pressure, and the residue extracted with 
ethyl acetate (3  25 mL). The organic layers were combined, dried (MgSO4), filtered and 
concentrated under reduced pressure to yield a yellow oil. Flash column chromatography 
(ethyl acetate) afforded methyl (2S)-5-(dimethoxyphosphoryl)-4-oxo-2-(p-
toluenesulfonyl)aminopentanoate (0.37 g, 57%) as a white solid. Mp. 93–96 Cmax 
(neat)/cm
–1 
3133 (NH), 2963 (CH), 1721 (CO), 1327, 1235, 1026, 810; []D
22
 
 –11.2 (c 0.5, 
CHCl3); H (400 MHz, CDCl3) 2.43 (3H, s, CH3C6H4), 2.59 (1H, dd, J 17.0, 5.0 Hz, 3-
HH), 2.75 (1H, dd, J 17.0, 5.0 Hz, 3-HH), 3.26 (1H, dd, J 22.5, 14.0 Hz, 5-HH), 3.39 (1H, 
dd, J 22.5, 14.0 Hz, 5-HH), 3.59 (3H, s, OMe), 3.73 (3H, d, J 11.2 Hz, OMe), 3.78 (3H, d, 
J 11.2 Hz, OMe), 4.28 (1H, dt, J 8.7, 5.0 Hz, 2-H), 6.54 (1H, d, J 8.7 Hz, NH), 7.32 (2H, d, 
J 8.4 Hz, ArH), 7.77 (2H, d, J 8.4 Hz, ArH); C (101 MHz, CDCl3) 21.6 (CH3), 29.7 
(CH2), 37.4 (d, J 129.1 Hz, CH2), 52.1 (CH3), 53.3 (d, J 2.9 Hz, CH3), 53.4 (d, J 2.9 Hz, 
CH3), 59.0 (CH), 127.3 (2  CH), 129.9 (2  CH), 137.2 (C), 143.9 (C), 171.1 (C), 198.8 
(C); m/z (CI) 408.0877 (MH
+
. C15H23NO8PS requires 408.0882), 252 (44%), 237 (19), 220 
(9), 157 (22).  
 
Dimethyl (2S)-5-(dimethoxyphosphoryl)-4-oxo-N-(tert-butoxycarbonyl)-N-(p-
toluenesulfonyl)-2-aminopentandioate 
 
 
 
To a solution of methyl (2S)-5-(dimethoxyphosphoryl)-4-oxo-2-(p-
toluenesulfonyl)aminopentanoate (247) (0.21 g, 0.51 mmol) in acetonitrile (15 mL) at 
room temperature was added di-tert-butyl dicarbonate (0.12 g, 0.56 mmol) and 4-
dimethylaminopyridine (0.01 g, 0.05 mmol). The mixture was stirred for 18 h, 
concentrated under reduced pressure, and the residue dissolved in ethyl acetate (25 mL). 
The organic layer was washed with 0.2 M citric acid solution (2  15 mL), saturated 
sodium hydrogen carbonate solution (30 mL) and brine. The organic layer was dried 
(MgSO4), filtered and concentrated under reduced pressure to yield a yellow oil. Flash 
column chromatography (ethyl acetate/petroleum ether 1:1 to 1:0) afforded dimethyl (2S)-
5-(dimethoxyphosphoryl)-4-oxo-N-(tert-butoxycarbonyl)-N-(p-toluenesulfonyl)-2-
aminopentandioate (0.17 g, 65%) as a colourless oil. NMR data for major rotomer: H (400 
MHz, CDCl3) 1.38 (9H, s, OtBu), 2.46 (3H, s, CH3), 2.55 (1H, dd, J 16.3, 5.2 Hz, 3-HH), 
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3.28 (1H, dd, J 16.3, 7.8 Hz, 3-HH), 3.36–3.58 (2H, m, 5-H2), 3.68 (3H, s, OMe), 3.82 
(3H, d, J 14.5 Hz, OMe), 3.85 (3H, d, J 14.5 Hz, OMe), 5.56 (1H, dd, J 7.8, 5.2 Hz, 2-H), 
7.36 (2H, d, J 8.1 Hz, ArH), 7.92 (2H, d, J 8.1 Hz, ArH); C (101 MHz, CDCl3) 21.7 
(CH3), 27.8 (3  CH3), 34.6 (CH2), 35.6 (d, J 134 Hz, CH2), 52.0 (CH3), 52.1 (CH3), 62.0 
(CH3), 62.1 (CH), 86.5 (C), 128.6 (CH), 128.8 (CH), 129.4 (CH), 129.5 (CH), 135.9 (C), 
145.2 (C), 150.0 (C), 170.6 (C), 195.9 (C).   
 
Dimethyl (2S)-2-(tritylamino)butanedioate
73
  
 
 
 
To a solution of dimethyl (2S)-2-aminobutanedioate hydrochloride (224) (7.36 g, 37.24 
mmol) in dichloromethane (100 mL) at 0 C was added triethylamine (10.32 mL, 74.99 
mmol) and triphenylmethyl chloride (12.46 g, 44.69 mmol). The mixture was warmed to 
room temperature then stirred for 20 h. The mixture was washed with 2 M citric acid 
solution (50 mL) then water (50 mL) and brine (50 mL), then dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure to yield a brown oil. 
Flash column chromatography (petroleum ether/diethyl ether 4:1) afforded the desired 
product (11.80 g, 79%) as a white solid. Mp. 70–71 C, lit.73 71–72 Cmax (neat)/cm
–1 
2338, 1736 (CO), 1443, 1173, 902; []D
29
 
 
+15.9 (c 1.0, CHCl3), lit.
73
 []D
24
 +36.6 (c 1.0, 
CHCl3); H (400 MHz, CDCl3) 2.50 (1H, dd, J 14.7, 7.1 Hz, 3-HH), 2.65 (1H, dd, J 14.7, 
5.4 Hz, 3-HH), 2.93 (1H, d, J 10.1 Hz, NH), 3.26 (3H, s, OMe), 3.67 (3H, s, OMe), 3.68–
3.72 (1H, m, 2-H), 7.08–7.19 (9H, m, ArH), 7.39–7.41 (6H, m, ArH); C (101 MHz, 
CDCl3) 40.3 (CH2), 51.8 (CH3), 52.0 (CH3), 53.7 (CH), 71.2 (C), 126.5 (3  CH), 127.9 (6 
 CH), 128.8 (6  CH), 145.7 (3  C), 171.0 (C), 173.9 (C); m/z (CI) 404.1858 (MH+. 
C25H26NO4 requires 404.1862), 326 (23%), 285 (31), 244 (100), 243 (100), 162 (73). 
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Methyl (2S)-2-(tritylamino)-5-(dimethoxyphosphoryl)-4-oxopentanoate
73
  
 
 
 
To a solution of dimethyl methylphosphonate (0.26 mL, 2.38 mmol) in tetrahydrofuran (15 
mL) at –78 C was added 1.6 M n-butyl lithium in hexanes (1.39 mL, 2.23 mmol). The 
mixture was stirred for 0.75 h, then added via cannula to a solution of dimethyl (2S)-2-
(tritylamino)butanedioate (225) (0.30 g, 0.74 mmol) in tetrahydrofuran (10 mL) at –78 C. 
The mixture was stirred for 3 h, then warmed to room temperature over 0.5 h and quenched 
with saturated ammonium chloride solution (10 mL). The mixture was concentrated under 
reduced pressure, the residue was extracted with ethyl acetate (3  20 mL), and the 
combined organic layers dried (MgSO4), filtered and concentrated under reduced pressure 
to afford a brown oil. Flash column chromatography (petroleum ether/ethyl acetate 1:4) 
afforded methyl (2S)-2-(tritylamino)-5-(dimethoxyphosphoryl)-4-oxopentanoate (0.32 g, 
88%) as a yellow solid. Mp. 112–114 C, lit.73 117–118 Cmax (neat)/cm
–1 
3321 (NH), 
2924 (CH), 1720 (CO), 1443, 1266, 1026; []D
25
 
 
+18.4 (c 0.6, CHCl3), lit.
73
 []D
24
 +31.1 
(c 1.0, CHCl3); H (400 MHz, CDCl3) 2.70 (1H, dd, J 16.8, 7.0 Hz, 3-HH), 2.81 (1H, dd, J 
16.8, 4.6 Hz, 3-HH), 2.86 (1H, d, J 9.4 Hz, NH), 2.97 (2H, dd, J 22.7, 1.7 Hz, 5-H2), 3.21 
(3H, s, OMe), 3.59–3.65 (1H, m, 2-H), 3.67 (3H, s, OMe), 3.70 (3H, s, OMe), 7.08–7.19 
(9H, m, ArH), 7.39–7.41 (6H, m, ArH); C (101 MHz, CDCl3) 41.9 (d, J 128 Hz, CH2), 
48.8 (CH2), 52.0 (CH3), 52.9 (CH), 53.1 (d, J 6.1 Hz, CH3), 53.2 (d, J 6.1 Hz, CH3), 71.3 
(C), 126.6 (3  CH), 127.9 (6  CH), 128.8 (6  CH), 145.7 (3  C), 174.1 (C), 199.3 (C); 
m/z (FAB) 496 (MH
+
. 8%), 417 (10), 251 (14), 242 (100), 153 (37).  
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Methyl (2S,5E)-2-(tritylamino)-4-oxo-8-phenyloct-5-enoate
73
 
 
 
 
To a solution of methyl (2S)-2-(tritylamino)-5-(dimethoxyphosphoryl)-4-oxopentanoate 
(226) (0.53 g, 1.06 mmol) in acetonitrile (30 mL) was added hydrocinnamaldehyde (0.28 
mL, 2.12 mmol) and anhydrous potassium carbonate (0.16 g, 1.17 mmol) and the mixture 
heated to 50 C for 48 h. The reaction mixture was cooled and concentrated under reduced 
pressure, and the residue dissolved in ethyl acetate (25 mL) and washed with water (25 
mL). The aqueous phase was extracted with ethyl acetate (25 mL) and the organic layers 
were combined then dried (MgSO4), filtered and concentrated under reduced pressure. 
Flash column chromatography (petroleum ether/diethyl ether 9:1 to 7:3) afforded methyl 
(2S,5E)-2-(tritylamino)-4-oxo-8-phenyloct-5-enoate (0.40 g, 75%) as a yellow oil. max 
(neat)/cm
–1 
3012 (CH), 2338, 1736 (CO), 1674 (CO), 1645 (C=C), 1204, 1026; []D
25
 
 
+19.3 (c 1.0, CHCl3), lit.
73
 []D
27
 +26.6 (c 1.0, CHCl3); H (40 0 MHz, CDCl3) 2.49–2.86 
(7H, m, 3-H2, 7-H2, 8-H2 and NH), 3.27 (3H, s, OMe), 3.70 (1H, m, 2-H), 6.05 (1H, dt, J 
16.0, 1.5 Hz, 5-H), 6.76 (1H, dt, J 16.0, 6.7 Hz, 6-H), 7.08–7.19 (9H, m, ArH), 7.39–7.41 
(6H, m, ArH); C (101 MHz, CDCl3) 34.2 (CH2), 34.4 (CH2), 45.0 (CH2), 51.9 (CH3), 53.7 
(CH), 71.3 (C), 126.3 (CH), 126.6 (3  CH), 127.9 (6  CH), 128.4 (2  CH), 128.6 (2  
CH), 128.9 (6  CH), 131.0 (CH), 140.7 (C), 145.9 (CH), 147.1 (3  C), 174.5 (C), 197.6 
(C); m/z (FAB) 504.2534 (MH
+
. C34H34NO3 requires 504.2539), 426 (69%), 378 (2), 266 
(6), 252 (78), 243 (100). 
 
Methyl (2S,5E)-4-oxo-8-phenyl-2-(trifluoroacetylamino)oct-5-enoate 
 
 
 
To a solution of methyl (2S,5E)-2-(tritylamino)-4-oxo-8-phenyloct-5-enoate (250) (70 mg, 
0.14 mmol) in dichloromethane (10 mL) at room temperature was added trifluoroacetic 
acid (103 L, 1.39 mmol), and the mixture was stirred for 3 h. The mixture was 
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concentrated under reduced pressure, the residue dissolved in water and washed with 
diethyl ether (2  10 mL). The aqueous phase was concentrated under reduced pressure 
then azeotroped with ethyl acetate and chloroform to afford a yellow oil. The oil was 
dissolved in dichloromethane (10 mL), to which was added triethylamine (46 L, 0.34 
mmol) and p-toluenesulfonyl chloride (36 mg, 0.19 mmol). The mixture was stirred for 18 
h, washed with 0.5 M hydrochloric acid solution (10 mL) then saturated sodium hydrogen 
carbonate solution (10 mL), dried (MgSO4), filtered and concentrated under reduced 
pressure to afford a yellow oil. Flash column chromatography (petroleum ether/diethyl 
ether 1:1) afforded methyl (2S,5E)-4-oxo-8-phenyl-2-(trifluoroacetylamino)oct-5-enoate 
(18 mg, 36%) as a colourless oil. max (neat)/cm
–1 
3022 (CH), 1751, 1727 (CO), 1628, 
1215; []D
29
 +65.9 (c 0.9, CHCl3); H (400 MHz, CDCl3) 2.55–2.60 (2H m, 7-H2), 2.80 
(2H, t, J 7.5 Hz, 8-H2), 3.11 (1H, dd, J 18.3, 4.0 Hz, 3-HH), 3.42 (1H, dd, J 18.3, 4.0 Hz, 
3-HH), 3.77 (3H, s, CH3), 4.81 (1H, dt, J 8.0, 4.0 Hz, 2-H), 6.11 (1H, dt, J 16.0, 1.5 Hz, 5-
H), 6.92 (1H, dt, J 16.0, 6.8 Hz, 6-H), 7.16–7.32 (5H, m, Ph), 7.43 (1H, d, J 8.0 Hz, NH); 
C (101 MHz, CDCl3) 34.2 (CH2), 34.3 (CH2), 40.4 (CH2), 48.5 (CH), 53.2 (CH3), 115.6 
(q, J 228 Hz, C)  126.4 (CH), 128.3 (2  CH), 128.6 (2  CH), 129.8 (CH), 140.3 (C), 
149.1 (CH), 156.5–157.4 (m, C), 169.8 (C), 197.2 (C); m/z (CI) 358.1267 (MH+. 
C17H19F3NO4 requires 358.1266), 302 (2%), 245 (5), 198 (3), 157 (8). 
 
Methyl 4-oxo-6-(2-phenylethyl)-1,4,5,6-tetrahydropyridine-2-carboxylate 
 
 
 
To a solution of methyl (2S,5E)-2-tritylamino-4-oxo-8-phenyloct-5-enoate (250) (0.30 g, 
5.96 mmol) in methanol (15 mL) was added 2 M hydrochloric acid solution (15 mL). The 
mixture was stirred for 1 h, filtered and concentrated under reduced pressure. The residue 
was azeotroped with toluene (3  20 mL), ethyl acetate (3  20 mL) and chloroform (3  
20 mL) and dried under reduced pressure. The residue was dissolved in dichloromethane 
(15 mL) to which was added triethylamine (0.17 mL, 1.24 mmol) and p-toluenesulfonyl 
chloride (0.13 g, 6.90 mmol). The mixture was stirred for 24 h, washed with 0.5 M 
hydrochloric acid solution (10 mL) then saturated sodium hydrogencarbonate solution (10 
mL), dried (MgSO4), filtered and concentrated under reduced pressure to yield a yellow 
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oil. Flash column chromatography (petroleum ether/diethyl ether 1:1) afforded a white 
solid, methyl (2S,5E)-2-(p-toluenesulfonylamino)-4-oxo-8-phenyloct-5-enoate. H 
(400MHz, CDCl3) 2.34 (3H, s, CH3C6H4), 2.43-2.49 (2H, m, 7-H2), 2.70 (2H, t, J 7.4 Hz, 
8-H2), 3.06 (1H, dd, J 17.9, 4.5 Hz, 3-HH), 3.14 (1H, dd, J 17.9, 4.0 Hz, 3-HH), 3.46 (3H, 
s, OMe), 4.04–4.08 (1H, m, 2-H), 5.60 (1H, d, J 8.2 Hz, NH), 5.97 (1H, dt, J 16.0, 1.4 Hz, 
5-H), 6.76 (1H, dt, J 16.0, 6.8 Hz, 6-H), 7.08–7.24 (7H, m, Ph and ArH), 7.65–7.68 (2H, 
m, ArH); C (100 MHz, CDCl3) 21.6 (CH3), 34.2 (CH2), 34.2 (CH2), 42.9 (CH2), 51.7 
(CH3), 52.8 (CH), 126.3 (CH), 127.2 (2  CH), 128.3 (2  CH), 128.6 (2  CH), 129.6 
(CH), 130.0 (2  CH), 137.0 (C), 140.5 (C), 143.6 (C), 148.3 (CH), 170.9 (C), 196.9 (C). 
The solid was dissolved in dimethylsulfoxide (10 mL) to which was added anhydrous 
potassium carbonate (2 mg, 16 mol). The mixture was stirred for 24 h then diluted with 
ethyl acetate (30 mL) and washed with water (2  15 mL). The organic layer was dried 
(MgSO4), filtered and concentrated under reduced pressure to yield a yellow oil. Flash 
column chromatography (petroleum ether/diethyl ether 7:3 to 1:4 with 1% triethylamine) 
afforded methyl 4-oxo-6-(2-phenylethyl)-1,4,5,6-tetrahydropyridine-2-carboxylate (14 mg, 
9% over three steps) as a pale yellow oil. max (neat)/cm
–1 
3356 (NH), 2931 (CH), 1732 
(CO), 1632 (C=C), 1589, 1269, 1161; H (400 MHz, CDCl3) 1.85–2.02 (2H, m, 1’-H2), 
2.32 (1H, dd, J 16.3, 12.7 Hz, 5-HH), 2.47 (1H, dd, J 16.3, 4.9 Hz, 5-HH), 2.60–2.72 (2H, 
m, 2’-H2), 3.59–3.65 (1H, m, 6-H), 3.80 (3H, s, OMe), 5.43 (1H, br s, NH), 5.63–5.64 (1H, 
m, 3-H), 7.11–7.26 (5H, m, Ph); C (101 MHz, CDCl3) 31.7 (CH2), 35.2 (CH2), 41.7 
(CH2), 52.7 (CH), 53.4 (CH3), 101.3 (CH), 126.4 (CH), 128.3 (2  CH), 128.8 (2  CH), 
140.3 (C), 147.7 (C), 163.9 (C), 194.5 (C); m/z (EI) 259.1208 (M
+
. C15H17NO3 requires 
259.1208), 155 (100%), 127 (24), 122 (21), 91 (70). 
 
Methyl (2S,6S)-4-oxo-6-(2-phenylethyl)piperidine-2-carboxylate and methyl (2S,6R)-
4-oxo-6-(2-phenylethyl)piperidine-2-carboxylate 
 
 
 
To a solution of methyl (2S,5E)-2-(tritylamino)-4-oxo-8-phenyloct-5-enoate (250) (150 
mg, 0.30 mmol) in methanol (10 mL) was added 2 M hydrochloric acid solution (2.5 mL). 
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The mixture was stirred for 1 h, then diluted with water (10 mL) and basified to pH 8 with 
N-ethyldiisopropylamine (1.5 mL). The mixture was stirred for 18 h then partitioned 
between ethyl acetate (20 mL) and brine (20 mL). The aqueous layer was separated and re-
extracted with ethyl acetate (20 mL). The organic layers were combined, dried (MgSO4), 
filtered and concentrated under reduced pressure. Flash column chromatography 
(petroleum ether/ethyl acetate 1:0 to 3:7 with 1% triethylamine) afforded methyl (2S,6S)-4-
oxo-6-(2-phenylethyl)piperidine-2-carboxylate (41 mg, 54%) as a white solid followed by 
(2S,6R)-4-oxo-6-(2-phenylethyl)piperidine-2-carboxylate (18 mg, 23%) as a colourless oil. 
Data for methyl (2S,6S)-4-oxo-6-(2-phenylethyl)piperidine-2-carboxylate: p. 76–78 
Cmax (neat)/cm
–1 
3212 (NH), 2924 (CH), 1736 (CO), 1713 (CO), 1435, 1265; []D
26
 
 –
15.1 (c 0.6, CHCl3);  H (400 MHz, CDCl3) 1.82–1.97 (2H, m, 1’-H2), 2.16 (1H, ddd, J 
14.4, 11.7, 0.9 Hz, 5-HH), 2.44 (1H, ddd, J 14.4, 12.2, 0.9 Hz, 3-Hax), 2.48 (1H, ddd, J 
14.4, 2.9, 2.0 Hz, 5-HH), 2.70 (1H, ddd, J 14.4, 3.4, 2.0 Hz, 3-Heq), 2.73–2.77 (2H, m, 2’-
H2), 2.86–2.91 (1H, m, 6-H), 3.63 (1H, dd, J 12.2, 3.4 Hz, 2-H), 3.79 (3H, s, OMe), 7.19–
7.33 (5H, m, Ph); C (101 MHz, CDCl3) 30.3 (CH2), 38.3 (CH2), 44.5 (CH2), 48.4 (CH2), 
52.5 (CH3), 55.2 (CH), 57.9 (CH), 126.2 (CH), 128.5 (2  CH), 128.6 (2  CH), 141.1 (C), 
171.8 (C), 206.8 (C); m/z (CI) 262.1444 (MH
+
. C15H20NO3 requires 262.1443), 202 (9%), 
156 (4), 135 (5), 113 (4). Data for (2S,6R)-4-oxo-6-(2-phenylethyl)piperidine-2-
carboxylate: max (neat)/cm
–1 
3333 (NH), 2924 (CH), 1728 (CO), 1435, 1196, 1173; []D
27
 
–22.4 (c 1.1, CHCl3);  H (400MHz, CDCl3) 1.71–1.87 (2H, m, 1’-H2), 2.21 (1H, ddd, J 
14.6, 9.6, 1.0 Hz, 5-Heq), 2.46 (1H, ddd, J 14.6, 3.9, 1.7 Hz, 5-Hax), 2.60–2.72 (4H, m, 2’-
H2 and 3-H2), 3.10–3.16 (1H, m, 6-H), 3.71 (3H, s, OMe), 4.04 (1H, dd, J 6.5, 4.2 Hz, 2-
H), 7.17–7.31 (5H, m, Ph); C (100 MHz, CDCl3) 31.9 (CH2), 37.6 (CH2), 42.3 (CH2), 47.6 
(CH2), 52.1 (CH3), 52.3 (CH), 55.7 (CH), 126.1 (CH), 128.3 (2  CH), 128.5 (2  CH), 
141.1 (C), 173.0 (C), 206.7 (C); m/z (CI) 262.1447 (MH
+
. C15H20NO3 requires 262.1443), 
247 (5%), 202 (9), 156 (5), 113 (13).  
 
Methyl (2S,5E)-2-(tritylamino)-8-methyl-4-oxonon-5-enoate
73
  
 
 
 
To a solution of methyl (2S)-2-(tritylamino)-5-(dimethoxyphosphoryl)-4-oxopentanoate 
(226) (0.30 g, 0.61 mmol) in acetonitrile (20 mL) was added isovaleraldehyde (0.13 mL, 
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1.21 mmol) and anhydrous potassium carbonate (0.09 g, 0.67 mmol), and the mixture 
heated to 50 C for 96 h. The reaction mixture was cooled and concentrated under reduced 
pressure, and the residue dissolved in ethyl acetate (25 mL) and washed with water (25 
mL). The aqueous phase was extracted with ethyl acetate (25 mL) and the organic layers 
were combined then dried (MgSO4), filtered and concentrated under reduced pressure. 
Flash column chromatography (petroleum ether/diethyl ether 1:0 to 3:2) afforded methyl 
(2S,5E)-2-(tritylamino)-8-methyl-4-oxonon-5-enoate (0.16 g, 58%) as a yellow oil. max 
(neat)/cm
–1
 3327 (NH), 2955 (CH), 1736 (CO), 1667 (CO), 1628 (C=C), 1204; []D
30
 
 
+18.9 (c 0.9, CHCl3), lit.
73
 []D
18
 +18.1 (c 1.0 CHCl3); H (400 MHz, CDCl3) 0.91 (6H, d, 
J 6.7 Hz, 2  CH3), 1.70–1.80 (1H, m, 8-H), 2.08 (2H, td, J 7.3, 1.4 Hz, 7-H2), 2.64 (1H, 
dd, J 15.4, 7.1 Hz, 3-HH), 2.79 (1H, dd, J 15.4, 5.2 Hz, 3-HH), 2.86 (1H, d, J 9.8 Hz, NH), 
3.27 (3H, s, OMe), 3.62–3.78 (1H, m, 2-H), 6.02 (1H, dt, J 15.9, 1.4 Hz, 5-H), 6.72 (1H, 
dt, J 15.9, 7.4 Hz, 6-H), 7.08–7.19 (9H, m, ArH), 7.39–7.41 (6H, m, ArH); C (101 MHz, 
CDCl3) 22.4 (CH3), 22.4 (CH3), 27.9 (CH), 41.8 (CH2), 44.9 (CH2), 51.9 (CH), 53.7 (CH3), 
71.2 (C), 126.5 (3  CH), 127.9 (6  CH), 128.8 (6  CH), 131.7 (CH), 145.8 (3  CH), 
147.3 (CH), 174.6 (C), 197.7 (C); m/z (FAB) 478.2359 (MNa
+
. C30H33NO3 requires 
478.2358), 378 (12%), 243 (100), 166 (17), 113 (4), 75 (11). 
 
Methyl (2S,5E)-2-(tritylamino)-4-oxonon-5-enoate 
 
 
 
To a solution of methyl (2S)-2-(tritylamino)-5-(dimethoxyphosphoryl)-4-oxopentanoate 
(226) (0.39 g, 0.78 mmol) in acetonitrile (25 mL) was added butyraldehyde (0.14 mL, 1.56 
mmol) and anhydrous potassium carbonate (0.12 g, 0.86 mmol), and the mixture heated to 
50 C for 96 h. The reaction mixture was cooled and concentrated under reduced pressure, 
and the residue dissolved in ethyl acetate (25 mL) and washed with water (25 mL). The 
aqueous phase was extracted with ethyl acetate (25 mL) and the organic phases were 
combined then dried (MgSO4), filtered and concentrated under reduced pressure. Flash 
column chromatography (petroleum ether/diethyl ether 1:0 to 2:3) afforded methyl 
(2S,5E)-2-(tritylamino)-4-oxonon-5-enoate (0.20 g, 59%) as a yellow oil. max (neat)/cm
–1 
3316 (NH), 2955 (CH), 1736 (CO), 1667 (CO), 1443, 1204, 1173; []D
27
 +28.6
 
(c 0.5, 
CHCl3); H (400 MHz, CDCl3) 0.93 (3H, t, J 7.3 Hz, 9-H3), 1.44–1.53 (2H, m, 8-H2), 2.18 
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(2H, dtd, J 7.4, 7.0, 1.5 Hz, 7-H2), 2.65 (1H, dd, J 15.3, 7.1 Hz, 3-HH), 2.79 (1H, dd, J 
15.3, 5.2 Hz, 3-HH), 2.85 (1H, d, J 9.8 Hz, NH), 3.27 (3H, s, OMe), 3.67–3.74 (1H, m, 2-
H), 6.04 (1H, dt, J 16.0, 1.5 Hz, 5-H), 6.74 (1H, dt, J 16.0, 7.0 Hz, 6-H), 7.08–7.19 (9H, m, 
ArH), 7.39–7.41 (6H, m, ArH); C (101 MHz, CDCl3) 13.7 (CH3), 21.3 (CH2), 34.5 (CH2), 
44.9 (CH2), 51.9 (CH), 53.6 (CH3), 71.2 (C), 126.5 (3  CH), 127.9 (6  CH), 129.1 (6  
CH), 130.7 (CH), 145.8 (C), 148.3 (CH), 174.6 (C), 198.0 (C); m/z (FAB) 442.2378 (MH
+
. 
C29H32NO3 requires 442.2382), 364 (60%), 243 (100), 198 (64), 165 (43). 
 
Methyl (2S,5E)-2-(tritylamino)-4-oxo-6-phenylhex-5-enoate
73
  
 
 
 
To a solution of methyl (2S)-2-(tritylamino)-5-(dimethoxyphosphoryl)-4-oxopentanoate 
(226) (0.30 g, 0.61 mmol) in acetonitrile (25 mL) was added benzaldehyde (0.12 mL, 1.21 
mmol) and anhydrous potassium carbonate (92 mg, 0.67 mmol), and the mixture heated to 
50 C for 96 h. The reaction mixture was cooled and concentrated under reduced pressure, 
and the residue dissolved in ethyl acetate (25 mL) and washed with water (25 mL). The 
aqueous layer was extracted with ethyl acetate (25 mL) and the organic layers were 
combined then dried (MgSO4), filtered and concentrated under reduced pressure. Flash 
column chromatography (petroleum ether/diethyl ether 1:0 to 2:3) afforded methyl 
(2S,5E)-2-(tritylamino)-4-oxo-6-phenylhex-5-enoate (0.20 g, 70%) as a yellow oil. NMR 
data consistent with literature.
73
 max (neat)/cm
–1 
3297 (NH), 1736 (CO), 1688 (CO), 1657 
(C=C), 1204, 1173, 1030; []D
27
 +48.6
 
(c 0.3, CHCl3); H (400 MHz, CDCl3) 2.83 (1H, dd, 
J 15.2, 6.9 Hz, 3-HH), 2.93–2.98 (2H, m, 3-HH and NH), 3.32 (3H, s, OMe), 3.84 (1H, m, 
2-H), 6.73 (1H, d, J 16.3 Hz, 5-H), 7.10–7.31 (9H, m ArH), 7.35–7.61 (12H, m, ArH and 
6-H);C (101 MHz, CDCl3) 45.7 (CH2), 51.9 (CH), 53.8 (CH3), 71.3 (C), 126.4 (CH), 
126.5 (3  CH), 127.9 (6  CH), 128.4 (2  CH), 128.8 (6  CH), 129.0 (2  CH), 130.6 
(CH), 134.4 (C), 143.3 (CH), 145.8 (3  C), 174.5 (C), 197.5 (C); m/z (FAB) 476.2238 
(MH
+
. C32H30NO3 requires 476.2226), 398 (35%), 307 (16), 243 (100), 131 (36). 
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Methyl (2S,5E)-2-(tritylamino)-6-(4-bromophenyl)-4-oxohex-5-enoate
73
  
 
 
 
To a solution of methyl (2S)-2-(tritylamino)-5-(dimethoxyphosphoryl)-4-oxopentanoate 
(226) (0.30 g, 0.61 mmol) in acetonitrile (20 mL) was added p-bromobenzaldehyde (0.22 
g, 1.21 mmol) and anhydrous potassium carbonate (0.09 g, 0.67 mmol), and the mixture 
heated to 50 C for 96 h. The reaction mixture was cooled and concentrated under reduced 
pressure, and the residue dissolved in ethyl acetate (25 mL) and washed with water (25 
mL). The aqueous phase was extracted with ethyl acetate (25 mL) and the organic phases 
were combined then dried (MgSO4), filtered and concentrated under reduced pressure. 
Flash column chromatography (petroleum ether/diethyl ether 1:0 to 2:3) afforded methyl 
(2S,5E)-2-(tritylamino)-6-(4-bromophenyl)-4-oxohex-5-enoate (0.29 g, 85%) as a yellow 
oil. max (neat)/cm
–1 
3312 (NH), 2949 (CH), 1733 (CO), 1688 (CO), 1658 (C=C), 1487, 
1071; []D
27
 +46.2
 
(c 1.0, CHCl3), lit.
73
 []D
27
 +64.6 (c 1.0 CHCl3); H (400 MHz, CDCl3) 
2.77 (1H, dd, J 15.2, 7.1 Hz, 3-HH), 2.89 (1H, dd, J 15.2, 5.1 Hz, 3-HH), 2.91 (1H, d, J 9.4 
Hz, NH), 3.28 (3H, s, OMe), 3.76–3.81 (1H, m, 2-H), 6.66 (1H, d, J 16.1 Hz, 5-H), 7.15–
7.25 (10H, m, ArH and 6-H), 7.40–7.62 (10H, m, ArH); C (101 MHz, CDCl3) 45.9 (CH2), 
52.0 (CH), 53.8 (CH3), 71.3 (C), 125.0 (C), 126.6 (2  CH), 126.8 (3  CH), 128.0 (6  
CH), 128.6 (6  CH), 129.7 (2  CH), 132.3 (CH), 133.3 (3  C), 141.8 (C), 145.8 (CH), 
174.4 (C), 197.3 (C); m/z (EI) 554 (M
+
, 1%), 478 (28%), 309 (30), 242 (100). 
 
Methyl (2S,5E)-2-(tritylamino)-6-(4-nitrophenyl)-4-oxohex-5-enoate 
 
 
 
To a solution of methyl (2S)-2-(tritylamino)-5-(dimethoxyphosphoryl)-4-oxopentanoate 
(226) (0.30 g, 0.61 mmol) in acetonitrile (25 mL) was added p-nitrobenzaldehyde (0.18 g, 
1.21 mmol) and anhydrous potassium carbonate (0.09 g, 0.67 mmol), and the mixture 
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heated to 50 C for 24 h. The reaction mixture was cooled and concentrated under reduced 
pressure, and the residue dissolved in ethyl acetate (25 mL) and washed with water (25 
mL). The aqueous phase was extracted with ethyl acetate (25 mL) and the organic phases 
were combined then dried (MgSO4), filtered and concentrated under reduced pressure. 
Flash column chromatography (petroleum ether/diethyl ether 1:0 to 3:7) afforded methyl 
(2S,5E)-2-(tritylamino)-6-(4-nitrophenyl)-4-oxohex-5-enoate (0.22 g, 69%) as an off-white 
solid. Mp. 139–141 Cmax (neat)/cm
–1 
2951 (CH), 1742 (CO), 1712 (CO), 1490, 1509 
(NO), 1341 (NO); []D
25
 +43.3
 
(c 0.2, CHCl3); H (400 MHz, CDCl3) 2.80 (1H, dd, J 15.5, 
6.9 Hz, 3-HH), 2.91 (1H, dd, J 15.5, 5.1 Hz, 3-HH), 2.95 (1H, br s, NH), 3.31 (3H, s, 
OMe), 3.81 (1H, m, 2-H), 6.77 (1H, d, J 16.2 Hz, 5-H), 7.17–7.51 (16H, m, 6-H and 3  
Ph), 7.66 (2H, d, J 8.8 Hz, ArH), 8.26 (2H, d, J 8.8 Hz, ArH); C (101 MHz, CDCl3) 46.2 
(CH2), 52.1 (CH3), 53.7 (CH), 71.3 (C), 124.3 (CH), 126.6 (3  CH), 128.0 (6  CH), 
128.8 (6  CH), 128.9 (2  CH). 129.6 (2  CH), 139.9 (CH), 140.6 (C), 145.7 (3  C), 
148.6 (C), 174.3 (C), 197.0 (C); m/z (FAB + NaI) 543.1903 (MNa
+
. C32H28NO5Na requires 
543.1896), 443 (9%), 413 (9), 351 (19), 243 (100), 176 (78). 
 
Methyl (2S,5E)-2-(tritylamino)-6-(4-methoxyphenyl)-4-oxohex-5-enoate
73
  
 
 
 
To a solution of methyl (2S)-2-(tritylamino)-5-(dimethoxyphosphoryl)-4-oxopentanoate 
(226) (0.30 g, 0.61 mmol) in acetonitrile (25 mL) was added p-methoxybenzaldehyde (0.15 
mL, 1.21 mmol) and anhydrous potassium carbonate (0.09 g, 0.67 mmol), and the mixture 
heated to 50 C for 144 h. The reaction mixture was cooled and concentrated under 
reduced pressure, and the residue dissolved in ethyl acetate (25 mL) and washed with 
water (25 mL). The aqueous phase was extracted with ethyl acetate (25 mL) and the 
organic phases were combined then dried (MgSO4), filtered and concentrated under 
reduced pressure. Flash column chromatography (petroleum ether/diethyl ether 1:0 to 2:3) 
afforded methyl (2S,5E)-2-(tritylamino)-6-(4-methoxyphenyl)-4-oxohex-5-enoate (0.14 g, 
46%) as a yellow oil. max (neat)/cm
–1 
3299 (NH), 3016 (CH), 1736 (CO), 1651 (CO), 1597 
(C=C), 1257, 1173; []D
25
 +47.8
 
(c 1.1, CHCl3), lit.
73
 []D
23
 +54.1 (c 1.0, CHCl3); H (400 
MHz, CDCl3) 2.81 (1H, dd, J 15.0, 6.9 Hz, 3-HH), 2.92–2.97 (2H, m, 3-HH and NH), 3.30 
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(3H, s, OMe), 3.81–3.84 (1H, m, 2-H), 3.88 (3H, s, OMe), 6.61 (1H, d, J 16.1 Hz, 5-H), 
6.95 (2H, d, J 8.7 Hz, ArH), 7.18–7.30 (9H, m, 6-H and ArH) 7.51–7.55 (9H, m, ArH); C 
(100 MHz, CDCl3) 45.7 (CH2), 51.9 (CH3), 53.9 (CH), 55.4 (CH3), 71.3 (C), 114.5 (2  
CH), 124.3 (CH), 126.5 (3  CH), 127.1 (C), 127.9 (6  CH), 128.8 (6  CH), 130.1 (2  
CH), 143.1 (CH), 145.8 (3  C), 161.8 (C), 174.5 (C), 197.4 (C); m/z (FAB) 506.2332 
(MH
+
. C33H32NO4 requires 506.2331), 428 (7%), 243 (100), 161 (22). 
 
Methyl (2S,5E)-2-(tritylamino)-6-(furan-2-yl)-4-oxohex-5-enoate
73
  
 
 
 
To a solution of methyl (2S)-2-(tritylamino)-5-(dimethoxyphosphoryl)-4-oxopentanoate 
(226) (0.33 g, 0.66 mmol) in acetonitrile (25 mL) was added 2-furfuraldehyde (0.11 mL, 
1.31 mmol) and anhydrous potassium carbonate (0.10 g, 0.72 mmol), and the mixture 
heated to 50 C for 72 h. The reaction mixture was cooled and concentrated under reduced 
pressure, and the residue dissolved in ethyl acetate (25 mL) and washed with water (25 
mL). The aqueous phase was extracted with ethyl acetate (25 mL) and the organic phases 
were combined then dried (MgSO4), filtered and concentrated under reduced pressure. 
Flash column chromatography (petroleum ether/diethyl ether 1:0 to 1:1) afforded methyl 
(2S,5E)-2-(tritylamino)-6-(furan-2-yl)-4-oxohex-5-enoate (0.26 g, 84%) as a yellow oil. 
max (neat)/cm
–1 
3017 (CH), 1734 (CO), 1653 (CO), 1604 (C=C), 1215, 1017; []D
25
 +47.0
 
(c 1.2, CHCl3), lit.
73
 []D
23
 +42.9 (c 0.3, CHCl3); H (400 MHz, CDCl3) 2.73 (1H, dd, J 
15.1, 7.0 Hz, 3-HH), 2.85 (1H, dd, J 15.1, 5.3 Hz, 3-HH), 2.90 (1H, d, J 8.6 Hz, NH), 3.27 
(3H, s, OMe), 3.68–3.84 (1H, m, 2-H), 6.48 (1H, dd, J 3.4, 1.8 Hz, ArH), 6.60 (1H, d, J 
15.9 Hz, 5-H), 6.66 (1H, d, J 3.4 Hz, ArH), 7.15–7.51 (17H, m, 6-H and ArH); C (101 
MHz, CDCl3) 46.2 (CH2), 51.9 (CH3), 53.9 (CH), 71.3 (C), 112.6 (CH), 116.0 (CH), 123.7 
(CH), 126.5 (3  CH), 127.9 (6  CH), 128.8 (6  CH), 129.2 (CH), 145.1 (CH), 145.8 (3 
 C), 151.0 (C), 174.4 (C), 197.0 (C); m/z (FAB) 466.2016 (MH+. C30H28NO4 requires 
466.2018), 388 (7%), 243 (100), 222 (7), 165 (6). 
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Methyl (2S,5E)-2-(tritylamino)-6-(naphthalen-2-yl)-4-oxohex-5-enoate
73
  
 
 
 
To a solution of methyl (2S)-2-(tritylamino)-5-(dimethoxyphosphoryl)-4-oxopentanoate 
(226) (0.20 g, 0.41 mmol) in acetonitrile (20 mL) was added naphthaldehyde (0.13 g, 0.81 
mmol) and anhydrous potassium carbonate (0.06 g, 0.45 mmol), and the mixture heated to 
50 C for 48 h. The reaction mixture was cooled and concentrated under reduced pressure, 
and the residue dissolved in ethyl acetate (25 mL) and washed with water (25 mL). The 
aqueous phase was extracted with ethyl acetate (25 mL) and the organic phases were 
combined then dried (MgSO4), filtered and concentrated under reduced pressure. Flash 
column chromatography (petroleum ether/diethyl ether 1:0 to 2:3) afforded methyl 
(2S,5E)-2-(tritylamino)-6-(naphthalen-2-yl)-4-oxohex-5-enoate (0.15 g, 73%) as a yellow 
oil. max (neat)/cm
–1 
3019 (CH), 1734 (CO), 1654 (C=C), 1604, 1215, 1175; []D
25
 +51.6
 
(c 
1.1, CHCl3), lit.
73
 []D
24
 +64.1 (c 1.0, CHCl3); H (400 MHz, CDCl3) 2.88 (1H, dd, J 15.1, 
7.1 Hz, 3-HH), 2.97–3.04 (2H, m, 3-HH and NH), 3.33 (3H, s, OMe), 3.84–3.90 (1H, m, 2-
H), 6.84 (1H, d, J 16.2 Hz, 5-H), 7.19–7.31 (9H, m, ArH), 7.54–7.58 (8H, m, ArH), 7.67–
7.71 (2H, m, 6-H and ArH), 7.87–7.97 (4H, m, ArH); C (101 MHz, CDCl3) 45.9 (CH2), 
52.0 (CH), 53.6 (CH3), 71.3 (C), 123.6 (CH), 126.5 (3  CH), 126.8 (CH), 127.5 (CH), 
127.8 (CH), 127.9 (6  CH), 128.2 (CH), 128.6 (CH), 128.8 (CH), 128.9 (6  CH), 130.6 
(CH), 131.9 (C), 133.3 (C), 134.4 (C), 143.4 (CH), 145.8 (3  C), 174.5 (C), 197.5 (C); m/z 
(FAB) 526.2388 (MH
+
. C36H32NO3 requires 526.2382), 448 (7%), 289 (7), 273 (11), 243 
(100), 181 (19), 152 (17).  
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Methyl (2S,6S)-6-(2-methylpropyl)-4-oxopiperidine-2-carboxylate and methyl 
(2S,6R)-6-(2-methylpropyl)-4-oxopiperidine-2-carboxylate 
 
 
 
To a solution of methyl (2S,5E)-2-(tritylamino)-8-methyl-4-oxonon-5-enoate (263) (65 mg, 
0.14 mmol) in methanol (10 mL) was added 2 M hydrochloric acid solution (2.5 mL). The 
mixture was stirred for 1 h, then diluted with water (10 mL) and basified to pH 8 with N-
ethyldiisopropylamine (1.5 mL). The mixture was stirred for 18 h then partitioned between 
ethyl acetate (20 mL) and brine (20 mL). The aqueous layers were separated and re-
extracted with ethyl acetate (20 mL). The organic phases were combined, dried over 
anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. Flash 
column chromatography (petroleum ether/ethyl acetate 1:0 to 3:7 with 1% triethylamine) 
afforded methyl (2S,6S)-6-(2-methylpropyl)-4-oxopiperidine-2-carboxylate (19 mg, 62%) 
as a colourless oil followed by (2S,6R)-6-(2-methylpropyl)-4-oxopiperidine-2-carboxylate 
(4 mg, 13%) as a colourless oil. Data for methyl (2S,6S)-6-(2-methylpropyl)-4-
oxopiperidine-2-carboxylate: max (neat)/cm
–1 
3332 (NH), 2957 (CH), 1740 (CO), 1716 
(CO), 1437, 1216; []D
26
 –11.2 (c 1.1, CHCl3); H (400 MHz, CDCl3) 0.91 (3H, d, J 5.2 
Hz, 3’-H3), 0.93 (3H, d, J 5.2 Hz, 2’-CH3), 1.31–1.39 (1H, m, 1’-HH), 1.46–1.53 (1H, m, 
1’-HH), 1.69–1.80 (1H, m, 2’-H), 2.07 (2H, ddd, J 14.1, 11.6, 0.9 Hz, 5-H2), 2.38–2.45 
(2H, m, NH and 3-Heq), 2.69 (1H, ddd, J 14.3, 3.4, 2.0 Hz, 3-Hax), 2.92 (1H, m, 6-H), 3.65 
(1H, dd, J 12.1, 3.4 Hz, 2-H), 3.78 (3H, s, OMe); C (101 MHz, CDCl3) 22.5 (CH3), 22.8 
(CH3), 24.4 (CH), 44.6 (CH2), 46.1 (CH2), 48.8 (CH2), 52.5 (CH3), 53.7 (CH), 58.0 (CH), 
171.9 (C), 207.2 (C); m/z (CI) 214.1446 (MH
+
. C11H20NO3 requires 214.1443), 187 (3%), 
154 (6), 130 (2), 112 (2). Data for (2S,6R)-6-(2-methylpropyl)-4-oxopiperidine-2-
carboxylate: max (neat)/cm
–1 
3329 (NH), 1729 (CO), 1717 (CO), 1436, 1216, 1166; []D
27
 
–15.0 (c 0.5, CHCl3); H (400 MHz, CDCl3) 0.91 (3H, d, J 5.2 Hz, 3’-H3), 0.93 (3H, d, J 
5.2 Hz, 2’-CH3), 1.20–1.29 (1H, m, NH), 1.39–1.45 (2H, m, 1’-H2), 1.69 (1H, m, 2’-H), 
2.14 (1H, dd, J 14.3, 9.9 Hz, 5-Hax), 2.40 (1H, d, J 14.3 Hz, 5-Heq), 2.63 (1H, dd, J 15.0, 
6.8 Hz, 3-Heq), 2.73 (1H, dd, J 15.0, 3.8 Hz, 3-Hax), 3.12–3.18 (1H, m, 6-H), 3.74 (3H, s, 
CH3), 4.04 (1H, dd, J 6.7, 3.8 Hz, 2-H); C (101 MHz, CDCl3) 21.9 (CH3), 23.2 (CH3), 
24.4 (CH), 42.2 (CH2), 45.2 (CH2), 48.2 (CH2), 50.4 (CH3), 52.3 (CH), 55.9 (CH), 173.1 
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(C), 207.0 (C); m/z (CI) 214.1441 (MH
+
. C11H20NO3 requires 214.1443), 195 (2%), 
154(18), 128 (2), 112 (5). 
 
Methyl (2S,6S)-4-oxo-6-propylpiperidine-2-carboxylate and methyl (2S,6R)-4-oxo-6-
propylpiperidine-2-carboxylate 
 
 
 
To a solution of methyl (2S,5E)-2-(tritylamino)-4-oxonon-5-enoate (264) (103 mg, 0.23 
mmol) in methanol (10 mL) was added 2 M hydrochloric acid solution (2.5 mL). The 
mixture was stirred for 1 h, then diluted with water (10 mL) and basified to pH 8 with N-
ethyldiisopropylamine (1.5 mL). The mixture was stirred for 18 h then partitioned between 
ethyl acetate (20 mL) and brine (20 mL). The aqueous layer was separated and re-extracted 
with ethyl acetate (20 mL). The organic layers were combined, dried (MgSO4), filtered and 
concentrated under reduced pressure. Flash column chromatography (petroleum ether/ethyl 
acetate 1:0 to 3:7 with 1% triethylamine) afforded methyl (2S,6S)-4-oxo-6-
propylpiperidine-2-carboxylate (26 mg, 56%) as a colourless oil followed by methyl 
(2S,6R)-4-oxo-6-propylpiperidine-2-carboxylate (11 mg, 24%) as a colourless oil. Data for 
methyl (2S,6S)-4-oxo-6-propylpiperidine-2-carboxylate: max (neat)/cm
–1 
3330 (NH), 2959 
(CH), 2359, 1740 (CO), 1715 (CO), 1437, 1217, 1009; []D
25
 –20.9 (c 0.5, CHCl3); H 
(400 MHz, CDCl3) 0.94 (3H, t, J 7.0 Hz, 3’-H3), 1.36–1.63 (4H, m, 1’-H2 and 2’-H2), 2.09 
(2H, dd, J 14.1, 11.7 Hz, 5-H2), 2.39–2.46 (2H, m, 3-Hax), 2.69 (1H, dddd, J 14.4, 3.4, 2.1, 
0.6 Hz, 3-Heq), 2.83–2.90 (1H, m, 6-H), 3.64 (1H, dd, J 12.2, 3.4 Hz, 2-H), 3.78 (3H, s, 
OMe); C (101 MHz, CDCl3) 14.0 (CH3), 18.8 (CH2), 38.9 (CH2), 44.5 (CH2), 48.4 (CH2), 
52.5 (CH3), 55.6 (CH), 57.9 (CH), 171.9 (C), 207.3 (C); m/z (EI) 199.1212 (M
+
. 
C10H17NO3 requires 199.1208), 156 (95%), 140 (97), 114 (70), 98 (96). Data for by methyl 
(2S,6R)-4-oxo-6-propylpiperidine-2-carboxylate: max (neat)/cm
–1
 3325 (NH), 2957 (CH), 
1732 (CO), 1717 (CO), 1435, 1120, 1163; []D
24
 –7.5 (c 1.0, CHCl3); H (400 MHz, 
CDCl3) 0.94 (3H, t, J 7.3 Hz, 3’-H3), 1.22–1.51 (4H, m, 1’-H2 and 2’-H2), 2.16 (1H, ddd, J 
14.5, 9.9, 0.9 Hz, 5-Hax), 2.43 (1H, ddd, J 14.5, 3.7, 1.7 Hz, 5-Heq), 2.64 (1H, ddd, J 15.0, 
6.6, 0.9 Hz, 3-Hax), 2.72 (1H, ddd, J 15.0, 3.9, 1.7 Hz, 3-Heq), 3.06–3.10 (1H, m, 6-H), 3.74 
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(3H, s, OMe), 4.04 (1H, dd, J 6.6, 3.9 Hz, 2-H); C (101 MHz, CDCl3) 13.9 (CH3), 18.7 
(CH2), 38.2 (CH2), 42.1 (CH2), 47.7 (CH2), 52.3 (CH), 52.4 (CH3), 55.8 (CH), 173.1 (C), 
207.1 (C); m/z (CI) 200.1292 (MH
+
. C10H18NO3 requires 200.1287), 181 (9%), 164 (7), 
156 (4), 140 (5). 
 
Methyl (2S,6R)-4-oxo-6-phenylpiperidine-2-carboxylate and methyl (2S,6S)-4-oxo-6-
phenylpiperidine-2-carboxylate 
 
 
 
To a solution of methyl (2S,5E)-2-(tritylamino)-4-oxo-6-phenylhex-5-enoate (265) (62 mg, 
0.13 mmol) in methanol (10 mL) was added 2 M hydrochloric acid solution (2.5 mL). The 
mixture was stirred for 1 h, then diluted with water (10 mL) and basified to pH 8 with N-
ethyldiisopropylamine (1.5 mL). The mixture was stirred for 18 h then partitioned between 
ethyl acetate (20 mL) and brine (20 mL). The aqueous layer was separated and re-extracted 
with ethyl acetate (20 mL). The organic phases were combined, dried (MgSO4), filtered 
and concentrated under reduced pressure. Flash column chromatography (petroleum 
ether/ethyl acetate 1:0 to 3:7 with 1% triethylamine) afforded methyl (2S,6R)-4-oxo-6-
phenylpiperidine-2-carboxylate (17 mg, 56%) as a colourless oil followed by methyl 
(2S,6S)-4-oxo-6-phenylpiperidine-2-carboxylate (9 mg, 29%)  as a colourless oil. Data for 
methyl (2S,6R)-4-oxo-6-phenylpiperidine-2-carboxylate: max (neat)/cm
–1 
3325 (NH), 3024 
(CH), 1728 (CO), 1705 (CO), 1435, 1211; []D
25
 +43.9
 
(c 0.9, CHCl3); H (400 MHz, 
CDCl3) 2.54–2.64 (4H, m, 5-H2, 3-Hax and NH), 2.79 (1H, ddd, J 14.5, 3.5, 1.5 Hz, 3-Heq), 
3.74–3.78 (4H, m, 2-H and OMe),  3.95 (1H, dd, J 10.0, 4.7 Hz, 6-H), 7.30–7.43 (5H, m, 
Ph); C (101 MHz, CDCl3) 43.9 (CH2), 50.1 (CH2), 52.5 (CH3), 57.9 (CH), 60.2 (CH), 
126.5 (2  CH), 128.2 (CH), 128.9 (2  CH), 141.7 (C), 171.4 (C), 206.5 (C); m/z (CI) 
234.1134 (MH
+
. C13H16NO3 requires 234.1130), 217 (2%), 190 (4), 174 (12), 131 (4). Data 
for methyl (2S,6S)-4-oxo-6-phenylpiperidine-2-carboxylate: max (neat)/cm
–1 
3322 (NH), 
3024 (CH), 1728 (CO), 1443, 1211, 1034; []D
25
 –34.3 (c 0.9, CHCl3); H (400 MHz, 
CDCl3) 2.55–2.59 (3H, m, 5-H2 and NH), 2.74–2.84 (2H, m, 3-H2), 3.77 (3H, s, OMe), 
4.13 (1H, dd, J 6.3, 3.8 Hz, 2-H), 4.21 (1H, dd, J 7.6, 6.6 Hz, 6-H), 7.29–7.41 (5H, m, Ph); 
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C (101 MHz, CDCl3) 41.8 (CH2), 49.2 (CH2), 52.3 (CH3), 56.0 (CH), 56.7 (CH), 126.6 (2 
 CH), 128.0 (CH), 128.8 (2  CH), 142.1 (C), 173.0 (C), 206.2 (C); m/z (CI) 234.1129 
(MH
+
. C13H16NO3 requires 234.1130), 200 (1%), 174 (2), 146 (1), 131 (1). 
 
Methyl (2S,6R)-6-(4-bromophenyl)-4-oxopiperidine-2-carboxylate and methyl 
(2S,6S)-6-(4-bromophenyl)-4-oxopiperidine-2-carboxylate 
 
 
 
To a solution of methyl (2S,5E)-2-(tritylamino)-6-(4-bromophenyl)-4-oxohex-5-enoate 
(266) (176 mg, 0.32 mmol) in methanol (10 mL) was added 2 M hydrochloric acid solution 
(2.5 mL). The mixture was stirred for 1 h, then diluted with water (10 mL) and basified to 
pH 8 with N-ethyldiisopropylamine (1.5 mL). The mixture was stirred for 18 h then 
partitioned between ethyl acetate (20 mL) and brine (20 mL). The aqueous layers were 
separated and re-extracted with ethyl acetate (20 mL). The organic phases were combined, 
dried (MgSO4), filtered and concentrated under reduced pressure. Flash column 
chromatography (petroleum ether/ethyl acetate 1:0 to 3:7 with 1% triethylamine) afforded 
methyl (2S,6R)-6-(4-bromophenyl)-4-oxopiperidine-2-carboxylate (39 mg, 39%) as a 
white solid followed by methyl (2S,6S)-6-(4-bromophenyl)-4-oxopiperidine-2-carboxylate 
(12 mg, 12%) as a white solid. Data for (2S,6R)-6-(4-bromophenyl)-4-oxopiperidine-2-
carboxylate: p. 166–168 C (decomposition)max (neat)/cm
–1 
3327 (NH), 2954 (CH), 
1721 (CO), 1435, 1250, 1227; []D
27
 +29.9
 
(c 1.1, CHCl3); H (400 MHz, CDCl3) 2.46 
(1H, ddd, J 14.5, 11.4, 0.8 Hz, 5-Heq), 2.51–2.55 (2H, m, NH and 5-Hax), 2.59 (1H, ddd, J 
14.5, 12.2, 0.8 Hz, 3-Heq), 2.76–2.82 (1H, m, 3-Hax), 3.75 (1H, dt, J 11.9, 3.0 Hz, 2-H), 
3.79 (3H, s, OMe), 3.92 (1H, dt, J 11.4, 3.0 Hz, 6-H), 7.30 (2H, d, J 6.8 Hz, ArH), 7.50 
(2H, d, J 6.8 Hz, ArH); C (101 MHz, CDCl3) 43.8 (CH2), 50.0 (CH2), 52.6 (CH), 57.8 
(CH3), 59.6 (CH), 122.0 (C), 128.3 (2  CH), 132.0 (2  CH), 140.8 (C), 171.3 (C), 206.0 
(C); m/z (CI) 314.0219 (MH
+
. C13H15
81
BrNO3 requires 314.0216), 252 (3%), 234 (8), 167 
(2). Data for methyl (2S,6S)-6-(4-bromophenyl)-4-oxopiperidine-2-carboxylate: p. 151–
153 C (decomposition)max (neat)/cm
–1 
3321 (NH), 2924 (CH), 1721 (CO), 1358, 1196, 
1003; []D
25
 –30.9 (c 1.1, CHCl3); H (400 MHz, CDCl3) 2.48–2.55 (3H, m, 5-H2 and NH), 
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2.74–2.83 (2H, m, 3-H2), 3.76 (3H, s, OMe), 4.12 (1H, dd, J 6.5, 3.6 Hz, 2-H), 4.20 (1H, 
dd, J 9.3, 4.8 Hz, 6-H), 7.28 (2H, d, J 6.8 Hz, ArH), 7.49 (2H, d, J 6.8 Hz, ArH); C (100 
MHz, CDCl3) 41.7 (CH2), 49.2 (CH2), 52.4 (CH3), 56.0 (CH), 56.2 (CH), 121.8 (C), 128.4 
(2  CH), 131.9 (2  CH), 141.2 (C), 173.0 (C), 205.8 (C); m/z (CI) 314.0217 (MH+. 
C13H15
81
BrNO3 requires 314.0216), 252 (6%), 234 (3), 211 (3), 156 (2). 
 
Methyl (2S,6R)-6-(4-nitrophenyl)-4-oxopiperidine-2-carboxylate and Methyl (2S,6S)-
6-(4-nitrophenyl)-4-oxopiperidine-2-carboxylate 
 
 
 
To a solution of methyl (2S,5E)-2-(tritylamino)-6-(4-nitrophenyl)-4-oxohex-5-enoate (267) 
(152 mg, 0.29 mmol) in methanol (10 mL) was added 2 M hydrochloric acid solution (2.5 
mL). The mixture was stirred for 1 h, then diluted with water (10 mL) and basified to pH 8 
with N-ethyldiisopropylamine (1.5 mL). The mixture was stirred for 18 h then partitioned 
between ethyl acetate (20 mL) and brine (20 mL). The aqueous layer was separated and re-
extracted with ethyl acetate (20 mL). The organic phases were combined, dried (MgSO4), 
filtered and concentrated under reduced pressure. Flash column chromatography 
(petroleum ether/ethyl acetate 1:0 to 3:7 with 1% triethylamine) afforded methyl (2S,6R)-
6-(4-nitrophenyl)-4-oxopiperidine-2-carboxylate (30 mg, 37%) as a white solid followed 
by methyl (2S,6S)-6-(4-nitrophenyl)-4-oxopiperidine-2-carboxylate (16 mg, 20%) as a 
white solid. Data for methyl (2S,6R)-6-(4-nitrophenyl)-4-oxopiperidine-2-carboxylate: Mp. 
121–123 Cmax (neat)/cm
–1 
3347 (NH), 2955 (CH), 1720, 1605, 1520 (NO), 1350 (NO), 
1219; []D
26
 +62.9
 
(c 1.4, CHCl3); H (400 MHz, CDCl3) 2.39 (1H, dd, J 14.6, 11.8 Hz, 3-
Hax), 2.49–2.58 (3H, m, 5-H2 and NH), 2.76 (1H, ddd, J 14.6, 3.2, 1.9 Hz, 3-Heq), 3.70–
3.74 (4H, m, 2-H and OMe), 4.03 (1H, dd, J 11.8, 3.0 Hz, 6-H), 7.56 (2H, d, J 8.7 Hz, 
ArH), 8.17 (2H, J 8.7 Hz, ArH); C (100 MHz, CDCl3) 43.7 (CH2), 49.8 (CH2), 52.7 
(CH3), 57.7 (CH), 59.4 (CH), 124.2 (2  CH), 127.5 (2  CH), 147.8 (C), 148.8 (C), 171.1 
(C), 205.0 (C); m/z (CI) 279.0975 (MH
+
. C13H15N2O5 requires 279.0981), 249 (7%), 219 
(10), 203 (2), 177 (2). Data for methyl (2S,6S)-6-(4-nitrophenyl)-4-oxopiperidine-2-
carboxylate: Mp. 133–135 Cmax (neat)/cm
–1 
3347 (NH), 2955 (CH), 1728 (CO), 1604 
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(C=C), 1520 (NO), 1350 (NO), 1204; []D
26
 –40.0 (c 0.9, CHCl3); H (400 MHz, CDCl3) 
2.42 (1H, dd, J 14.5, 10.5 Hz, 5-Hax), 2.50 (1H, ddd, J 14.5, 4.0, 1.2 Hz, 5-Heq), 2.51 (1H, 
br s, NH), 2.70–2.80 (2H, m, 3-H2), 3.71 (3H, s, OMe), 4.11 (1H, dd, J 6.3, 3.6 Hz, 2-H), 
4.31 (1H, dd, J 10.5, 4.0 Hz, 6-H), 7.53 (2H, d, J 8.8 Hz, ArH), 8.16 (2H, d, J 8.8 Hz, 
ArH); C (100 MHz, CDCl3) 41.7 (CH2), 49.0 (CH2), 52.5 (CH3), 56.0 (CH), 56.2 (CH), 
124.1 (2  CH), 127.5 (2  CH), 147.7 (C), 149.4 (C), 172.8 (C), 204.8 (C); m/z (CI) 
279.0987 (MH
+
. C13H15N2O5 requires 279.0981), 249 (5%), 243 (6), 207 (4), 167 (3). 
 
Methyl (2S,6R)-6-(4-methoxyphenyl)-4-oxopiperidine-2-carboxylate and methyl 
(2S,6S)-6-(4-methoxyphenyl)-4-oxopiperidine-2-carboxylate 
 
 
 
To a solution of methyl (2S,5E)-2-(tritylamino)-6-(4-methoxyphenyl)-4-oxohex-5-enoate 
(268) (51 mg, 0.10 mol) in methanol (10 mL) was added 2 M hydrochloric acid solution 
(2.5 mL). The mixture was stirred for 1 h, then diluted with water (10 mL) and basified to 
pH 8 with N-ethyldiisopropylamine (1.5 mL). The mixture was stirred for 18 h then 
partitioned between ethyl acetate (20 mL) and brine (20 mL). The aqueous layer was 
separated and re-extracted with ethyl acetate (20 mL). The organic phases were combined, 
dried (MgSO4), filtered and concentrated under reduced pressure. Flash column 
chromatography (petroleum ether/ethyl acetate 1:0 to 3:7 with 1% triethylamine) afforded 
methyl (2S,6R)-6-(4-methoxyphenyl)-4-oxopiperidine-2-carboxylate (15 mg, 56%) as a 
colourless oil followed by methyl (2S,6S)-6-(4-methoxyphenyl)-4-oxopiperidine-2-
carboxylate (8 mg, 30%) as a colourless oil. Data for methyl (2S,6R)-6-(4-
methoxyphenyl)-4-oxopiperidine-2-carboxylate: max (neat)/cm
–1 
3317 (NH), 2955 (CH), 
1743 (CO), 1713 (CO), 1512, 1250, 1219; []D
25
 +38.4
 
(c 1.1, CHCl3); H (400 MHz, 
CDCl3) 2.52–2.54 (3H, m, 5-H2 and NH), 2.59 (1H, dd, J 14.4, 12.2 Hz, 3-Hax), 2.78 (1H, 
dd, J 14.4, 3.3 Hz, 3-Heq), 3.75 (1H, dd, J 12.2, 3.3 Hz, 2-H), 3.78 (3H, s, OMe), 3.81 (3H, 
s, OMe), 3.90 (1H, dd, J 8.2, 6.7 Hz, 6-H), 6.90 (2H, d, J 7.0 Hz, ArH), 7.33 (2H, d, J 7.0 
Hz, ArH); C (101 MHz, CDCl3) 43.9 (CH2), 50.2 (CH2), 52.5 (CH3), 55.3 (CH3), 57.9 
(CH), 59.7 (CH), 114.2 (2  CH), 127.7 (2  CH), 133.9 (C), 159.4 (C), 171.4 (C), 206.6 
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(C); m/z (EI) 263.1161 (M
+
. C14H17NO4 requires 263.1158), 204 (25%), 161 (100), 84 (32), 
50 (33). Data for (2S,6S)-6-(4-methoxyphenyl)-4-oxopiperidine-2-carboxylate: max 
(neat)/cm
–1 
3319 (NH), 2932 (CH), 1728 (CO), 1612 (C=C), 1512, 1250, 1219; []D
25
 –
16.5
 
(c 0.2, CHCl3); H (400 MHz, CDCl3) 2.52–2.61 (2H, m, 3-H2), 2.73–2.82 (2H, m, 5-
H2), 3.76 (3H, s, OMe), 3.81 (3H, s, OMe), 4.11 (1H, dd, J 6.2, 3.9 Hz, 2-H), 4.16 (1H, dd, 
J 9.0, 5.1 Hz, 6-H), 6.89 (2H, d, J 8.7 Hz, ArH), 7.30 (2H, d, J 8.7 Hz, ArH); C (101 MHz, 
CDCl3) 41.8 (CH2), 49.3 (CH2), 52.3 (CH3), 55.3 (CH3), 55.9 (CH), 56.2 (CH), 114.1 (2  
CH), 127.8 (2  CH), 134.3 (C), 159.3 (C), 173.0 (C), 206.4 (C); m/z (EI) 263.1164 (M+. 
C14H17NO4 requires 263.1158), 220 (8%), 204 (12), 161 (66), 134 (16). 
 
Methyl (2S,6R)-6-(furan-2-yl)-4-oxopiperidine-2-carboxylate and methyl (2S,6S)-6-
(furan-2-yl)-4-oxopiperidine-2-carboxylate 
 
 
 
To a solution of methyl (2S,5E)-2-(tritylamino)-6-(furan-2-yl)-4-oxohex-5-enoate (269) 
(134 mg, 0.29 mmol) in methanol (10 mL) was added 2 M hydrochloric acid solution (2.5 
mL). The mixture was stirred for 1 h, then diluted with water (10 mL) and basified to pH 8 
with N-ethyldiisopropylamine (1.5 mL). The mixture was stirred for 18 h then partitioned 
between ethyl acetate (20 mL) and brine (20 mL). The aqueous layer was separated and re-
extracted with ethyl acetate (20 mL). The organic phases were combined, dried (MgSO4), 
filtered and concentrated under reduced pressure. Flash column chromatography 
(petroleum ether/ethyl acetate 1:0 to 3:7 with 1% triethylamine) afforded methyl (2S,6R)-
6-(furan-2-yl)-4-oxopiperidine-2-carboxylate (21 mg, 33%) as a colourless oil followed by 
methyl (2S,6S)-6-(furan-2-yl)-4-oxopiperidine-2-carboxylate (7 mg, 11%) as a colourless 
oil. Data for methyl (2S,6R)-6-(furan-2-yl)-4-oxopiperidine-2-carboxylate: max (neat)/cm
–1
 
3356 (NH), 2924 (CH), 1743 (CO), 1636 (C=C), 1589, 1219, 1173; []D
24
 +11.3
 
(c 0.4, 
CHCl3); H (400 MHz, CDCl3) 2.55 (1H, dd, J 14.6, 12.0 Hz, 3-Hax), 2.61–2.68 (3H, m, 5-
H2 and NH), 2.78 (1H, dd, J 14.6, 3.4 Hz, 3-Heq), 3.74–3.79 (4H, m, 2-H and OMe), 4.11 
(1H, dd, J 7.9, 7.0 Hz, 6-H), 6.25 (1H, d, J 3.3 Hz, ArH), 6.35 (1H, dd, J 3.3, 1.8 Hz, ArH), 
7.40 (1H, dd, J 1.8, 0.8 Hz, ArH); C (101 MHz, CDCl3) 44.2 (CH2), 46.2 (CH2), 52.6 
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(CH), 53.1 (CH3), 57.5 (CH), 106.2 (CH), 110.3 (CH), 142.4 (CH), 153.8 (C), 171.3 (C), 
205.7 (C); m/z (CI) 224.0927 (MH
+
. C11H14NO4 requires 224.0923), 196 (5%), 156 (100), 
121 (2), 96 (3). Data for methyl (2S,6S)-6-(furan-2-yl)-4-oxopiperidine-2-carboxylate: max 
(neat)/cm
–1 
3342 (NH), 2955 (CH), 1743 (CO), 1636 (C=C), 1589, 1219, 1173; []D
24
 
+14.3
 
(c 0.1, CHCl3); H (400 MHz, CDCl3) 2.55 (1H, dd, J 15.2, 8.6 Hz, 3-Hax), 2.59–2.72 
(4H, m, 3-Heq, 5-H2 and NH), 3.66–3.71 (4H, m, 2-H and OMe), 4.50 (1H, t, J 5.5 Hz, 6-
H), 6.11 (1H, d, J 3.3 Hz, ArH), 6.24 (1H, dd, J 3.3, 1.8 Hz, ArH), 7.31 (1H, dd, J 1.8, 0.7 
Hz, ArH); C (101 MHz, CDCl3) 43.2 (CH2), 44.3 (CH2), 50.3 (CH), 52.5 (CH3), 54.1 
(CH), 107.9 (CH), 110.2 (CH), 142.6 (CH), 153.7 (C), 172.3 (C), 205.7 (C); m/z (CI) 
224.0921 (MH
+
. C11H14NO4 requires 224.0923), 196 (5%), 156 (100), 155 (13), 69 (2). 
 
Methyl (2S,6R)-6-(naphthalen-2-yl)-4-oxopiperidine-2-carboxylate and methyl 
(2S,6S)-6-(naphthalen-2-yl)-4-oxopiperidine-2-carboxylate 
 
 
 
To a solution of methyl (2S,5E)-2-(tritylamino)-6-(naphthalen-2-yl)-4-oxohex-5-enoate 
(270) (150 mg, 0.29 mmol) in methanol (10 mL) was added 2 M hydrochloric acid solution 
(2.5 mL). The mixture was stirred for 1 h, then diluted with water (10 mL) and basified to 
pH 8 with N-ethyldiisopropylamine (1.5 mL). The mixture was stirred for 18 h then 
partitioned between ethyl acetate (20 mL) and brine (20 mL). The aqueous was separated 
and re-extracted with ethyl acetate (20 mL). The organic phases were combined, dried 
(MgSO4), filtered and concentrated under reduced pressure. Flash column chromatography 
(petroleum ether/ethyl acetate 1:0 to 3:7 with 1% triethylamine) afforded methyl (2S,6R)-
6-(naphthalen-2-yl)-4-oxopiperidine-2-carboxylate (53 mg, 66%) as a white solid followed 
by methyl (2S,6S)-6-(naphthalen-2-yl)-4-oxopiperidine-2-carboxylate (28 mg, 34%) as a 
white solid. Data for methyl (2S,6R)-6-(naphthalen-2-yl)-4-oxopiperidine-2-carboxylate: 
Mp. 115–117 Cmax (neat)/cm
–1 
3325 (NH), 2953 (CH), 1735 (CO), 1712 (CO), 1435, 
1248, 1211; []D
25
 +36.9
 
(c 1.2, CHCl3); H (400 MHz, CDCl3) 2.64–2.72 (4H, m, 5-H2, 3-
Hax and NH), 2.86 (1H, ddd, J 14.5, 3.4, 1.3 Hz, 3-Heq), 3.82 (3H, s, OMe), 3.85 (1H, dd, J 
12.1, 3.5 Hz, 2-H), 4.15 (1H, dd, J 9.3, 5.4 Hz, 6-H), 7.49–7.57 (3H, m, ArH), 7.86–7.90 
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(4H, m, ArH); C (101 MHz, CDCl3) 43.9 (CH2), 50.1 (CH2), 52.6 (CH3), 58.0 (CH), 60.3 
(CH), 124.5 (CH), 125.3 (CH), 126.2 (CH), 126.4 (CH), 127.7 (CH), 127.9 (CH), 128.7 
(CH), 133.2 (C), 133.4 (C), 139.1 (C), 171.4 (C), 206.4 (C); m/z (CI) 284.1287 (MH
+
. 
C17H18NO3 requires 284.1287), 243 (7%), 224 (2), 182 (2), 156 (2). Data for methyl 
(2S,6S)-6-(naphthalen-2-yl)-4-oxopiperidine-2-carboxylate: Mp. 87–90 Cmax (neat)/cm
–
1 
3327 (NH), 2953 (CH), 1732 (CO), 1437, 1198, 1161; []D
25
 –39.7 (c 1.0, CHCl3); H 
(400 MHz, CDCl3) 2.62–2.73 (3H, m, 5-H2 and NH), 2.82–2.84 (2H, m, 3-H2), 3.78 (3H, s, 
OMe), 4.16 (1H, dd, J 5.7, 4.5 Hz, 2-H), 4.40 (1H, dd, J 9.5, 4.6 Hz, 6-H), 7.47–7.53 (3H, 
m, ArH), 7.82–7.87 (4H, m, ArH); C (101 MHz, CDCl3) 41.9 (CH2), 49.0 (CH2), 52.4 
(CH3), 56.0 (CH), 56.8 (CH), 124.6 (CH), 125.4 (CH), 126.2 (CH), 126.4 (CH), 127.7 
(CH), 127.9 (CH), 128.7 (CH), 133.1 (C), 133.3 (C), 139.5 (C), 173.0 (C), 206.2 (C); m/z 
(CI) 284.1291 (MH
+
. C17H18NO3 requires 284.1287), 224 (4%), 181 (2), 156 (2). 
 
Methyl (2S,4R,6S)-4-hydroxy-6-(2-phenylethyl)piperidine-2-carboxylate 
 
 
 
To a solution of a methyl (2S,6S)-4-oxo-6-(2-phenylethyl)piperidine-2-carboxylate (262a) 
(49 mg, 0.19 mmol) in tetrahydrofuran (10 mL) at room temperature was added sodium 
triacetoxyborohydride (48 mg, 0.23 mmol), and the reaction stirred for 120 h. The mixture 
was quenched with 2 M hydrochloric acid solution then partitioned between saturated 
sodium hydrogen carbonate solution (15 mL) and ethyl acetate (15 mL). The organic layer 
was separated, washed with brine, dried (MgSO4), filtered and concentrated under reduced 
pressure. Flash column chromatography afforded the desired product (43 mg, 87%) as a 
colourless oil and a 13:1 syn:anti mixture of diastereomers. max (neat)/cm
–1 
3330 
(NH/OH), 2946 (CH), 1739 (CO), 1436, 1262, 1213; []D
29
 –2.2 (c 0.7, CHCl3); NMR data 
for major diastereomer: H (400 MHz, CDCl3) 0.99 (1H, q, J 11.2 Hz, 5-HH), 1.26 (1H, q, 
J 11.8 Hz, 3-HH), 1.65–1.81 (2H, m, 1’-H2), 1.94–1.99 (1H, m, 5-HH), 2.22–2.28 (1H, m, 
3-HH), 2.49–2.56 (1H, m, 6-H), 2.58–2.70 (2H, m, 2’-H2), 3.30 (1H, dd, J 11.8, 2.7 Hz, 2-
H), 3.60–3.69 (4H, m, 4-H and OMe), 7.10–7.23 (5H, m, Ph); C (101 MHz, CDCl3) 32.2 
(CH2), 38.2 (CH2), 38.5 (CH2), 41.5 (CH2), 52.2 (CH3), 53.6 (CH), 57.2 (CH), 68.9 (CH), 
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125.9 (CH), 128.3 (2  CH), 128.5 (2  CH), 141.7 (C), 172.9 (C); m/z (EI) 263.1519 (M+. 
C15H21NO3 requires 263.1521), 204 (100%), 187 (12), 158 (49), 140 (28), 91 (57). 
 
Methyl (2S,4R,6R)-4-hydroxy-6-(4-methoxyphenyl)piperidine-2-carboxylate 
 
 
 
To a solution of a methyl (2S,6R)-6-(4-methoxyphenyl)-4-oxopiperidine-2-carboxylate 
(276a) (33 mg, 0.13 mmol) in tetrahydrofuran (10 mL) at room temperature was added 
sodium triacetoxyborohydride (32 mg, 0.15 mmol), and the reaction stirred for 144 h. The 
mixture was quenched with 2 M hydrochloric acid solution then partitioned between 
saturated sodium hydrogen carbonate solution (15 mL) and ethyl acetate (15 mL). The 
organic layer was separated, washed with brine, dried (MgSO4), filtered and concentrated 
under reduced pressure. Flash column chromatography afforded the desired product (31 
mg, 96%) as a colourless oil and a 23:1 syn:anti mixture of diastereomers. max (neat)/cm
–1 
3333 (NH/OH), 2926 (CH), 1738 (CO), 1612 (C=C), 1514, 1245; []D
25
 +16.4
 
(c 0.9, 
CHCl3); NMR data for major diastereomer: H (400 MHz, CDCl3) 1.45–1.53 (2H, m, 3-
HH and 5-HH), 2.08–2.12 (1H, m, 3-HH), 2.38–2.42 (1H, m, 5-HH), 3.52 (1H, dd, J 11.8, 
2.6 Hz, 6-H), 3.64 (1H, dd, J 11.5, 2.5 Hz, 2-H), 3.74 (3H, s, OMe), 3.80 (3H, s, OMe), 
3.79–3.88 (1H, m, 4-H), 6.85–6.88 (2H, m, ArH), 7.29–7.32 (2H, m, ArH); C (101 MHz, 
CDCl3) 37.6 (CH2), 43.1 (CH2), 52.2 (CH), 55.3 (CH), 57.5 (CH3), 58.5 (CH3), 69.3 (CH), 
113.9 (2  CH), 128.0 (2  CH), 135.2 (C), 159.0 (C), 172.5 (C); m/z (CI) 266.1396 (MH+. 
C14H20NO4 requires 266.1392), 248 (30%), 234 (6), 206 (4), 178 (3). 
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Methyl (2S,4R,6R)-4-hydroxy-6-(naphthalen-2-yl)piperidine-2-carboxylate 
 
 
 
To a solution of a methyl (2S,6R)-6-(naphthalen-2-yl)-4-oxopiperidine-2-carboxylate 
(278a) (67 mg, 0.24 mmol) in tetrahydrofuran (10 mL) at room temperature was added 
sodium triacetoxyborohydride (60 mg, 0.28 mmol), and the reaction stirred for 72 h. 
Further sodium triacetoxyborohydride (50 mg, 0.24 mmol) was added and the the mixture 
stirred for a further 72 h. The mixture was quenched with 2 M hydrochloric acid solution 
then partitioned between saturated sodium hydrogen carbonate solution (15 mL) and ethyl 
acetate (15 mL). The organic layer was separated, washed with brine, dried (MgSO4), 
filtered and concentrated under reduced pressure. Flash column chromatography afforded 
the desired product (67 mg, 100%) as a white solid and a 17:1 syn:anti mixture of 
diastereomers. Mp. 109–111 Cmax (neat)/cm
–1 
3275 (NH/OH), 1728 (CO), 1431, 1223, 
1123, 1049; []D
25
 +25.3
 
(c 0.1, CHCl3); H (400 MHz, CDCl3) 1.50–1.61 (2H, m, 3-HH 
and 5-HH), 2.17–2.22 (1H, m, 3-HH), 2.41–2.47 (1H, m, 5-HH), 3.57 (1H, dd, J 11.9, 2.6 
Hz, 2-H), 3.75 (3H, s, OMe), 3.84 (1H, dd, J 11.5, 2.3 Hz, 6-H), 3.85–3.93 (1H, m, 4-H), 
7.43–7.51 (3H, m, ArH), 7.80–7.84 (4H, m, ArH); C (101 MHz, CDCl3) 37.6 (CH2), 43.2 
(CH2), 52.3 (CH3), 57.5 (CH), 59.2 (CH), 69.3 (CH), 125.1 (CH), 125.2 (CH), 125.8 (CH), 
126.1 (CH), 127.6 (CH), 127.9 (CH), 128.3 (CH), 133.0 (C), 133.4 (C), 140.5 (C), 172.6 
(C); m/z (CI) 286.1444 (MH
+
. C17H20NO3 requires 286.1443), 266 (17%), 226 (4), 209 (2), 
95 (3).  
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(2S,4R,6S)-4-Hydroxy-6-(2-phenylethyl)piperidine-2-carboxylic acid hydrochloride 
 
 
 
Methyl (2S,4R,6S)-4-hydroxy-6-(2-phenylethyl)piperidine-2-carboxylate (283a) (58 mg, 
0.22 mmol) was dissolved in 6 M hydrochloric acid (5 mL) and heated to 100 C for 48 h. 
The mixture was cooled and concentrated under reduced pressure to afford a white solid, 
which was azetroped with acetone then dried under reduced pressure to afford the desired 
product (39 mg, 62%) as a white solid and a 13:1 syn:anti mixture of diastereomers. p. 
219–221 Cmax (neat)/cm
–1 
3408 (NH/OH), 2921 (CH), 1757 (CO), 1453, 1184, 1066; 
[]D
26
 +50.3
 
(c 0.1, MeOH); H (400 MHz, CD3OD) 1.35–1.43 (1H, m, 5-HH), 1.56–1.63 
(1H, m, 3-HH), 1.90–1.98 (1H, m, 1’-HH), 2.10–2.16 (1H, m, 1’-HH), 2.33–2.36 (1H, m, 
5-HH), 2.52–2.55 (1H, m, 3-HH), 2.67–2.73 (1H, m, 2’-HH), 2.78–2.84 (1H, m, 2’-HH), 
3.23–3.27 (1H, m, 6-H), 3.88–3.94 (1H, m, 4-H), 4.04–4.07 (1H, m, 2-H), 7.18–7.31 (5H, 
m, ArH); C (101 MHz, CD3OD) 32.3 (CH2), 35.8 (2  CH2), 37.6 (CH2), 56.0 (CH), 57.1 
(CH), 66.3 (CH), 127.5 (CH), 129.4 (2  CH), 129.8 (2  CH), 141.6 (C), 170.6 (C); m/z 
(EI) 249.1368 (M
+
. C14H19NO3 requires 249.1365), 204 (100%), 160 (28), 144 (93), 126 
(36), 117 (25), 91 (82).   
 
(2S,4R,6R)-4-Hydroxy-6-(4-methoxyphenyl)piperidine-2-carboxylic acid 
hydrochloride 
 
 
 
Methyl (2S,4R,6R)-4-hydroxy-6-(4-methoxyphenyl)piperidine-2-carboxylate (284a) (29 
mg, 0.11 mmol) was dissolved in 6 M hydrochloric acid (5 mL) and heated to 100 C for 
48 h. The mixture was cooled and concentrated under reduced pressure to afford a white 
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solid, which was azetroped with acetone then dried under reduced pressure to afford the 
desired product (21 mg, 67%) as a white solid and a 23:1 syn:anti mixture of 
diastereomers. p. 173–175 Cmax (neat)/cm
–1 
3323 (NH/OH), 2926 (CH), 1732 (CO), 
1612 (C=C), 1518, 1254; []D
29
 –2.1 (c 1.0, MeOH); H (400 MHz, CD3OD) 1.71–1.78 
(1H, m, 3-HH), 1.91–1.98 (1H, m, 5-HH), 2.24–2.27 (1H, m, 5-HH), 2.60–2.63 (1H, m, 3-
HH), 3.82 (3H, s, OMe), 4.07–4.11 (1H, m, 4-H), 4.22–4.24 (1H, m, 2-H), 4.34–4.36 (1H, 
m, 6-H), 7.01 (2H, d, J 6.8 Hz, ArH), 7.46 (2H, d, J 6.8 Hz, ArH); C (101 MHz, CD3OD) 
35.4 (CH2), 39.3 (CH2), 55.9 (CH3), 57.8 (CH), 59.5 (CH), 66.9 (CH), 115.6 (2  CH), 
128.6 (C), 130.2 (2  CH), 162.2 (C), 170.4 (C); m/z (EI) 251.1156 (M+. C13H17NO4 
requires 251.1158), 234 (19%), 206 (100), 179 (28), 163 (74), 135 (62). 
 
(2S,4R,6R)-4-Hydroxy-6-(naphthalen-2-yl)piperidine-2-carboxylic acid hydrochloride 
 
 
 
Methyl (2S,4R,6R)-4-hydroxy-6-(naphthalen-2-yl)piperidine-2-carboxylate (285a) (61 mg, 
0.21 mmol) was dissolved in 6 M hydrochloric acid (5 mL) and heated to 100 C for 48 h. 
The mixture was cooled and concentrated under reduced pressure to afford a white solid, 
which was azetroped with acetone then dried under reduced pressure to afford the desired 
product (46 mg, 70%) as a white solid and a 17:1 syn:anti mixture of diastereomers. p. 
203–205 Cmax (neat)/cm
–1 
3327 (NH/OH), 2951 (CH), 1744 (CO), 1622, 1410, 1213; 
[]D
27
 +10.1
 
(c 1.1, MeOH); H (400 MHz, CD3OD) 1.82–1.90 (1H, m, 3-HH), 2.04–2.12 
(1H, m, 5-HH), 2.39–2.41 (1H, m, 5-HH), 2.67–2.70 (1H, m, 3-HH), 4.17–4.23 (1H, m, 4-
H), 4.37 (1H, dd, J 13.1, 2.6 Hz, 2-H), 4.64 (1H, dd, J 12.7, 1.9 Hz, 6-H), 7.54–7.58 (2H, 
m, ArH), 7.66 (1H, dd, J 8.5, 1.4 Hz, ArH), 7.91 (1H, dd, J 6.1, 3.4 Hz, ArH), 7.95 (1H, 
dd, J 6.1, 3.4 Hz, ArH), 7.99 (1H, d, J 8.5 Hz, ArH), 8.07 (1H, s, ArH); C (101 MHz, 
CD3OD) 35.5 (CH2), 39.6 (CH2), 58.0 (CH), 60.1 (CH), 66.9 (CH), 125.6 (CH), 128.0 
(CH), 128.3 (CH), 128.3 (CH), 128.9 (CH), 129.3 (CH), 130.3 (CH), 134.2 (C), 134.7 (C), 
135.1 (C), 170.4 (C); m/z (EI) 271.1205 (M
+
. C16H17NO3 requires 271.1208), 226 (100%), 
205 (41), 183 (46), 155 (54), 128 (23).   
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N-tert-Butoxycarbonyl-2-oxopiperidine
102
 
 
 
 
To a solution of piperidin-2-one (1.00 g, 10.1 mmol) in dichloromethane (100 mL) was 
added triethylamine (2.92 mL, 21.2 mmol), 4-dimethylaminopyridine (0.25 g, 2.00 mmol) 
and di-tert-butyl dicarbonate (4.40 g, 20.2 mmol). The mixture was stirred for 48 h then 
washed with 1 M hydrochloric acid solution (20 mL). The aqueous layer was extracted 
with dichloromethane (20 mL), the organic layers were combined then washed with 
saturated sodium hydrogencarbonate solution (20 mL) and brine (20 mL). The organic 
layer was dried (MgSO4), filtered and concentrated under reduced pressure to afford an 
orange oil. Flash column chromatography (petroleum ether/ethyl acetate 4:1) afforded N-
tert-butoxycarbonyl-2-oxopiperidine (1.51 g, 75%) as a colourless oil. NMR data consitent 
with literature.
102
 max (neat)/cm
–1 
2977 (CH), 1769 (CO), 1708 (CO), 1287, 1246, 1136; H 
(400 MHz, CDCl3) 1.55 (9H, s, OtBu), 1.81–1.87 (4H, m, 4-H2 and 5-H2), 2.51–2.54 (2H, 
m, 3-H2), 3.65–3.69 (2H, m, 6-H2); C (101 MHz, CDCl3) 20.5 (CH2), 22.8 (CH2), 28.0 (3 
 CH3), 34.9 (CH2), 46.3 (CH2), 82.9 (C), 152.8 (C), 171.3 (C); m/z (CI) 100 
(MH
+C5H9O2), 71 (31%). 
 
N-tert-Butoxycarbonyl-Z-[(trifluoromethyl)sulfonyloxy]-1,4,5,6-tetrahydropyridine
89
 
 
 
 
To a solution of 1 M lithium hexamethyldisilazide (750 L, 0.75 mol) in tetrahydrofuran 
(30 mL) at –78 C was added a solution of N-tert-butoxycarbonyl-2-oxopiperidine (301) 
(100 mg, 0.50 mmol) in tetrahydrofuran (10 mL). The mixture was stirred for 1 h, then a 
solution of N-(5-chloro-2-pyridyl)bis(trifluoromethanesulfonimide) (493 mg, 1.25 mmol) 
in tetrahydrofuran (10 mL) was added and the mixture was stirred for 2 h. The mixture was 
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warmed to room temperature and 10% wt. sodium hydroxide solution (20 mL) was added. 
The aqueous phase was separated and extracted with diethyl ether (2  20 mL). The 
organic phases were combined, washed with brine (2  20 mL), dried (MgSO4), filtered 
and concentrated under reduced pressure to yield an orange solid. Flash column 
chromatography (petroleum ether/ethyl acetate 9:1 with 1% triethylamine) afforded N-tert-
butoxycarbonyl-Z-[(trifluoromethyl)sulfonyloxy]-1,4,5,6-tetrahydropyridine (134 mg, 
80%) as a colourless oil. NMR data consistent with literature.
89
 max (neat)/cm
–1 
2982 (CH), 
1721 (CO), 1682 (C=C), 1420, 1331, 1204, 1138; H (400 MHz, CDCl3) 1.52 (9H, s, 
OtBu), 1.75–1.81 (2H, m, 5-H2), 2.29 (2H, td, J 6.8, 4.0 Hz, 4-H2), 3.61–3.64 (2H, m, 6-
H2), 5.31 (1H, t, J 4.0 Hz, 3-H); C (101 MHz, CDCl3) 22.2 (CH2), 22.4 (CH2), 28.0 (3  
CH3), 45.5 (CH2), 82.8 (C), 107.1 (CH), 118.4 (q, J 318 Hz, C), 140.2 (C), 152.7 (C); m/z 
(EI) 231 (M
+C5H9O2+H), 158 (82%), 149 (63), 101 (42). 
 
tert-Butyl-6-(1-hydroxybutyl)-3,4-dihydropyridine-1(2H)-carboxylate 
 
 
 
A solution of nickel chloride (0.8 mg, 6 mol) and chromium chloride (223 mg, 1.81 
mmol) in degassed dimethylformamide (15 mL) was stirred for 0.25 h, to which was added 
butyraldehyde (163 L, 1.81 mmol) and a solution of N-tert-butoxycarbonyl-Z-
[(trifluoromethyl)sulfonyloxy]-1,4,5,6-tetrahydropyridine (302) (100 mg, 0.30 mmol) in 
degassed dimethylformamide (10 mL). The mixture was stirred for 18 h then cooled to 0 
C, diluted with diethyl ether (20 mL) and quenched with 1% triethylamine in water (10 
mL). The organic phase was separated and the aqueous phase extracted with diethyl ether 
(3  15 mL). The combined organic phases were washed with water (2  15 mL) and brine 
(15 mL), then dried (MgSO4), filtered and concentrated under reduced pressure to yield a 
colourless oil. Flash column chromatography (petroleum ether/ethyl acetate 19:1 to 4:1) 
afforded tert-butyl-6-(1-hydroxybutyl)-3,4-dihydropyridine-1(2H)-carboxylate (51 mg, 
66%) as a colourless oil. max (neat)/cm
–1 
3417 (OH), 2932 (CH), 1682 (C=C), 1366, 1250, 
1157; H (400 MHz, CDCl3) 0.94 (3H, t, J 7.3 Hz, 4’-H3), 1.24–1.67 (4H, m, 2’-H2 and 3’-
H2), 1.52 (9H, s, OtBu), 1.73–1.86 (2H, m, 5-H2), 2.13–2.18 (2H, m, 4-H2), 3.17–3.22 (1H, 
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m, 6-HH), 3.78–3.83 (1H, m, 6-HH), 4.10–4.15 (1H, m, 1’-H), 5.44 (1H, t, J 3.8 Hz, 3-H); 
C (101 MHz, CDCl3) 14.1 (CH3), 19.5 (CH2), 22.9 (CH2), 23.3 (CH2), 28.3 (3  CH3), 
37.1 (CH2), 45.6 (CH2), 74.2 (CH), 81.2 (C), 116.5 (CH), 142.0 (C), 154.7 (C); m/z (CI) 
182 (M
+C4H9O), 165 (19%), 113 (24). 
 
tert-Butyl-6-[(4-fluorophenyl)(hydroxy)methyl]-3,4-dihydropyridine-1(2H)-
carboxylate 
 
 
 
A solution of nickel chloride (0.8 mg, 6 mol) and chromium chloride (223 mg, 1.81 
mmol) in degassed dimethylformamide (15 mL) was stirred for 0.25 h, to which was added 
4-fluorobenzaldehyde (194 L, 1.81 mmol) and a solution of N-tert-butoxycarbonyl-Z-
[(trifluoromethyl)sulfonyloxy]-1,4,5,6-tetrahydropyridine (302) (100 mg, 0.30 mmol) in 
degassed dimethylformamide (10 mL). The mixture was stirred for 18 h then cooled to 0 
C, diluted with diethyl ether (20 mL) and quenched with 1% triethylamine in water (10 
mL). The organic phase was separated and the aqueous phase extracted with diethyl ether 
(3  15 mL). The combined organic phases were washed with water (2  15 mL) and brine 
(15 mL), then dried (MgSO4), filtered and concentrated under reduced pressure to yield a 
colourless oil. Flash column chromatography (petroleum ether/ethyl acetate 19:1 to 4:1) 
afforded tert-butyl-6-[(4-fluorophenyl)(hydroxy)methyl]-3,4-dihydropyridine-1(2H)-
carboxylate (66 mg, 71%) as a colourless oil. max (neat)/cm
–1 
3381 (OH), 2932 (CH), 1680 
(CO), 1507, 1393, 1367; H (400 MHz, CDCl3) 1.33 (9H, s, OtBu), 1.73–1.88 (2H, m, 5-
H2), 2.18–2.22 (2H, m, 4-H2), 2.98–3.03 (1H, m, 6-HH), 3.82 (1H, dt, J 12.7, 4.0 Hz, 6-
HH), 5.33 (1H, d, J 9.4 Hz, 1’-H), 5.51 (1H, t, J 3.7 Hz, 3-H), 6.12 (1H, br s, OH), 6.96–
7.01 (2H, m, ArH), 7.29–7.33 (2H, m, ArH); C (101 MHz, CDCl3) 23.0 (CH2), 23.0 
(CH2), 28.0 (3  CH3), 45.6 (CH2), 75.6 (CH), 81.4 (C), 114.4 (CH), 114.6 (CH), 118.6 
(CH), 128.6 (CH), 128.7 (CH), 138.0 (C), 141.2 (C), 154.2 (C), 161.7 (d, J 244.2 Hz, C); 
m/z (CI) 308.1664 (MH
+
. C17H23FNO3 requires 308.1662), 290 (100%), 276 (33), 235 
(100), 207 (66), 190 (32). 
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1-(4-Fluorophenyl)-1,5,6,7-tetrahydro[1,3]-oxazolo[3,4-a]pyridin-3-one 
 
 
 
To a solution of 60% wt. sodium hydride (10 mg, 0.26 mmol) in tetrahydrofuran (5 mL) 
was added tert-butyl-6-[(4-fluorophenyl)(hydroxy)methyl]-3,4-dihydropyridine-1(2H)-
carboxylate (309) (40 mg, 0.13 mmol). The mixture was heated to 65 C for 0.75 h then 
allyl bromide (34 L, 0.39 mmol) was added and the mixture stirred for a further 2.25 h. 
The reaction mixture was cooled to room temperature then quenched with ice. The mixture 
was concentrated under reduced pressure and the residue extracted with diethyl ether (3  
15 mL). The combined organic layers were dried (MgSO4), filtered and concentrated under 
reduced pressure to yield a yellow oil. Flash column chromatography (petroleum 
ether/ethyl acetate 19:1 to 3:1) afforded 1-(4-fluorophenyl)-1,5,6,7-tetrahydro[1,3]-
oxazolo[3,4-a]pyridin-3-one (20 mg, 66%) as a yellow oil. max (neat)/cm
–1 
2942 (CH), 
1761 (CO), 1697 (C=C), 1512, 1366, 1229; H (400 MHz, CDCl3) 1.72–1.86 (2H, m, 6-
H2), 2.03–2.09 (2H, m, 7-H2), 3.54 (2H, t, J 5.9 Hz, 5-H2), 4.53 (1H, td, J 4.1, 2.1 Hz, 8-
H2), 5.81–5.82 (1H, m, 1-H), 6.99–7.05 (2H, m, ArH), 7.25–7.30 (2H, m, ArH); C (101 
MHz, CDCl3) 20.2 (CH2), 20.7 (CH2), 40.0 (CH2), 78.7 (CH), 96.6 (CH), 115.8 (CH), 
116.0 (CH), 128.9 (CH), 129.0 (CH), 133.1 (C), 136.9 (C), 155.4 (C), 163.2 (d, J 248.4 Hz, 
C); m/z (EI) 233.0856 (M
+
. C13H12FNO2 requires 233.0852), 188 (67%), 148 (32), 123 
(84), 95 (48). 
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